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INTRODUCTION - HISTORY AND BACKGROUND 
A. Atherosclerosis: Pathogenesis and Etiology 
The World Health Organization (1) defined atheroscle­
rosis as "a variable combination of changes of the intima 
of arteries consisting of the focal accumulation of lipids, 
complex carbohydrates, blood and blood products, fibrous 
tissue and calcium deposits and associated with medial 
changes." Thus, the ma jor characteristic aspect of the 
disease is thickening of the arterial walls caused by de­
position of various lipid substances. Both human and 
animal, and experimental atherosclerosis have been studied 
and described for many years (2, J), however, only in the 
last twenty years have experimental techniques made pos­
sible detailed pathological and biochemical descriptions 
of the atherosclerotic lesion and its development. 
The consequences of atherosclerosis may be extremely 
severe since it contributes to or aggravates several other 
diseased states. Atherosclerotic disease is an almost 
universal affliction and its occurrence and intensity in­
crease with increasing age of the victim. The ma jor 
results of the disease include possible bursting of the 
artery walls, proliferation of arterial tissues causing 
blockage of the artery or the induction of clotting which 
may interfere with or stop normal blood flow (4). Addi­
tionally, narrowing of the arterial lumen may cause an 
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ischemic reduction of blood flow to an organ or an occlud­
ing plaque may become dislodged and later become trapped 
in a vessel or artery causing myocardial or cerebral 
infarct (5), The time required to develop such a condition 
is measured in years or decades but the resulting accident 
which may lead to death takes place over a period of 
seconds. Often, death due to atherosclerosis is premature 
since at the time of death the unaffected bodily organs 
are usually functioning well and could have been expected 
to continue to do so for several more years (4). There­
fore, a cure or at least an inhibition which would retard 
the progress of this disease would be expected to increase 
the life expectancy of the victim. 
In the large elastic arteries atherosclerosis appears 
to begin as a focus where the innermost layers of the 
artery wall exhibit indications of damage followed by 
growth and repair of the tissue (4). The repair processes 
usually include cell proliferation and the production of 
new fibrous tissue, This very early lesion does not 
contain abnormal quantities of lipids. 
Soon after the initiating event the first ma jor type 
of lesion, the fatty streak, begins to develop. This is 
a flat intimal lesion which stains with the lipid stain 
Sudan IV and causes very little obstruction of blood flow 
(5), The predominant cell in the lesion is the modified 
smooth muscle cell, which is elongated, has a central 
nucleus, and contains longitudinally arranged myofilaments 
3 
in the cytoplasm (6). In human fatty streaks fat droplets 
begin to accumulate in these smooth muscle cells to such 
an extent that the cell becomes filled with lipid and is 
called a foam cell (4, 7), Most of the lipid enters through 
junctions between the endothelial cells or, perhaps, by 
pinocytosis (8). Esterified cholesterol is the major and 
triglycerides are the minor component of these lipids. 
As the accumulation of fat in this lesion continues 
more foam cells appear. This process continues until some 
foam cells in the center of the lesion die, perhaps from 
anoxia. The intima and inner media of the aorta obtain 
oxygen by means of diffusion from the lumen (6). Any 
factor which causes interference with oxygen diffusion 
(such as proliferation of cells or accumulation of lipid) 
may inhibit respiration of the foam cells. It is there­
fore reasonable to suggest that continued lipid deposition 
may contribute to oxygen starvation of the cells in the 
developing lesion, resulting in death and necrosis of the 
cells. This is supported by the observation that hypoxia 
increases susceptibility to atherosclerosis while high 
oxygen tension appears to protect against the process (6). 
The lipid released from dying foam cells begins devel­
opment of fibrous plaques, the second major type of 
atherosclerotic lesion. This is a firm lesion which con­
tains a fat base covered by a layer of fibrous connective 
tissue (5), Since this is a raised lesion it may cause 
some obstruction of blood flow. The lipid portion which 
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is released from foam cells contains amorphous cholesterol, 
some cholesterol crystals, triglycerides, phospholipids, 
and steroids (4). The cells around this deposit are 
irritated by the cellular lipid debris and respond by pro­
liferation to form a thick, fibrous cover over the lesion. 
The extracellular fat may be phagocytized by macrophages, 
which may also develop into foam cells by the continued 
uptake of fat. If these cells do not or are not able to 
migrate away from the lesion they may disintegrate and 
contribute their contents to the lipid deposit. The 
fibrous plaque spreads down into the artery wall destroying 
the elastic lamella until the entire media has been trans­
formed into a lipid paste. As this process continues 
cellular debris from destruction of arterial structural 
cells contributes to the growing plaque. This lesion is 
capable of growth which is so extensive that it may break 
through the outer adventitial vascular coat. 
The final stage of plaque development consists of the 
appearance of insoluble calcium deposits (4, 5) which 
occur throughout the plaque and contribute to hardening of 
the lesion. This phase may be accompanied by vascular­
ization by a system of capillaries, which may be an 
attempt to provide nutrition for any cells remaining alive. 
At this stage of development the lesion has caused no 
ma jor compromise of vessel functions. The destructive 
phase begins when a piece of the plaque becomes dislodged 
from the site of the lesion. The dislodged portion of 
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plaque may be carried away by the blood stream and become 
trapped in a narrow vessel. This contributes to occlusive 
damage. The gap remaining in the lesion after loss of a 
portion of plaque may become filled with blood and form a 
clot . . Continuation of ulceration in this manner may lead 
to hemorrhage (4). The artery wall may become so weakened 
that it bulges outwards. The resulting aneurysm is a 
serious complication since it is capable of either pressing 
on an ad jacent organ or rupturing. Rupture of the artery 
occurs most often if the vessel passes through soft or 
yielding tissue, such as the brain, and is enhanced by 
high blood pressure. 
Another serious atherosclerotic complication is 
thrombosis, which appears to occur more often in athero­
sclerotic than in normal arteries and more often in 
individuals with high blood lipids and hypertension. 
Although the mechanism of thrombus formation related to 
atherosclerosis is not well known, microscopic cracks in 
the surface of plaques may initiate its development (4). 
Study of atherosclerosis and its complications is 
hampered by the lack of a readily available, suitable 
experimental model for the disease. Atherosclerosis in 
man, the ob ject of most concern with respect to the disease, 
can be studied only after death since the observation of 
arterial interiors cannot readily be repeated with the same 
sub ject. However, observation of man does provide impor­
tant information concerning possible factors which 
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contribute to the disease. Problems associated with the 
choice of a suitable experimental animal are centered on 
differences in the disease process between the animal model 
and man. In most cases the conditions required for devel­
opment of atherosclerosis in an experimental animal are 
too different from those apparently necessary for spon­
taneous development in man, or the lesion itself is con­
sidered too different from the lesion found in man (9) , 
Perhaps the best available model is the nonhuman primate; 
some species of monkey develop atherosclerosis spontane­
ously with.aging as well as by feeding lipid rich diets 
which are similar to the diets related to the disease in 
man (9), However, the necessary facilities for housing 
and caring for primates and the extended periods of lipid 
feeding required to develop the disease often make it 
impossible to use this animal as an experimental model. 
Perhaps because of the ease of inducing lesions and the 
reproducibility of these lesions, the rabbit has been the 
major experimental animal studied. Thus, muc·h of the 
experimental data related to atherosclerosis in man has 
been derived from observation of rabbits as well as rats 
and may therefore be considered circumstantial evidence or 
proof by analogy, However, the overwhelming nature of 
this data provides some support for its fidelity. 
There are several theories which attempt to explain 
the mechanism by which athe.rosclerotic lesions are ini ti­
ated. The single unifying feature of the various theories 
7 
is the experimental fact that the lesion is composed of 
lipid material of uncertain origin. One of the theories 
with much support is the filtration theory. Very simply 
stated this theory explains that arterial lesions are de­
rived from filtration of plasma components into the arterial 
wall (10-12). The initiating event for this infiltration 
of lipid is thought to be some irritation or injury to the 
arterial intima. Accumulating lipids and lipoproteins are 
irritants and they provoke a proliferation reaction by the 
arterial tissues (4, 11) which results in a fatty metamor­
phosis of the intimal cells, ending in disintegration. 
This is based upon the fact that most vessel walls do not 
have a vascular system, and therefore the metabolic needs 
of the wall are supplied by continuous diffusion of fluid 
from the lumen to adventitial lymphatic channels. When 
the blood lipids reach high levels, some of the largest 
lipids and lipoproteins are not able to pass completely 
through the artery wall and they begin to accumulate causing 
a proliferative response by the arterial wall. Support for 
this theory is derived from the observation that human 
populations with abnormally high concentrations of blood 
lipids exhibit a higher occurrence of atherosclerosis 
than populations with lower blood lipid concentrations. 
Further, high blood lipid levels in animals are known to 
induce atherosclerotic lesions similar to those found in 
man. 
Recent support for the filtration theory is the work 
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of Colton et al. (1J) who studied ultrafiltration of 
lipoproteins through synthetic membranes. These workers 
found that ultrafiltration of solutions containing low and 
very low density lipoproteins was accompanied by the for­
mation of a lipoprotein layer on the membrane, a phenom­
enon known as concentration polarization. It was proposed 
that concentration polarization may be the major control­
ling factor for the movement of lipoproteins into arterial 
walls. Low density lipoprotein concentrations are im­
portant in coronary heart disease as well as atherosclerosis 
and these results suggest that low density lipoprotein 
transport into arterial walls would be favored by increased 
concentration polarization under conditions of high con­
centrations of low density lipoprotein relative to very low 
density lipoprotein. 
Zilversmit (14), however, has shown that simple fil­
tration may not be the sole governing factor. Study of 
rabbit aorta lesions induced by high cholesterol diets 
showed that the accumulated cholesterol in the lesions was 
derived from circulating blood. The kinetic studies of 
lipid influx and accumulation suggested that, rather than 
being governed by simple filtration and retention, there 
was a gradual increase of permeability of the artery wall 
which promotes influx and retention of serum lipoprotein 
and cholesterol. This evidence indicated that the fil­
tration of lipid material into arterial walls was enhanced 
by permeability changes of the wall itself and provided 
further support for the basic mechanism of filtration 
theory, 
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An interesting variation of lipid filtration theory 
has been suggested by the work of Constantinides (4, 12) 
who has emphasized the importance of injury to the arterial 
wall. These experiments showed that arterial walls which 
have been either chemically or physically injured exhibit 
faster lipid deposition at lower blood lipid levels than 
uninjured arteries. Furthermore, in jury alone did not 
appear to lead to atherosclerotic lesions, but in the 
presence of elevated blood lipid levels lesion development 
was rapid. Agents capable of arterial injury include free 
fatty acids, desoxycholate, and phosphatidyl ethanolamine 
when infused directly into the arterial lumen. 
The injury modification of the lipid filtration theory 
maintains that under normal conditions small molecules 
such as oxygen, water, electrolytes, sugars, and free fatty 
acids readily cross the endothelium and that large mole­
cules do not (12), After arterial in jury the endothelial 
junctions become so widened that the entire plasma with its 
lipoproteins may enter the wall and begin the lipid 
accumulation process. In this context in jury includes 
necrosis and sloughing off of cells and may be caused by 
anoxia, amines, and high concentrations of lipids. Other 
investigators have also found evidence for the entrance of 
plasma into the arterial wall through endothelial 
junctions (15), 
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When in jured artery wall is exposed to lipemia, ath­
erGmata may form either at the center or margins of the 
in jury site (4). Atheromata developed from the center of 
an in jury site are indistinguishable from early human fatty 
streaks. If these lesions are allowed to grow they develop 
into plaques which are also indistinguishable from those 
found in the human disease. Those plaques which develop 
from the marginal areas of injury sites grow into foam 
cells. 
The thrombogenic theory differs considerably from the 
filtration theory in explaining the origin of atheroscle­
rotic disease. The thrombogenic theory maintains that 
atherosclerotic plaques are initiated by flat or mural 
microscopic thrombi on the surface of arterial walls. It 
is postulated by this theory (11) that in the circulation 
fibrin is constantly formed and degraded by fibrinolysis. 
When the rate of fibrin formation exceeds that of fibri­
nolysis the excess fibrin becomes deposited on an artery 
wall and initiates formation of a thrombus. Initiation of 
the true plaque takes place when the thrombus is incor­
porated into the arterial wall by overgrowth of epithelial 
and vascular cells (4). 
The most serious deficiency of the thrombogenic theory 
is its inability to account for the formation of fatty dots 
and streaks which are presumably the earliest gross 
expressions of the atherosclerotic process (11). The 
theory requires all early lesions to be in the form of 
11 
muFal thrombi deposited on normal arterial wall tissue 
(12). Thrombi observed in human atherosclerotic aorta 
appear to take an intermediate position in development of 
the lesion since they are usually found on the atheroscle­
rotic wall with thick fibrous caps or on thick fibrous 
arterial walls. Additionally, the thrombogenic theory does 
not provide for transitional forms between the early mural 
thrombus and the plaque stages of development. Thus, it 
appears that thrombi make a much more important contri­
bution to growth and development of atherosclerotic lesions 
than to their initiation. 
Each of the ma jor theories concerning initiation and 
development of atherosclerotic lesions accounts for a vast 
body of experimental observation. However, each theory 
contains deficiencies in its explanation of experimental 
data. Similarly, each contains common principles or con­
cepts which relate it to the others. Atherosclerosis and 
its complications provide a problem of such a complex 
nature that no single theory can be expected to account 
for all its aspects at this time. Therefore, rather than 
attempt to formulate comprehensive theories it is probably 
more productive to consider the process as the result of 
several factors acting in concert to produce the observed 
disease state, Several of these factors are apparently 
unrelated and require further study to clarify their 
respective contributions. 
Several factors have been shown to be correlated with 
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the incidence of atherosclerosis and on this basis they are 
said to contribute to or predispose an individual to the 
disease more so than if a particular factor were absent. 
Many of these contributing or risk factors are involved 
with or are part of common daily practices. Because of 
interrelationships among some of these factors and the 
habitual nature of others they have often been collectively 
referred to as the effect of "life style'' on disease de­
velopment. Among the more important contributing factors 
are blood cholesterol and triglyceride levels (5, 16, 17), 
hypertension, diabetes and cigarette smoking (5, 17), and 
exercise (18, 19), Although they probably do not contri­
bute to the disease directly, age and sex have been shown 
to be highly correlated with its occurrence; atherosclero­
sis is more prevalent in advanced age and is very rare in 
premenopausal women. 
The incidence of atherosclerosis has risen very 
sharply since the beginning of the twentieth century. This 
is not an indication that the disease is new because evidence 
of it has been found in Egyptian mummies over three 
thousand years old. The increased observation of athero­
sclerotic events since the turn of the century is probably 
due to the use of chemotherapeutic agents (20). The preva­
lence of infectious diseases, especially tuberculosis, in 
the early years of this century caused death at an early 
age. Because serious complications associated with 
atherosclerosis do not occur until late in life the many 
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victims of death by infectious diseases did not live long 
enough to become susceptible to atherosclerotic conditions. 
The advent of chemotherapy removed infectious disease as 
a ma jor cause of death and drastically increased life span 
allowing much larger segments of the population to live 
long enough to become victims of atherosclerotic diseases. 
In addition, more ac�urate documentation of the cause of 
death during this century has increased the awareness of 
atherosclerosis. 
Thyroid function has been proposed to be an important 
factor in the development of atherosclerosis; thyroid 
deficiency enhances atherosclerosis and thyroid adminis­
tration delays the disease in experimental animals (20). 
In an attempt to determine if this relationship is valid 
in humans, Barnes (20) studied 70, 000 autopsies performed 
in Graz, Austria. This region of the world exhibited an 
extremely high incidence of goiter until iodized salt was 
introduced in 1963, The autopsies indicated a strong 
positive correlation between thyroid deficiency and oc­
currence of atherosclerosis. This suggested that premature 
death from coronary disease might be prevented by thyroid 
treatment. Thus� after administering thyroid therapy to 
1569 patients for approximately six years only four new 
cases of coronary disease were observed, whereas 72 were 
expected from comparing the experimental group with a 
control group matched for age, sex, hypertension, and 
hypereholesterolemia (20). It should be noted that this 
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apparent 94% protection against atherosclerotic complication 
of coronary disease was associated only with thyroid therapy 
since there were no reported changes in diet, smoking, or 
exercise patterns. 
Physical activity may play an important role in the 
development of atherosclerosis. In a study of Irish born 
brothers, one of whom lived in Ireland, the other in Boston, 
Brown et al. (18) were able to examine the effect of nu­
trition on atherosclerosis. The choice of brothers elimi­
nated both hereditary and racial differences among the 
sub jects and placed the emphasis of the study on nutrition 
and mode of living. With very few exceptions trends of 
food consumption in Ireland and Boston were very similar; 
although the Ireland brothers consumed J700-4JOO calories 
per day while the Boston brothers consumed only approx­
imately JOOO calories per day. In light of the similar 
nutritional conditions in the two experimental groups, the 
U. S. death rate for atherosclerotic and myocardial disease 
was JOO more per one hundred thousand than that observed in 
Ireland (using 1950 statistics). Furthermore, the death 
rate increased the longer an Irish family had lived in this 
country. Since the Irish brothers consumed more calories 
but weighed less than their Boston brothers it was con­
cluded that the Irish brothers were more physically active 
and stored fewer calories as fat. Thus, it was suggested 
that the quantity and general quality of food intake was 
less important when a large proportion of calories consumed 
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were expended by physical activity (18). This study indi­
cated the importance of exercise in prevention of athero­
sclerotic development. 
A possible physiological explanation of the apparent 
protection afforded by exercise is the observation of 
anoxia in the arterial wall. It has been observed (19) 
that the activity of certain enzymes in the human aorta 
decreases with advancing age and increasing severity of 
atherosclerosis, the loss being most severe in the middle 
media. This observation has led Adams et al. (19) to pro­
pose that the loss of enzyme activity may be due to anoxia. 
Since lipids enter the intima from the lumen and move 
outward, anoxia of enzyme systems responsible for trans­
port or metabolism of these lipids may cause them to 
accumulate at the site of entry and therefore contribute 
to an atheromatous lipid deposit. It also seems reasonable 
that the reverse process could take place, that is, the 
accumulation of lipids by any of the previously discussed 
mechanisms could contribute to anoxia which, in turn, con­
tributes to further lipid deposition. Thus, it is tempting 
to suggest that physical exercise may prevent anoxia of 
the affected enzyme systems and therefore make lipid accu­
mulation an unfavorable process. 
Smoking is also a risk factor for atherosclerosis (17) 
and may be related to anoxia. Decreased oxygen supply 
caused by vasoconstriction and decreased oxygen carrying 
capacity of the blood due to increased carbon monoxide 
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levels could contribute to the effects of anoxia. 
Turbulence of blood flow has also been implicated in 
the genesis of atherosclerosis; however, the validity of 
this hypothesis is in doubt. The stenosis or arterial 
constriction used to study this effect is accompanied by 
increased blood pressure proximal to and turbulent blood 
flow behind the constriction. It is therefore uncertain 
if the relationships between arterial stenosis and athero­
sclerotic lesions are due to hypertension or to turbulent 
blood flow. Aars and Solberg (21) were able to cause a 
stenotic constriction of the middle ascending aorta of 
rabbits in such a manner that distal turbulence of the 
blood flow was produced without proximal hypertension. 
Development of atherosclerotic lesions in these animals by 
cholesterol feeding showed that the stenosis did not 
influence the location or extent of lesions. These data 
indicate the absence of a relationship between turbulent 
blood flow and the development of lesions, and indirectly 
support the view that hypertension is an important con­
tributing factor. 
Triglycerides are also frequently observed constituents 
of atherosclerotic plaques. An increase of the circulating 
triglyceride levels, even though cholesterol levels may be 
considered normal, is a condition predisposing to athero­
sclerosis (16). Both cholesterol and the triglycerides 
are important contributors to lesion development. For a 
given cholesterol level, coronary disease increases with 
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triglyceride concentration in the blood; similarly, for a 
given triglyceride level incidence of these diseases in­
creases with cholesterol concentration (16). Therefore, 
high cholesterol and high triglyceride levels in the blood 
are both independent risk factors for atherosclerosis. 
The most important contributing factor for athero­
sclerosis is the concentration of lipids, especially 
cholesterol, in the blood. Of all the lipids found in the 
blood and plaques, cholesterol is probably the most strongly 
implicated lipid in atherogenesis. A sixteen year follow­
up study of the Framingham study (17) found that of the 
5209 adults examined the serum cholesterol level was one 
of the highest correlating factors in development of 
atherosclerotic diseases. The high correlation between 
serum cholesterol levels and atherosclerosis is diagnos­
tically valid only when comparing geographically or 
racially distinct populations and not when comparing 
individuals within those populations (5), This fact is 
illustrated by the wide variation in the extent of lesions 
in individuals from homogeneous subgroups. 
Serum cholesterol levels have been correlated with 
the occurrence of atherosclerosis in a vast number of 
studies (22); however, the circumstantial nature of this 
correlation is often noted by the investigator. Similarly, 
a logical step in the treatment of a disease is removal of 
the causative factors. In the case of atherosclerosis, 
since there is no absolute proof that cholesterol causes 
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the disease, some investigators feel that therapy by re­
moval of this tentative causative factor would only 
probably be beneficial but, at least, would not be harmful 
(23-25), This apparent confusion can be interpreted as 
another illustration of the complexity of atherosclerosis 
and that many factors acting together contribute to the 
development of the disease. Because of the large body of 
experimental evidence, cholesterol can indeed be considered 
to be intimately involved with atherosclerosis and its 
removal may very well prove to be beneficial. 
The correlation between cholesterol and atherosclerosis 
is an old one; early investigators (26) used cholesterol 
feeding to study the pathogenesis of the disease in rab­
bits. Cholesterol is known to accumulate in human arteries 
and its deposition is a process which requires extended 
periods of time. The lipid composition of early lesions 
is very similar to that of blood plasma (24), suggesting 
that lipids found in these lesions are derived from the 
blood. As growth progresses the amount of cholesterol in 
the plaque increases until, in the late stages, it is the 
ma jor constituent. This is further indirect evidence that 
lowering serum cholesterol levels should inhibit athero­
genesis. 
A smaller body of evidence exists which indicates no 
relationship between cholesterol and atherosclerosis. In 
an attempt to surmount the problem of not being able to 
examine the human aorta before death Land� and Sperry (27) 
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studied serum cholesterol levels and the severity of 
atherosclerosis in victims of sudden accidents. Their 
graphical results showed no correlation between serum 
cholesterol levels and severity of the disease at autopsy. 
Similarly, a more recent study (28) showed that when the 
expected positive correlation with age was removed there 
was no significant relationship between lesion severity 
and cholesterol levels. Thus, there appears to be a 
positive correlation between serum cholesterol levels and 
the incidence and severity of atherosclerosis; although, as 
shown, there is not complete agreement on this matter. 
B. Cholesterol Biosynthesis 
The biosynthesis of cholesterol is a very complex 
process of which most tissues are capable but which occurs 
most actively in the liver. The biochemical building unit 
for this synthesis is acetyl coenzyme A (acetyl CoA) 
which, through the series of initial reactions (Figure 1) 
is converted to the key intermediate mevalonic acid. This 
early portion of the entire biosynthetic sequence is most 
important to the present work. Following its production 
mevalonic acid is successively phosphorylated by ATP to 
afford 5-pyrophospho-J-phosphomevalonic acid (Figure 2). 
This compound decarboxylates and loses the J-phosphate 
function to form 3-isopentenyl pyrophosphate which, in 
turn, is rapidly isomerized to dimethylallyl pyrophosphate. 
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Figure 1: The biosynthetic conversion of Acetyl CoA to 
Mevalonic Acid. 
Nucleophilic attack on dimethylallyl pyrophosphate by another 
molecule of 3-isopentenyl pyrophosphate leads to geranyl 
pyrophosphate, The repetition of this reaction with the 
new substrate leads to farnesyl pyrophosphate, two mole­
cules of which couple to form squalene. The elegantly 
designed cyclization of squalene-2, J-epoxide (Figure J) 
leads to lanosterol which, after several steps, is con­
verted to cholesterol, 
By following the conversion of 1-c14-acetate to cho­
lesterol in fractionated rat liver homogenates, Bucher and 
McGarrahan (29) found that neither mitochondrial, micro­
somal, nor supernatant fractions alone were capable of 
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cholesterol synthesis. Combination of the three fractions 
showed that most of the synthesis took place in the micro­
some, both in vitro and in vivo. Further localization of 
this process has shown that both the rough and smooth 
endoplasmic reticulum are capable of cholesterol synthesis 
from 2-c 14-mevalonic acid (JO). 
The earliest chemical studies of cholesterol biosyn­
thesis were performed by Bloch and co-workers (31-34, 36). 
Initial attempts to determine the biological precursors 
of cholesterol consisted of feeding mice deuterioacetate, 
isolation of the biosynthesized cholesterol, and deter­
mination of its isotopic content by mass spectrometric 
techniques (31, 32). The first important result from 
these experiments was that deuterium labeled sodium acetate 
was incorporated into cholesterol. In addition, the 
quantity of label found made it possible to rule out fatty 
acids as the biosynthetic intermediates in sterol biosyn­
thesis (31). These results stimulated fuFther feeding 
experiments using various deuterium labeled acid salts. 
Of all the salts examined only acetate was capable of par­
ticipation in cholesterol biosynthesis (32), and since the 
function of acetate as a metabolic intermediate was not 
then known this provided the first clue that coupling of 
very small molecules might be involved. 
Conclusive proof that acetate is indeed the basic 
biosynthetic unit awaited double labeling experiments. 
Thus, incubation of rat liver slices with sodium acetate 
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labeled with deuterium in the methyl group and c1 J in the 
carboxyl position showed that the isolated cholesterol 
c0ntained both isotopes (JJ) . Having established the basic 
unit, Bloch and his co-workers turned their attention to 
the quantitative aspects of label incorporation. Using 
variations of the original double label technique it was 
found that of the 27 carbon atoms of cholesterol, 15 were 
derived from the methyl group and 12 from the carboxyl 
carbon of acetate (J4). Finally, using combinations of 
both chemical degradation and radioisotopic labeling ex­
periments, the work of several investigators led to the 
elucidation of the origin of most of the carbon atoms in 
cholesterol (J4-J6) as illustrated in Figure 4. 
HO 
Figure 4: The chemical origin of carbon atoms of choles­
terol (J4-J6) . Positions numbered 1, J, 5, 17, 
18, 19, 21, 22, 24, 26, and 27 are derived from 
the methyl group of acetate ; those numbered 2, 
4, 6, 10, 20, 2J, and 25 are derived from the 
acetate carboxyl carbon . 
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The above discussion of cholesterol biosynthesis is 
breif and emphasizes the early historical work and elu­
cidation of the important function of acetate. The re­
maining aspects, especially conversion of lanosterol to 
cholesterol, are very complex and all of the mechanistic 
details are not clearly known. Since the present work is 
primarily concerned with the early portion of the biosyn­
thetic pathway the remaining discussion will be centered 
on those reactions which mediate the conversion of acetate 
to mevalonic acid, 
The early work of Bloch and other investigators 
indicates that the basic precursor or building block is 
acetate. Successful use of sodium acetate in incorporation 
studies using tissue slices or homogenates as well as in 
vivo experiments naturally led to the conclusion that 
acetate is probably employed without further biochemical 
modification. However, it is now known that intermediates 
occurring early in cholesterol biosynthesis (up to and in­
cluding J-hydroxy-J-methylglutaryl CoA) are all present 
as thioesters with coenzyme A (CoA). Light was shed on the 
question of whether coenzyme A is neces sary in repeated 
use of acetate during cholesterol biosynthesis by the 
development of truly coenzyme A deficient rats (37), 
Correlation of reduced plasma and liver cholesterol levels 
with this deficiency proved the requirement for this co­
factor in the conversion of acetate to cholesterol. This 
was the first indication that in acetate feeding experiments 
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the initial step of the synthetic pathway consists of the 
conversion of acetate · to its CoA thioester. Under normal 
physiological conditions this step may not be required 
since the end product of other metab0lic sequences (such 
as glycolysis and fatty acid degradation) is acetyl CoA. 
Further investigation of the incorporation of labeled 
compounds as p0ssible cholesterol precursors indicated the 
role of a four carbon compound. In vivo and in vitro ex­
periments established that this compound was acetoacetate 
(39, 41); it therefore appeared that the second step of 
cholesterol biosynthesis was the condensation of two mole­
cules of acetyl CoA to provide acetoacetyl CoA. Con­
siderable confusion was caused by radioactivity incor­
poration data since some results were interpreted to show 
that prior to incorporation acetoacetate was equilibrated 
with a two carbon pool or was degraded in some other 
manner (38). This conclusion was based on the observation 
that incorporation of radioactive acetoacetate afforded 
cholesterol in which the labeled atoms were found widely 
distributed over the entire molecule. Similarly, the then 
unknown reversible nature of acetate condensation to form 
acetoacetate probably contributed to the confusion by 
causing label dilution. Other investigators (39) found 
direct incorporation of intact acetoacetate with no prior 
degradation to two carbon units. 
The earliest indication of the nature of the third 
step of cholesterol biosynthesis was related to the 
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erroneous proposal that dimethylacrylic acid was a choles­
terol precursor. This compound was probably obtained as 
an artifact by oxidation of dimethylallyl pyrophosphate 
during isolation. Rudney (40) proposed that this compound 
could be the result of dehydration and decarboxylation of 
µ-hydroxy- j3 -methylglutaric acid (HMG) as shown in equa­
tion 1 .  To test this proposal HMG was biosynthesized from 
2-c 14-acetate using a rat liver homogenate. Degradation 
and measurement of radioactivity from each carbon atom of 
the isolated compound showed very high c 14 content at C2, 
C4, and C6. The most important aspect of this study was 
that HMG was correctly envisioned as being the product of 
the condensation of acetyl CoA and acetoacetate. Further 
investigation of this reaction showed that the four carbon 
precursor to HMG was definitely acetoacetyl CoA rather 
than free acetoacetate (41). 
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(eq. 1) 
Additional study of the reaction (42, 43) revealed 
several important features of this step of cholesterol 
biosynthesis. The stoichiometry of the reaction showed 
that one mole of acetyl C0A reacts with one mole of 
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acetoacetyl CoA to provide a single mole of both /3 -
hydroxy- � -methylglutaryl CoA (HMG CoA) and free coenzyme A 
and that the dicoenzyme A thioester was not formed. Ap­
propriate labeling experiments (equation 2) conclusively 
proved that the free coenzyme A produced in the reaction 
was derived exclusively from acetyl CoA and not from 
acetoacetyl CoA. One of the most important aspects of this 
investigation was the proposal, based on structural simi­
larities, that HMG CoA may be biochemically reduced to 
mevalonic acid which is an excellent substrate for choles­
terol biosynthesis. It should be emphasized that up to 
and including biosynthesis of acetoacetyl CoA the pathways 
for fatty acid and isoprenoid syntheses are identical. 
Synthesis of HMG CoA is the branch point between these 
pathways. The biochemical alternatives for utilization 
of HMG CoA are either cleavage to acetoacetyl CoA and 
acetate and subsequent reentry into the two carbon pool or 
reduction to mevalonic acid and continuation into sterol 
biosynthesis. 
+ 
CoA-SH 
(eq. 2) 
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Important contributions to the elucidation of the final 
and most important early step of cholesterol biosynthesis 
were made by Ferguson et al. (44). Using yeast extracts 
these investigators established that HMG CoA was indeed 
reduced to mevalonic acid. These experiments completed the 
elucidation of the ectrly sequence of reactions of choles­
terol biosynthesis as shown in equation J. This reduction 
( eq. J) 
requires NADPH and the enzyme which mediates the reaction, 
HMG CoA reductase, accepts only the CoA thioester of HMG 
as substrate, not the free acid. · Using 1-c 14-HMG CoA as 
substrate the resulting mevalonic acid was converted to its 
barium salt and pyrolyzed. The carbon dioxide generated 
from the resulting barium carbonate was found to be highly 
radioactive. This result proves that the free carboxyl 
group of HMG CoA remains intact during the reduction and 
therefore, the reduction takes place at the thioester car­
bonyl group (equation 4). Incubation of the enzyme with 
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2-c14 -mevalonic acid, NADP, oxidized glutathione, and free 
coenzyme A showed that the reaction is not reversible. The 
irreversibility of this reduction has important conse­
quences on the entire series of reactions in early choles­
terol biosynthesis. Thus, once the two carbon precursors 
have reached the mevalonic acid step they are not capable 
of reentering the two carbon pool and their progress 
toward incorporation into sterols becomes committed. 
+ 2 NADPH > 
+ 
CoA-SH 
( eq. 4) 
Since the reduction of HMG CoA to mevalonic acid 
requires two moles of NADPH it is tempting to suggest that 
the reaction takes place via an aldehyde intermediate. 
However, addition of unlabeled mevaldic acid or semicar­
bazide in an attempt to trap the aldehyde does not sig­
nificantly lower incorporation of label into mevalonic acid 
(44, 62). Therefore, if an aldehyde is an intermediate in 
the reaction, it may occur as an enzyme bound species such 
as the thiohemiacetal of coenzyme A (44). 
Concurrent with these studies Knauss and co-workers 
were investigating mammalian sterol synthesis. They in­
dependently discovered a rat liver preparation which was 
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capable of synthesizing mevalonic acid from acetate (45), 
These results established that the early steps of cholester­
ol biosynthesis in this mammalian system were identical 
with those shown in equation 3, 
These early steps, from acetyl CoA to mevalonic acid, 
are very important with respect to the overall control of 
�holesterol biosynthesis. Many of the physiological 
phenomena known to alter sterol synthesis exert their 
effects at one of these steps. In this regard, HMG CoA 
reductase is the ma jor site of action for several of these 
metabolic controls (46). For example, the detergent 
Triton WR 1339 and X-irradiation exert a stimulating effect 
on the conversion of acetyl CoA to both squalene and cho­
lesterol but a much less noticable effect on the conversion 
of mevalonic acid to squalene or cholesterol (47) , This 
suggests that the effect is exerted on one of the early 
reactions prior to mevalonic acid. The opposite is seen 
in response to fasting or cholesterol feeding. Conversion 
of acetate to cholesterol is greatly reduced, but conver­
sion of mevalonic acid to cholesterol is altered to a much 
smaller degree. Again, the early steps -are implicated as 
the sites of action. Studies of this type are the basis of 
suggestions that the early reactions of cholesterol bio­
synthesis include the rate limiting step for the entire 
pathway and that this step is probably located between 
acetoacetyl CoA and mevalonic acid (46, 47), Since these 
early hypotheses it has been found that the true rate 
limiting step is the reduction of HMG CoA to mevalonic 
acid. 
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In the first example above, X-irradiation of rats 
causes an increase of cholesterol biosynthesis in the 
treated animals. The mechanism of this response is not 
clearly defined. It is known, however, that this process 
is not under adrenal control since adrenalectomized rats 
respond to X-irradiation just as do control animals (48). 
Similarly, hypophysectomy does not appear to alter the 
response although the results are not clear since the less 
drastic increase of cholesterol biosynthesis in these 
animals could have been due to poor condition of the animal, 
lack of pituitary hormones, or both (48). 
The case of cholesterol feeding is more clearly illus­
trated. It is known that feeding cholesterol (0,5% of the 
diet) is associated with a marked decrease of cholesterol­
genesis as measured by the incorporation of radioactive 
acetate (49), This is a specific inhibition of cholesterol 
synthesis and not a general metabolic liver depression 
since fatty acid and carbon dioxide production do not 
change. Decreased cholesterol biosynthesis in response to 
cholesterol feeding is complemented by an increase of bio­
synthesis after biliary obstruction or diversion (50, 51). 
Because cycloheximide administration blocks this rise in 
synthetic activity it i£ probable that changes in protein 
synthesis rates are responsible for these effects (50). 
By analogy this also indicates that cholesterol itself is 
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not a direct enzyme inhibitor. 
As with cholesterol feeding, biliary diversion is a 
specific stimulus since the conversion of radioactive 
acetate to carbon dioxide or to fatty acids is not signifi­
cantly changed. Restoration of the enterohepatic circu­
lation of biliary diverted animals by intravenous or intra­
je junal infusion of taurocholic acid, glycocholic acid, 
combinations of taurocholic and taurodeoxycholic acids, 
cholic acid, deoxycholic acid, or phospholipids did not 
block the increase of hepatic cholesterol biosynthesis 
observed after biliary diversion (51), Blockage of in­
testinal lymph flow, which caused interruption of the 
enterolymphatic circulation of endogenous cholesterol, also 
caused an increase of hepatic cholesterol biosynthesis 
which was quantitatively identical to that observed in re­
sponse to biliary diversion. It was therefore concluded 
that the bile acids have no direct control on hepatic 
cholesterolgenesis; rather, they control absorption of 
cholesterol which is the true mediator (51). Localization 
of this effect shows that enhancement of HMG CoA reductase 
is the mechanism by which the observed increase of sterol 
synthesis takes place. Thus, cholesterol appears to par­
ticipate in control of cholesterol biosyrithesis by acting 
at the level of HMG CoA reductase; although, as discussed 
below, it does not interact directly with the enzyme. 
Further support for this regulatory mechanism was provided 
by the work of Bricker et al. (53-), Using a desmosterol 
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suppres sion technique it was shown that cholesterol feeding 
caused an effective in vivo regulation of cholesterol bio­
synthesis. This control has also been found to operate in 
man (52) where the activity of the control system varied 
with the levels of dietary cholesterol. 
In feeding experiments of relatively short duration 
the site of control which dietary cholesterol exerts upon 
cholesterol biosynthesis is located at the reduction 
mediated by HMG CoA reductase. However, there are some in­
dications that under varied feeding conditions other less 
important control sites . may exist after the formation of 
mevalonic acid. These additional sites are difficult to 
detect under normal experimental conditions but if choles­
terol feeding is extended for long periods of time they 
become significant. By appropriate labeling experiments 
it has been shown that conversion of squalene is unaltered 
but conversion of farnesyl pyrophosphate to cholesterol is 
reduced to 3 to 35% of control values in response to long 
term cholesterol feeding of rats (54). This site alone 
does not account for the magnitude of depression of con­
version of mevalonic acid to chelesterol observed in these 
same experiments. This suggests that an additional c0ntrol 
site exists between mevalonic acid and farnesyl pyrophos­
phate. The contribution of these postmevalonate sites in­
creases with feeding times until complete suppression of 
cholesterol biosynthesis is achieved. Thus, HMG CoA re­
ductase is the most important regulatory site under normal 
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an1 most exper imental c ond i t i ons bn t when bloc kade ap­
proac hes c omple teness  as w i th c hole s terol  feeding f or ex­
tended peri ods, the postmevaloni c  ac i d  s i tes  become impor­
tan t. 
Although most stud i e s  of c hole s terol biosynthe s i s  are 
c onc erned N i th hepatic synthes i s, extrahepat j c  t i s sues are 
als o c apable of c hole s te rol synthe s i s. In a c omprehen:o ive 
s tudy of  synthe s i s  and c ontrol c harac teristics  of various 
rat tissues, D ie tschy and Siperste in ( 5 5 )  found that, per 
gram of ti s s ue, the l iv e r, ileum, transverse c olon, an:l 
s tomac h  exhibited the highe s t  rate s of inc orporat i on of  
ace tate into  chole s terol. The  es ophagus, j e j unum, te s t i s , 
lung, adrenal, s k in, k idney, duodenum, and spleen showed 
2-10% of the hepatic rate while smooth mu scle, skele tal 
musc le, and brain had inc orpora t i on rates  le ss  that 0. 6% 
that of hepatic  rat8 s. Even th ough s everal organs are 
c apable of cholesterol  b i osynthe s i s  the ability to c ontrol 
the proc e s s  by chole s terol feed ing rema i ns unique to the 
liver. In the s e  exper iments ( 5 5 )  chole s terol  feed ing was 
of s ix weeks duration. Add i ti onally, fas ting for 48 hours 
depre s sed chole sterol  bi osynthe s is only in the liver. 
Of all  the extrahepati c  tis sues, chole s terol b i osyn­
the s i s  has been most thoroughly examined in the gas tro­
inte s t inal trac t. The rate of synthe s i s  varies  along the 
length of the inte s tine, w i th ileum being highest  ( 56, 57 ), 
This  variation extend s  to  the type of t issue examine d ;  
intestinal smoo th muscle and villi are poor in chole s te rol 
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biosynthetic ability and the highest rates are observed in 
crypt cells. As in liver t biliary diversion increases 
intestinal sterol synthesis but does not alter other syn­
thetic pathways. This effect has been attributed to in­
creased activity of HMG CoA reductase (56) , Restoration 
of the enterohepatic circulation by infusion of whole bile 
or solutions of bile acids suppresses synthesis; however, 
infusion of bile from which bile acids have been removed 
shows no effect. This data can be interpreted to suggest 
that either bile acids participate in control of intestinal 
cholesterol biosynthesis or that bile acids play a secondary 
role by facilitating entry of cholesterol into the intes­
tinal mucosa where it is the true mediator of regulation. 
The second possibility may be doubtful because cholesterol 
feeding appears to have no effect on intestinal synthesis 
(56). Similarly, intestinal synthesis is relatively re­
sistant to the effects of fasting seen in hepatic tissue. 
It can be concluded that although liver and intestinal 
sterol synthesis are physiologically controlled, the mecha­
nisms of control in the two tissues are considerably dif­
ferent. 
In man, the results are similar to those found in 
animals (58). The ma jor difference is that fasting for 48 
hours reduces human intestinal cholesterol biosynthesis to 
50% of control values (58). As with animals, cholesterol 
feeding does not inhibit cholesterol biosynthesis in human 
intestine. The gastrointestinal tract is therefore 
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probably an important s ourc e of endogenous choles terol 
under c onditions of high chole sterol intake when liver 
synthe sis is drastically decreased. Finally , when the 
enterohepatic circulation is interrup ted human inte s tinal 
tissue responds with an inc reased level of chole ste rol 
biosynthe sis. This  sugge sts that man has a bile acid as­
sociated c ontrol sys tem similar to the one obs erved in 
animals ( 58 ) • 
Hepatic c hole s terol biosynthe sis exhibits a diurnal 
rhythm with its maximum occurring around midnight at levels 
four to ten times  higher than the minimum, which oc curs at 
noon (59-61 ) .  Although feeding bile acids inhibits bio­
synthe s i s  in rats there is no c orrelation between the di­
urnal rhythm and hepatic bile acid c oncentrations. There­
fore , the bile acids are not the cause of the rhy thm ( 59), 
Rather, sinc e HMG CoA  red'Jc tas e has been previously im­
plicated as a ma j or c ontrol point for the ent ire sequenc e 
of reac tions and s i nce  fac tors capable of altering the 
rhythm appear to  ac t through this enzyme it is be lieved 
that the c yclic c hange s are due to similar change s at  the 
enzyme level. Adminis tration of cycloheximide abolishes  
the  diurnal ris e d uring the dark period ( 59 ) ,  This is c on­
clusive evidenc e that the nature of this rhythm is based  on 
enzyme synth� sis rather than on c hange s  of enzyme ac tivity . 
Several experimental manipulations have effe c ts on 
this c yclic rhy thm and ,  in vitro, the se  can be  studied by 
measuring the inc orporation of radioac tive ac e tyl CoA or 
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mevalonic acid into cholesterol. Fasting , which normally 
reduces the magnitude of hepatic cholesterol synthesis , 
also effects the diurnal rhythm of synthesis (60). Under 
fasting conditions the cyclic nature of the rhythm is main­
tained but the magnitude of synthesis is greatly reduced. 
Also, after bilateral adrenalectomy the rhythm is abolished , 
but the level of cholesterol synthesis is maintained at 
approximately the maximum level observed during dark 
periods. Adrenalectomy does not alter the biosynthesis of 
cholesterol as measured from mevalonic acid incorporation. 
This once again implicates the important enzyme HMG CoA 
reductase as being the site through which synthetic al­
terations are expressed (60). The regulator of this 
rhythm cannot be norepinephrine since this agent causes 
enhancement of cholesterol synthesis. A possible regulator 
is corticosterone (60) since this adrenal steroid also is 
sub ject to diurnal variations . The diurnal variations of 
corticosterone levels can be abolished by cutting the af­
ferent nerves to the medial basal hypothalamus or by main­
taining the experimental animal in continuous light. If 
corticosterone is the mediator it would be expected that 
these condition� would destroy diurnal variations of 
cholesterol synthesis also. A similar experiment will be 
discussed in a later section. 
The diurnal rhythm has also been demonstrated under in 
vivo conditions in rat intestinal tissue as well as in 
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liver (61). Reversal of light-dark cycles is accompanied 
by a similar phase shift of the biosynthetic rhythm. Since 
rats consume most of their daily food ration during dark 
periods and the 2, 5 hours preceding onset of darkness it is 
suggested that the true stimulus of the rhythm is food 
consumption rather than darkness. To test this suggestion 
rats were allowed access to food under normal lighting .con­
ditions (lights on 6 AM to 6 PM) only from 9 AM to 1 PM. 
This caused a shift of daily rhythm and the new maximum of 
cholesterol synthesis activity occurred at 6 PM (61). 
C .  /J -Hydroxy-,8 -methylglutaryl Coenzyme A Reductase 
Early definitive studies on the reduction of HMG CoA 
were done by Durr and Rudney -(62). Using an enzyme prepa­
ration derived from bakers • yeast these workers described 
properties of the reaction which were later found to be in 
common with the same enzyme derived from mammalian sources. 
As the enzyme was purified beyond a specific activity of 
1. 0 it became increasingly unstable and required thiol 
protecting reagents to maintain the activity. This, as 
well as the subsequent finding that reduction of the sub­
strate was completely inhibited by Q-hydroxymercuribenzoate, 
demonstrated the enzymatic requirement for free thiol 
groups. For each mole of HMG CoA reduced two moles of 
NADPH are consumed and one mole each of free coenzyme A and 
mevalenic acid are produced (equation 4). The enzyme was 
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found to be specific for HMG C0A only and acyl transfer or 
phosphate transfer were n0t required. Additionally, the 
reaction was demonstrated to take place irreversibly. The 
irreversible nature of the reaction is reasonable since 
thioester bonds are high energy sources and their reductive 
cleavage is accompanied by free energy loss of approxi­
mately 8200 calories per mole (62). The monodirectional 
biosynthetic flow at this reaction is one of the early 
stimuli which suggested the regulatory nature of this 
enzyme, Finally, the continuing question of the identity 
of possible reaction intermediates was opened by this in­
vestigation (62). Inability to inhibit reduction of HMG 
CoA by the addition of semicarbazide or the semicarbazone 
of mevaldic acid was evidence that the free aldehyde was 
not involved as an intermediate. 
Reduction of HMG CoA to mevalonic acid is the first 
unique step as well as the rate limiting step of polyiso­
prenoid biosynthesis (6J, 64). Early suggestions that this 
unique position is related to possible regulatory functions 
of the enzyme were made by Siperstein (64). Using incor­
poration experiments and a rat liver preparation it was 
shown that chelesterol feeding exerted its effects on this 
enzyme. Conversion of squalene to cholesterol or of meva­
l0nic acid t0 squalene were not depressed by cholesterol 
feeding and therefore it was reasoned that the site of syn­
thesis depression must be prior to mevalonic acid. 
Acetoacetyl CoA is a precursor for the synthesis of long 
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chain fatty acids as well as for cholesterol, Similarly, 
HMG CoA is a precursor not only of cholesterol but also 
of ketone bodies, acetoacetate and P -hydroxybutyric acid. 
Therefore, if cholesterol feeding exerts its effects at the 
conversion of acetate to acetyl CoA, acetyl CoA to aceto­
acetyl CoA, or of acetoacetyl CoA to HMG CoA a block of 
fatty acid and ketone body synthesis would be observed 
along with a block of cholesterol biosynthesis (Figure 5), 
Since cholesterol feeding is known to alter only choles­
terol biosynthesis it was concluded that the site of this 
action must be HMG CoA reductase (64). 
C O2 t 
Fatty Acids 
,8-Hydroxy 
Butyric Acid, 
Ketone Bodies 
Acetate < > Acetyl CoA E'<-"""">- Acetoacetyl CoA < > HMG CoA 
Figure 5: 
l 
Cholesterol �<'--�- Squalene E<'--�- Mevalonic Acid 
Alternate pathways for the early intermediates 
in cholesterol biosynthesis, after Siperstein 
( 64). 
The elegant efficiency of placing a regulatory site 
at this position is striking; synthesis of mevalonic acid 
is the first reaction subsequent to the final branching 
point for alternate pathways of these early intermediates. 
A regulatory site located closer to cholesterol would cause 
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unnecessary synthesis of intermediates and would create the 
problem of disposal of those intermediates. With the regu­
latory site located at mevalonic acid synthesis the latter 
problem does not exist since the earlier reactions are 
reversible and alternate synthetic pathways are available 
to the intermediates. On the other hand, if the regulatory 
site is located prior t0 mevalonic acid synthesis, the pro­
duction of other important metabolic products would be 
altered along with the normal regulation of cholesterol 
biosynthesis. 
Mammalian hepatic HMG CoA reductase is bound to the 
endoplasmic reticulum and therefore is found in microsomes 
on isolation, Centrifugal fractionation of rat liver micro­
somes has shown that the smooth and "smooth" smooth endo­
plasmic reticulum together contain the ma jority (81%) of 
enzyme activity while the rough membrane fraction accounts 
for only 14% of the activity (65), The observation of a 
small amount of enzyme activity in the polysome fraction 
is reasonable since this is the most probable site of 
enzyme synthesis, The subcellular localization of this 
reductase is important with respect ,to the location of 
HMG CoA condensing and cleavage enzymes. The latter two 
enzymes, which catalyze the forward and reverse reactions 
shown in equation 2, respectively, are located in rat liver 
mit0chondria (66), Since the cleavage enzyme is approxi­
mately ten times more active than the condensing enzyme it 
might appear that net cholesterol biosynthesis would be 
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considerably hampered, if not impossible. Compartmental­
ization of these enzymes explains why liver tissue is 
capable of overcoming this apparent anomaly. Being con­
fined to mitoch0ndria, the cleavage enzyme destroys only 
mitochondrial HMG C0A. Small amounts of condensing enzyme 
attached to microsomal membranes allows all of its product, 
as well as any HMG Co.A:"-which might leave the mitochondria, 
to be available to the reductase (66). Thus, it can be 
seen that because of this compartmentalization the earliest 
steps of cholesterol biosynthesis, where intermediates 
are employed in alternate pathways, take place in the 
mitochondria. The unique step, mevalonic acid synthesis, 
and reactions subsequent to it take place on the endo­
plasmic reticulum. 
Even though HMG CoA reductase is bound to the endo­
plasmic reticulum membranes the enzyme has been solubilized 
and refined to various degrees of purity (67-70) allowing 
study of several of its properties. The earliest suc­
cessful attempt at solubilization provided an acetone 
powder derived from rat liver (67) and was not an entirely 
satisfactory preparation. Using deoxycholate to remove 
the enzyme frem membranes Kawachi and Rudney (68) obtained 
a preparation from rat liver which allowed the determina­
tion of some physical and kinetic properties. The molecular 
weight of the purified enzyme was measured in the range 
217, 000 to 226, 000 and the previous report of a thiol 
requirement (62) for the enzyme was substantiated and 
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confirmed with this purified preparation. 
Recent success in solubilizing the reductase from rat 
liver microsomes illustrates the delicacy with which it 
must be handled. Taurocholic acid, pH change, presence or 
absence of salts, and quick freezing methods all proved 
unsuccessful in removing the enzyme from endoplasmic 
reticulum membranes (69). However, a slow freeze-thaw 
cycle (8-10°C per minute to -50°C) provided a soluble 
enzyme preparation containing 80% of the activity of the 
original rat liver microsomal pellet. Further purification 
of this preparation is possible by ammonium sulfate pre­
cipitation followed by agarose gel chromatography (69). 
Similarly, the most recent attempts also emphasize the 
delicate nature of the enzyme. Thus, incubation of rat 
liver microsomal pellets with potassium chloride solutiGns 
or suspension of a previously frozen pellet in glycerol 
provided active reductase preparations (70). These gentle 
conditions removed only approximately 25% of the micr0somal 
protein. Also, the electron microscopic appearance of 
microsomes after removal of the reductase showed that they 
remained intact throughout the procedure. This ease of 
removing the enzyme without either disrupting the membrane 
or apparently breaking covalent bonds indicated that the 
reductase was peripherally located on the surface of, 
rather than being an integral component of the microsomal 
membranes. This is in agreement with the observation that 
HMG C0A reductase is synthesized and destroyed in vivo much 
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faster than the remaining microsomal protein (93), 
As with most other chemical reactions which take place 
in living systems the reduction mediated by HMG CoA re­
ductase is stereospecific. Using HMG CoA and the hemithio­
acetal of mevaldic acid as substrate for the yeast enzyme, 
Dugan and Porter (71) demonstrated that only A-side, or 
(4R)-4-H3-NADPH, incorporated the tritium atom into mev­
alonic acid. If the two proton transfers involved in this 
reduction took place with opposite stereochemistry, that 
is, one transfer from the 4R side and one from the 4S side 
of NADPH, the maximum theoretical yield of 5-H3-mevalonic 
acid would be 50% , However, with HMG CoA as substrate 78% 
transfer of tritium was observed. Similarly, using the 
hemithioacetal of mevaldic acid as substrate showed a high 
transfer of the isotope. These data are conclusive evi­
dence that both proton transfers from NADPH take place 
stereospecifically and from the 4R side of the pyridine 
ring. Other investigators (72, 73) have confirmed this 
finding. Blattmann and Retey (72) found that the yeast 
enzyme acted stereospecifically with respect to CJ and C5 
of the substrate. In each case reduction of the monothio­
hemiacetals of (JRS)-mevaldate with coenzyme A and (JRS)­
mevaldate with (R)-pantetheine as well as (JRS)-mevaldate 
alone, using (4R)-4-H3-NADPH provided only (JR, 5S)-5-H3-
mevalonic acid (Figure 6). 
As discuss�g previousty, free mevaldic acid is probably 
not an intermediate in this reduction (44, 62). Beyond 
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this fact, the question of an intermediate for this two 
step reaction is clouded by conflicting experimental 
results. Brodie and Porter (74) were able to trap radio­
active mevaldic acid after incubating a rat liver microsomal 
preparation with 1 -c 14-acetate, however, the amount of 
mevaldic acid detected was not large enough to justify the 
suggestion of a free aldehyde intermediate. Therefore , it 
was proposed that HMG CoA is first reduced to an enzyme 
bound thiohemiacetal which is hydrolyzed to give enzyme 
bound mevaldic acid. This would explain the small amount 
of mevaldic acid detected as being a result of leakage from 
the surface of the enzyme. 
These data are in accord with the later experiments 
of Kirtley and Rudney (75), From kinetic studies with a 
yeast enzyme preparation these investigators found that 
mevalonic acid is an uncompetitive inhibitor with respect to 
NADPH. Uncompetitive inhibition by the product was in­
terpreted to mean that the product was bound to a different 
form of the enzyme from that which bound the substrate. A 
possible mechanism was proposed which involves an enzyme 
bound mevaldic acid (Figure 7), 
Retey and co-workers investigated the possibility of 
enzyme bound intermediates in the yeast system (76). 
Using radioactive coenzyme A it was found that the reductase 
did not participate in acyl exchange as illustrated in 
equation 5, This indicates that there is probably no 
transfer of HMG to a free SH group on the enzyme surface 
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HMG CoA + ESH < > ES-HMG + CoASH 
ES-HMG + NADPH + � <  > ES-MAL + NADP 
ES-MAL + NADPH + � < > ES-MVA + NADP 
ES-MVA > ESH + MVA 
Figure 7 :  Mechanism proposed by Kirtley and Rudney (75) 
illustrating enzyme bound mevaldic acid, E = 
enzyme, MAL = mevaldic acid, MVA = mevalonic 
acid. 
and, therefore, no formation of enzyme bound intermediates 
as proposed by Kirtley and Rudney (75) and by Brodie and 
Porter (74). This enzyme preparation did not reduce 
HMG-S-pantetheine, but (RS)-mevaldic acid-pantetheine hemi­
thioacetal was readily reduced almost as fast as normal 
substrate. This observation indicates that conversion of 
substrate to a hemithioacetal and reduction of this hemi­
thioacetal to mevalonic acid occur at two different sites 
on the enzyme surface. The first proposed site would be 
strictly specific for HMG CoA as substrate while the latter 
site would accept mevaldate CoA hemithioacetal. It is 
clear that further experiments are necessary to fully 
elucidate the true nature of possible intermediates in this 
reaction, and specifically, whether these two sites 
actually exist and, if so, whether they represent physically 
distinct regions of the enzyme, conformational changes 
taking place at the active site, or both. 
HMG CoA + 14 � 14 C -CoASH HMG-C -CoA + CoASH ( eq . 5) 
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The developmental pattern of HMG CoA reductase in rats 
has been studied by Rodwell et al, (77, 78). In general, 
enzyme activity rises very rapidly just prior to birth then 
sharply falls after birth to a level near that of adults. 
This level is maintained for eight days then declines pre­
cipitously. On the third day after weaning enzyme activity 
overshoots adult levels threefold and slowly declines until 
adult levels are reached in the second week after weaning. 
It is interesting to note that throughout development 
cholesterol synthesis parallels these variations in enzyme 
activity, indicating that the reductase is the rate deter­
mining step of cholesterol biosynthesis during development. 
The drastic fall of activity prior to weaning is not 
due to cholesterol in suckling milk. This was demonstrated 
by the observation that hepatic cholesterol levels change 
very little during suckling; both free and total hepatic 
cholesterol levels remain within ± 10% of adult levels 
throughout development (77), Premature weaning caused a 
rise in activity as did normal weaning and late weaning 
prevented this rise. Thus, it appears that the rise of 
activity associated with weaning is due to dietary changes 
which take place at weaning. 
Evidence for the presence of an inhibitor of the 
reductase in suckling rat liver was observed (77), In­
cubation of adult rat liver microsomal enzyme preparations 
with the 7, 000 x g and 50, 000 x g supernatant from suckling 
liver homogenates caused a 20% reduction of adult activity. 
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This depression was not observed with adult supernatant 
solutions. The inhibitor could be precipitated by am­
monium sulfate and was nondialyzable but has not been 
characterized. The initial rise of enzyme activity from 
the low suckling values to adult levels was not blocked by 
cycloheximide administration and therefore must be due to 
relief of an inhibition of the enzyme which takes place at 
weaning, rather than by alterations in protein synthesis. 
Thus, the developmental pattern of this enzyme seems to be 
controlled by dietary factors which appear to regulate 
enzyme synthesis as well as by an uncharacterized hepatic 
inhibitor of the reductase. 
Most of the previ0usly discussed factors which alter or 
regulate cholesterol biosynthesis have been shown to act 
by exerting their influence on HMG CoA reductase. As a 
body, this work provides proof of the important rate 
limiting and regulatory functions of this enzyme. Many of 
these studies have been approached by measuring changes in 
the degree of incorporation of one intermediate into another 
or into cholesterol itself in response to some physiological 
or experimental condition. A note of caution has been 
raised concerning this method (79) since it assumes that 
changes of incorporation rates directly reflect changes of 
rates of biosynthesis. 
Rates of incorporation of radioactivity into a spe­
cific product are not necessarily equal to rates of syn­
thesis of that product because of possible dilution of 
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the radioactive precursor by endogenously synthesized 
precursor . For example, using rat liver microsomes White 
and Rudney (79) found that the specific activity 0f labeled 
acetoacetate was only 16% of what it should have been if 
c14-acetyl CoA were the only precursor. This effect was due 
to formation of acetoacetate by endogenous synthesis and 
dilution of the labeled pool. These results cast doubt on 
experiments showing HMG CoA reductase to be the control 
point for cholesterol biosynthesis since this work is based 
on incorporation of labeled substrate into a product. 
Changes of incorporation into a product are an accurate 
measure of an alteration of the synthesis of that product 
only if the specific activity of the precursors remains 
unchanged. Thus, in the present case of cholesterol syn­
thesis when some experimental condition alters incorpo­
ration of acetyl CoA but not of mevalonic acid into cho­
lesterol the alternate explanation to considering HMG CoA 
reductase as a regulatory reaction is that unlabeled sub­
strate from endogenous sources may have entered the 
pathway. _prior to mevalonic acid. This would reduce the 
specific activity of precursors and therefore make it 
appear that synthesis has . been inhibited. If the experi­
mental condition enhanced fatty acid oxidation or gly­
colysis, the pool size and therefore the specific activity 
of acetyl CoA would change. 
Possible solutions to this problem include removal of 
endogenous substrate pools from the test system or using 
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such large quantities of radioactive substrate that 
endogenous contributions would be insignificant. The former 
solution is not feasible while the latter would be satis­
factory only for single step reactions and the high �on­
centrations of substrate necessary may inhibit other 
reactions. White and Rudney have solved this problem in a 
general manner by developing a method for the direct 
measurement of acetoacetate; pince this intermediate is 
related to both HMG CoA and mevalonic acid, the necessary 
specific activities could be calculated (79), Similarly, 
these investigators developed three systems for the direct 
assay of HMG CoA reductase as well as a method which 
cleanly separates and measures HMG and mevalonic acid. The 
results showed that for the early steps of cholesterol 
biosynthesis the tacit assumption of equality of label in­
corporation and synthesis rates was accurate; therefore 
previous experiments indicating the regulatory nature of 
the reductase remain valid. Thus, after unveiling this 
potentially serious problem White and Rudney (79) have 
provided a satisfactory general solution. 
Among all the experimental conditions used to study 
this enzyme, cholesterol feeding is perhaps the best known. 
As described previously, dietary cholesterol reduces choles­
terol biosynthesis and it has been found that this regu­
latory action takes place at the site of HMG CoA reductase 
(63, 78, 80-8J). The reductase is always the most important 
site of inhibition, but if cholesterol feeding is of 
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extended duration other sites also contribute to the 
overall blockade. The inhibition obtained by feeding cho­
lesterol is drastic; short periods provide 80-90% or more 
depression of cholesterol biosynthesis while extended 
feeding periods are associated with complete suppression of 
synthesis . 
Most evidence indicating that HMG CoA reductase is the 
true regulatory site for cholesterol biosynthesis is of 
an indirect nature. Siperstein and Fagan (81) developed 
gas chromatographic analytical techniques which allowed 
separation and measurement of HMG and mevalonic acid, As in 
other systems cholesterol feeding caused depressi�n of 
synthesis by more than 95% as measured from rat liver 
microsomes while there was no effect on the condensing 
enzyme. Direct measurement showed that HMG levels were 
normal , but mevalonic acid · 1evels were severely depressed 
in cholesterol fed animals. The depression of mevalonic 
acid levels was sufficient to account for the corresponding 
depression of cholesterol synthesis . These data substan­
tiate previous indirect evidence that the reductase is the 
site of action during cholesterol feeding and the analytical 
technique used makes this work the first direct observation 
of this fact. 
Using the computational technique (79) which avoids 
the assumption that incorporation rates are equal to syn­
thesis rates White and Rudney also showed that in rat liver 
microsome preparations cholesterol feeding caused depression 
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of reductase activity by more than 90% (83) , When a 
soluble system was used small degrees of depression of HMG 
CoA condensing enzyme were observed under cholesterol 
feeding conditions. This work agrees with the fact that 
the major effect is on HMG CoA reductase but also indicates 
that under conditions where substrate availability for the 
reductase is limiting the slight inhibition of condensing 
enzyme may become important. 
The mechanism of the clearly demonstrated lowering of 
HMG CoA reductase activity caused by dietary cholesterol 
has been the object of much investigation. Possible 
mechanisms include (78, 82): 1) direct inhibition of the 
enzyme, 2) allosteric inhibition of the enzyme, 3) changes 
of the rate of enzyme synthesis by interfering with mRNA 
synthesis, de stabilization of polysomes, or interference 
with incorporation of the completed enzyme into the endo­
plasmic reticulum, or 4) increasing the rate of disso­
ciation of the enzyme from the endoplasmic reticulum or 
enhancing the degradation rate of the enzyme, or both . 
The first possibility may be excluded since cholesterol 
or some other soluble compound does not act as a direct 
inhibitor (82) , This conclusion was derived from the 
observations that albumin or propylene glycol suspensions 
of cholesterol, as well as cholesterol rich low and very 
low density lipoproteins from livers of both normal and 
cholesterol fed animals did not alter reductase activity 
in vitro (78), Similarly, mixing experiments where liver 
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preparations from cholesterol fed animals were added to 
normal preparations showed no alterations of activity and 
therefore the absence of a soluble inhibitor, The second 
possible mechanism may also be excluded. Although the total 
activities of the enzyme derived from normal and cholesterol 
fed animals are vastly different their kinetic properties 
are so similar that the reductase cannot be an allosteric 
enzyme (78), It is therefore evident that dietary choles­
terol is not a true feedback inhibitor of cholesterol 
biosynthesis. 
The apparent inhibitory effect of cholesterol on HMG 
CoA reductase is actually one of altering the amount of 
enzyme rather than the activity of the reductase (78, 82). 
Experiments involving study of the diurnal rhythm of this 
enzyme indicate that dietary cholesterol acts to alter the 
rate of rise of enzyme synthesis while the normal rate of 
degradation is maintained. Thus, the true mechanism of 
dietary cholesterol on cholesterol biosynthesis is an un­
known effect which alters synthesis rates of HMG CoA 
reductase. 
As with cholesterol feeding, severe lowering of HMG 
CoA reductase levels is caused by fasting (6J, 78, 80, BJ), 
a physiological condition which is apparently opposite to 
that of cholesterol feeding. This effect is expressed at 
the reductase step and appears to be associated with changes 
of enzyme synthesis. The mechanism of this phenomenon is 
not understood, 
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The ma jor site at which the effects of cholesterol 
feeding and fasting are expressed is HMG CoA reductase. In 
an attempt to determine if other secondary regulatory 
sites exist Slakey et al. (84) studied the effects of fast­
ing and refeeding on the seven enzymes which mediate the 
conversion of HMG CoA to squalene. Sterol synthesis from 
C1 4  t t d c 1 4  1 · · -ace a e an -meva onic acid was depressed by fasting 
and rose in response to refeeding. For each enzyme examined 
except mevalonic kinase and phosphomevalonic kinase, the 
total activity fell during fasting; however, with respect 
to HMG CoA reductase the magnitude of these depressions was 
small. It was concluded that during most of the fasting 
and refeeding periods the overall rate of cholesterol bio­
synthesis was controlled by the amount of HMG CoA reductase. 
The time course for conversion of acetate to digitonin 
precipitable sterols was parallel to that of reductase 
activity ; and total activity of the reductase was considered 
sufficient to account for the observed rate of sterol syn­
thesis. This conclusion was based on studies of only the 
initial and final components of the entire sterol biosyn­
thetic pathway. Kinetic analysis indicated that the enzymes 
in this seven membered segment of the pathway are not co­
ordinately controlled and that the flux of material thr0ugh 
this portion of the pathway was not well explained by con­
sidering HMG CoA reductase as the sole regulatory step. 
Thus, it was concluded that there may be two additional 
regulatory sites between mevalonic acid and squalene. 
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This conclusion was in agreement with the work of Gould and 
Swyryd (54) who postulated the existence of two secondary 
regulatory sites between mevalonic acid and squalene. The 
additional sites detected by Slakey et al. (84) may be 
identical to those proposed by Gould and Swyryd and, like 
the latter, may become important only under certain con­
ditions. 
As previously discussed for cholesterol biosynthesis, 
with very little emphasis placed on the role of the rate 
limiting reaction, bile acids alter the conversion of 
acetate to cholesterol, their presence being associated 
with decreases and absence with increases. It has been 
shown that these effects are due to changes in the level 
of HMG CoA reductase (78, 85, 86) although the exact 
mediator of these changes is a sub ject of considerable dis­
agreement. Using rat liver microsomes Hamprecht et al. 
(85) showed that bile acids inhibited the reductase in vitro 
and taurochenodeoxycholate and taurodeoxycholate were the 
most efficient inhibitors. Since the total bile acid 
concentration in rat liver is only approximately O. J mM, 
in vitro inhibition of cholesterol biosynthesis by bile 
acids is probably not due to actual inhibition of the enzyme 
because the above experiments were done with concentrations 
of bile acids greater than the physiological concentration. 
Similarly, this inhibition was neither fully reversible nor 
fully irreversible, indicating that bile acids were not 
allosteric inhibitors of the reductase. Therefore, it was 
58 
proposed that in vitro effects of bile acids on this enzyme 
were due to a nonspecific detergent action on the membrane 
bound enzyme (85). In vivo experiments (85) indicated that 
bile acids altered synthesis of the enzyme and that their 
in vitro activity did not accurately reflect in vivo ac­
tivity. 
Two possibilities for the mechanism of bile acid in­
hibition of cholesterol biosynthesis were considered: The 
bile acids either altered synthesis, degradation, or both, 
of HMG CoA reductase or they enhanced absorption of choles­
terol which was the true mediator (86). When absorbed in 
the gut cholesterol must pass through the thoracic duct 
before reaching the liver. On the other hand, bile acids 
reach the liver directly after absorption via the portal 
vein. For these reasons, in rats with cannulated thoracic 
ducts cholesterol is eliminated after absorption and never 
reaches the liver. This allows the study of the effects 
of bile acids independent of any effects related to choles­
terol absorption. Cholic acid feeding of rats with this 
lymphatic diversion depressed hepatic HMG CoA reductase. 
Thus, Hamprecht et al. (86) believe that bile acids exert 
their effect on cholesterol biosynthesis by interfering 
with the synthesis of HMG CoA reductase. These results 
are in direct disagreement with the work of Weiss and 
Dietschy (51) who, by experiments with bile fistula rats, 
claim that bile acids alter cholesterol biosynthesis only 
by improving intestinal absorption of cholesterol. 
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As with many biochemical processes, hormones influence 
HMG CoA reductase but their effects have been studied to 
a much less comprehensive extent than dietary and drug 
effects. Thyroid hormones were found to alter reductase 
levels. Using isolated perfused rat liver, Gries et al. 
(87) studied the effects of these hormones on levels of the 
reductase as well as of other enzymes and discovered that 
the level of reductase present was a function of the con­
centration of thyroid hormone present. It was observed 
that after perfusion with DL-thyroxine, enzyme levels in­
creased and paralleled cholesterol biosynthesis. After 
thyroidectomy, HMG CoA reductase levels fell until activity 
was barely detectable; however, this activity could be re­
established by triiodothyronine. Similarly, with rat liver 
. 
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thyroid function of the test animal caused the reductase 
activity to be lowered to 42% of control values (88). 
Thyroidectomy caused a fall in reductase levels to 35% of 
normal levels, in agreement with the experiments of Gries 
et al, (87), Finally, hypothyroid animals were injected 
with 3, 3 ' , 5 ' -triiodothyronine, killed, and HMG CoA reduc­
tase activity was assayed in the livers. Until JO hours 
after injection reductase activity remained in the range 
typical of thyroidectomized animals. Thereafter, activity 
rose rapidly until 45 hours after injection when normal 
reductase activity was achieved and maintained for the 
remainder of the experiment. The JO hour latent period in 
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these experiments indicated that triiodothyronine was 
stimulating enzyme synthesis rather than having a direct 
effect on the enzyme itself (88). It is possible that this 
activity of thyroid hormones is due to their general stim­
ulation of metabolic functions, although later experiments 
show this to be unlikely. 
Another hormone which alters HMG CoA reductase 
activity is insulin. It has been recently demonstrated 
that rat liver microsomal reductase activity increased two 
to threefold with respect to controls after subcutaneous 
insulin administration (89) and diabetic rats exhibited 
an even larger increase of activity. For both the normal 
and diabetic animals, the observed increases of activity 
corresponded to increases of acetate incorporation into 
cholesterol. Glucagon, the physiological insulin antago­
nist, completely blocked these enhancements when admin­
istered two hours prior to insulin. These experiments 
are another case in which the effect of an experimental 
condition on HMG CoA reductase is believed to have been 
caused by increase of activity due to the stimulation of 
synthesis of new enzyme. In similar experiments it has 
been found that the reductase activity of alloxan diabetic 
rat liver microsomes is lower than the activity in healthy 
animals (90). As expected, insulin administration caused 
an increase of enzyme levels to the normal range. Contrary 
to the results of the previous example, Huber et al. 
observed an increase of activity in re sponse to glucagon 
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in jection (90). However, this effect was transient in 
nature and was followed by depression of activity to below 
control levels. The mechanisms of these recently reported 
effects are yet to be elucidated. 
Finally, it has been suggested that norepinephrine 
enhances HMG CoA reductase activity (91). Within twelve 
hours after norepinephrine in jection cholesterol biosyn­
thesis had doubled, as assayed in rat liver tissue slices. 
This increase was not a direct effect since addition of 
norepinephrine to a tissue slice incubation had no effect. 
Treatment with puromycin abolished this increase_but did 
not inhibit conversion of labeled mevalonic acid to cho­
lesterol. On this basis stimulation of enzyme synthesis 
was suggested as the mechanism of the norepinephrine 
effect. 
Very recent work has shown that addition of 3 ' , 5 ' ­
cyclic AMP to rat liver microsomes, liver cells, and 5, 000 
x g liver supernatant lowers the incorporation of acetate 
and acetyl CoA into cholesterol but does not alter the 
incorporation of mevalonic acid (92). Similarly, addition 
of ATP and Mg++ to rat liver microsome preparations was 
shown to lower reductase activity. However, if the micro­
somal pellet was washed three times with buffer the ability 
of ATP and magnesium ion to inhibit the reductase was lost. 
This indicated that some soluble agent with inhibitory 
capabilities was present. On investigation of the nature 
of this agent it was found that addition of 100, 000 x g 
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supernatant to washed microsomes restored the ability of 
ATP and magnesium ion to inhibit the enzyme. Th� inhib­
iting factor was found to be protein in nature since the 
reductase activity was also decreased by preincubation 
with material precipitated from 100 , 000 x g supernatant 
by ammonium sulfate. These experiments demonstrate the 
presence in rat liver cytosol of a protein, perhaps a 
kinase , which inhibits HMG CoA reductase activity. A 
possible mechanism for this inhibition may be an altera­
tion of the conformation of the reductase by interaction 
with this protein material. 
The previously discussed diurnal rhythm of cholesterol 
biosynthesis is caused by a diurnal rhythm of HMG CoA 
reductase (63 , 78). This cyclic variation of enzyme level 
has been intensively studied but there remain several 
aspects which are not clearly defined or agreed upon. 
Maximum reductase levels occur at approximately midnight 
while the minimum occurs close to noon (93) and the 
difference in activity between these two points is five to 
tenfold. Study of the fine structure of the rhythm shows 
that, in fact, there are two maxima occurring at midnight 
and 1 : 45 AM (94). There are several po£sible explanations 
for this pair of maxima. A labile enzyme degrading system 
could appear for short periods destroying a portion of the 
increased levels of reductase present (78). It is also 
possible that there exists a metabolically programed limit 
to enzyme levels and when this limit is exceeded cellular 
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controls act to decrease enzyme synthesis (78) , If this is 
true then it is reasonable to assume that both peaks are 
due to the same rise of enzyme synthesis. The decline 
of activity between these maxima would then be caused by a 
control overshoot and when the enzyme has reached low 
enough levels for the control system to stop functioning 
enzyme levels would begin to rise. It should be noted that 
these plausable explanations are speculative and their 
confirmation or disproval awaits further experimentation. 
Fasting is known to depress cholesterol biosynthesis 
and therefore might be expected to alter the diurnal 
rhythm. Hamprecht et al. (95) showed that in fasted rats 
the rhythm persists but at a much lower amplitude than in 
fed controls. This has been interpreted as evidence that 
the rhythm is not a response to eating habits of the 
animals. 
Several investigators have probed the mechanism and 
causative factors associated with the diurnal rhythm of 
this enzyme. One possible cause for the rhythm is changes 
in the rate of enzyme synthesis, degradation , or both , 
Measurement of formation and destruction constants for the 
reductase at various times during the cycle show that the 
breakdown constant changes very little but the formation 
constant increases seven to tenfold during the diurnal rise 
over that observed during diurnal fall (96). It therefore 
appears that the rhythm is due to increased enzyme syn­
thesis during the rise with almost constant degradation 
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rate s throughout the cycle . Other inve stigators have also 
implicated prote in synthes i s  as the ma j or rhythm c ontrolling 
fac tor . Under the assumption that amino acid inc orporation 
was a val id measure of protein synthes is , HJ -leuc ine in­
c orporation into the enzyme has been studied ( 6J , 97 ) ,  
Variation of radioac tivi ty in the isolated enzyme accu­
rate ly reflec ted the rise and fall of activity throughout 
the cycle . Increase of label  inc orporation precedes  the 
cyc l ic enzyme rises  by four to s ix hours and this  may be 
the time nec e ssary for prote in synthe s i s  to be re flec ted 
in enzyme levels . Higgins et  al . ( 97 )  c laim that the se  
data provide unequivocal evidence that the diurnal enzyme 
variation is due to an increased rate of enzyme synthe -
s i s  for s ix hours during cyclic rise followed by c omplete 
c e s sation of enzyme synthe s i s  for f ifteen hours during the 
cyclic decline . 
Additi onal evidenc e for the role of enzyme synthesis  
was provided by the work of  Edwards and Gould ( 93 ) . 
Following in j e c tion of rats with cyc loheximide , HMG C oA 
reduc tase activity always declined . If a degradatory 
prote in were the ac tual cause of the rhythm , cycloheximide 
administration would have inhibited its synthesis and re­
duc tase leve ls would have declined slower than normal . 
This was not observed and enzyme synthe sis  was onc e again 
implicated . Shapiro and Rodwe ll ' s  experiments are in 
c omplete disagreement with this hypothe sis  ( 98 ) . They 
found that cyc loheximide treatment caused a c omplete block 
of the normal diurnal rise of reductase levels; however, 
enzyme levels remained elevated after cycloheximide treat­
ment, indicating that the diurnal fall had also been 
blocked. These experiments are evidence that the diurnal 
rise is due to enzyme synthesis but that the fall is caused 
by synthesis of a degradatory protein rather than by ces­
sation of reductase synthesis. 
The relationship of feeding habits and light-dark 
cycles to the diurnal rhythm of this enzyme have been in­
vestigated. When the light-dark cycle under which experi­
mental animals were housed was shifted by twelve hours the 
diurnal enzyme rhythm also exhibited a twelve hour shift 
within seven days (99), maintaining peak activity in the 
dark phase. During this same period food consumption was 
also shifted into the new dark phase, obscuring whether 
light and dark cycles or feeding habits were important 
factors. Similarly, regardless of the magnitude of the 
shift in light-dark cycles, maximum enzyme levels were 
always observed very close to six hours after the onset of 
darkness (9J), however, since rats normally feed during 
darkness, food consumption always shifted also. Strong 
evidence for effects of food consumption was provided by 
experiments where feeding was restricted to the period 
8: JO AM to 10 1 JO AM (96). Under these conditions enzyme 
levels rose rapidly and peaked at approximately noon. 
Rats maintained in continuous light for nine days exhibited 
a diurnal rhythm of normal magnitude but the peak enzyme 
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levels occurred slightly later than normal and minimum 
levels were slightly higher than control (100), Similarly, 
rats kept in continuous darkness for nine days showed 
normal rhythm where peak enzyme levels occurred slightly 
earlier than normal. Examination of the rhythm in continu­
ous light conditions is the experiment suggested by 
Hickman et al, (60), and preservation of the rhythm under 
these conditions excludes corticosterone as a regulator of 
these cyclic variations. Finally, superior cervical 
ganglionectomy did not abolish reductase rhythm (100), in­
dicating lack of involvement of the pineal gland. 
Adrenalectomized rats have been shown to maintain 
normal diurnal rhythm of the reductase (101). This means 
that enzyme variations are not controlled by corticosterone, 
which is produced in the adrenal cortex, supporting the 
above results with continuous lighting, or by catechol­
amines, which are produced in the adrenal medulla. Con­
sidering the rate limiting nature of the reductase, this 
observation is contradictory to the experiments of Hickman 
et al. (60) who found that adrenalectomy abolished the 
diurnal rhythm of cholesterol biosynthesis but that the 
rate of biosynthesis was maintained at high levels. 
Clearly, an unknown factor appears to be related to both 
rhythms. Thus, in view of the contradictory nature of 
much of the evidence concerning diurnal variations, it 
appears that food consumption is a primary controlling 
factor but that other factors may also be involved. 
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Another aspect of the involvement of HMG CoA reductase 
with cholesterol synthesis and regulation is presented by 
hepatoma tissue. Numerous investigators have shown that 
cholesterol biosynthesis in several hepatomas does not 
respond to fasting and cholesterol feeding as do normal 
cells (63, 78, 102-106). This apparent los s  of regulation 
has been observed in several types of hepatomas in rat 
(102, 104, 105), mouse (102, 103, 106), and man (104). 
Early investiga�ions of this phenomenon were done by 
Siperstein and Fagan (102) who found that rat and mouse 
hepatomas synthesize cholesterol and that the site of 
dietary cholesterol effects, HMG CoA reductase, was indeed 
present and functioning. Their experiments showed that the 
absence of cholesterol biosynthesis regulation by dietary 
cholesterol was not caused by the rapid growth of tumor 
tissue, lack of HMG CoA reductase, or loss of the ability 
of tumor tissue to synthesize cholesterol; rather, it was 
concluded that the loss of regulation was due to mal­
functioning regulatory mechanisms. Later studies of 
kinetic properties of HMG CoA reductase isolated from both 
tumor cells and normal liver cells demonstrated that the 
tumor enzyme was not measurably different from the normal 
enzyme (103), It therefore appeared that failure of regu­
lation in hepatomas was due to the inability of dietary 
cholesterol to reach the site where it acts or to a defect 
in the regulatory system itself. In addition to the lack 
of control by dietary cholesterol or fasting, tumor tissue 
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exhibited no diurnal variations of cholesterol biosynthe­
sis (107). 
Attempts to experimentally define a defective regu­
latory system in these hepatomas may not be necessary since 
some investigators suggest the true defect to be inability 
of dietary cholesterol to enter hepatoma cells (63, 78, 106, 
108, 109). Using mouse liver slices and mouse liver 
homogenates, Sabine (108) studied the effects of bile acids 
on hepatomas 512JC and BW7756 and found that cholesterol 
biosynthesis was not affected in these hepatomas by removal 
of bile acids. However, in vitro addition of bile acids to 
cell free hepatoma preparations caused inhibition of tumor 
cholesterol biosynthesis as effectively as normal choles­
terol synthesis. On the other hand, addition of bile acids 
to whole cells exhibited inhibition in normal liver but 
not in hepatoma cells. The inescapable conclusion is that 
hepatomas do not exhibit regulation of cholesterol biosyn­
thesis because the regulating agent is not able to enter the 
cells. 
Finally, using label uptake experiments, Harry et al. 
(109) observed that administration of HJ-cholesterol to 
rats was followed by uptake of radioactivity into normal 
liver cells but not into Morris hepatoma 7787 cells. This 
provided clear evidence that the lack of cholesterol regu­
lation by tumor cells was due to the inability of choles­
terol to enter the cell, not to a regulatory system defect. 
The above discussion shows that cholesterol, its 
biosynthesis, and HMG CoA reductase play important roles 
in atherosclerotic diseases. In at least one case, famil­
ial hypercholesterolemia, HMG CoA reductase has been dem­
onstrated to be the most important, if not causative, 
disease factor (110). Familial hypercholesterolemia is an 
autosomal dominant trait which the heterozygote usually 
carries for JO to 60 years in an asymptomatic condition. 
Homozygotes for this gene develop (110) : 1) extremely high 
plasma cholesterol levels, often exceeding 800 mg per 100 
ml, 2) cutaneous planar xanthomas in early life, J) coro­
nary, cerebral, and peripheral occlusive vascular diseases 
in childhood. These conditions are associated with ac­
cumulation of cholesterol in atheromatous plaques. Death 
usually occurs in these individuals as a result of myo­
cardial infarction often prior to the age of JO, 
Goldstein and Brown (110) have recently studied HMG 
CoA reductase obtained from fibroblasts of homozygotes for 
familial hypercholesterolemia. Normal human fibroblasts 
maintained on fetal calf serum exhibited low levels of 
reductase activity. If the medium was replaced with 
human lipoprotein deficient plasma, reductase activity in­
creased. When human low density lipoprotein was added, 
enzyme activity declined in a manner which was both time 
and concentration dependent. This observation is remi­
niscent of certain conditions which have regulatory effects 
on this enzyme. Under the same experimental conditions 
HMG CoA reductase from human homozygote fibroblasts 
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exhibited sixty times higher activity than normal human 
cells when maintained on fetal calf serum. Replacement of 
the calf serum with human lipoprotein deficient plasma or 
human low density lipoprotein was accompanied by no change 
in enzyme activity. This lack of regulation was shown to 
be unrelated to added materials since incubation of low 
density lipoprotein, derived from normal and homozygote 
subjects, with normal fibroblasts was able to depress 
enzyme activity. These experiments are a clear demon­
stration of defective HMG CoA reductase regulation being 
integrally related to a hypercholesterolemic disease 
with atherosclerotic complications. 
Because kinetic properties of the reductase from 
normal and homozygote are nearly identical the genetic 
determinant for the enzyme itself does not appear to con­
tain the defect. Further, a genetic alteration would cause 
changes of enzyme structure which would be expressed as 
changes of enzyme activity, not regulation. It was con­
cluded that the genetic mutation of familial hypercholes­
terolemia causes a defect in the regulation of HMG CoA 
reductase activity by lipoproteins (110). It is possible 
that this could occur by mutation of a gene which normally 
specifies the elaboration of a protein which is critical 
to enzyme regulation. This regulatory defect results in 
the extremely high rate of cholesterol biosynthesis ex­
hibited by the homozygote. Thus, the ability to inhibit 
cholesterol biosynthesis, preferably at the reduction of 
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HMG CoA to mevalonic acid with no other metabolic changes, 
would provide an effective means of treatment of familial 
hypercholesterolemia. Such an ability does not exist at 
this time. 
D. Hypocholesterolemic Agents 
Treatment of atherosclerotic diseases is confronted 
with a unique quandary. The problem arises from two con­
siderations: first, the great difficulty of proving a 
causal relationship between hyperlipidemia and hypercho­
lesterolemia and the diseases and second, the multifaceted 
nature of the several factors which evidently act together 
to produce these diseases. Thus, it is not possible to 
positively state that lowering of serum cholesterol and 
lipid levels will in fact aid in the prevention 0f athero­
sclerosis. This is emphasized by a statement from the 
American Heart Association Study Group, "Primary Preven­
tion of the Atherosclerotic Diseases" when referring to 
drug treatment of atherosclerosis : "What is yet to be de­
termined is whether biochemical action of these or similar 
drugs will exert any favorable effect on the cause of the 
atherosclerotic diseases and whether long-term continued 
use of these substances produces significant deleterious 
effects" (117) , However, in spite of this uncertainty it 
is generally accepted that even though lowering of blood 
cholesterol and lipid levels may not provide an absolute 
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cure for atherosclerosis, it certainly cannot be harmful 
and might even be beneficial. Therefore, an important 
means of approaching atherosclerosis therapy is by attempt­
ing to lower blood levels of these substances. 
Several methods are known for lowering ch0lesterol 
levels. Dietary measures can be designed which limit the 
consumption of cholesterol and other lipid substances 
although the magnitude of lowering obtained with these 
programs is often small. Enhancement of cholesterol ex­
cretion, metabolism, or both is a second method. Like 
dietary measures this program does not generally produce 
dramatic results . Furthermore, consumption of t�e _large 
quantities of polymeric resins necessary to achieve these 
effects often acts as a negative incentive for such a 
therapeutic regimen. Finally, the most extensively explored 
method of lowering cholesterol levels is by inhibition of 
its biosynthesis. Several agents have been developed for 
this purpose and varying degrees of success have been 
achieved. A discussion of the choice of the inhibition 
site and the design of these agents will be found in a 
later section . Although a vast number of agents which 
reduce serum cholesterol levels have been synthesized, only 
a few of the more important examples_ will be considered 
here. 
The initial approach to treatment of hypercholes­
terolemia and hyperlipidemia is dietary (25, 111). An 
early method of dietary management consisted of addition 
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of sitosterol to the diet. The rationale for this treat­
ment was that sitosterol is not absorbed from the intes­
tines but does form single crystals with cholesterol from 
which neither component can be physically separated. 
Pollak (112) found that feeding rabbits varying quantities 
of sitosterol along with enough cholesterol to induce 
atherosclerosis resulted in the lowering of blood choles­
terol levels. This was a graded response; the higher daily 
sitosterol doses caused greater depres sion of cholesterol 
levels. In addition, sitosterol feeding protected against 
atherosclerosis which normally developed in cholesterol fed 
rabbits. Extension of these studies to humans afforded 
es sentially identical results (113), In these experiments 
it was noted that the cholesterol lowering effects were 
greater for high initial blood levels than for low initial 
levels. One drawback of this method is that very high 
consumption of sitosterol (up to 10 grams per day) is 
required. 
Dietary management of hypercholesterolemia can also 
be accomplished by adoption of a modified diet. These 
diets are usually designed to reduce obesity and to depress 
blood lipids as  much as pos sible. A diet designed for 
moderate reduction of blood cholesterol levels eliminates 
butter fats and vegetable oils, replaces meat with fish, 
and employs skim milk and polyunsaturated fats. This diet 
has been shown to yield a 17% lowering of serum cholesterol 
levels (114). Similarly, strict cholesterol lowering 
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diets completely eliminate butter and margarine fats, 
drastically reduce meat consumption, and use high protein 
vegatables such as peas and beans . Strict observation of 
this diet reduces serum cholesterol levels 29% (114). 
Many methods of dietary lowering of blood lipid levels 
replace saturated fats with unsaturated ones. The lipid 
lowering effects of unsaturated fats are not caused by 
enhanced fecal sterol excretion or redistribution of lipids 
to other body pools. Several investigators believe that 
these effects are due to changes in plasma lipoprotein 
compositions caused by unsaturated fats taking the place of 
saturated fats . In light of the established lipid lower­
ing properties of unsaturated fats it has been proposed 
that these fats are incorporated into low density lipo­
protein where, because of their unsaturation, they occupy 
more area than the corresponding saturated fats (115, 116) . 
This may cause eonformational changes of the lipoprotein 
resulting in fewer lipid molecules being accomodated by 
the protein portion of low density lipoprotein thin when 
saturated fatty acids are incorporated. The overall result 
is that the total lipid content of lipoprotein is lowered. 
Although this hypothesis has not been rigorously proved, 
it is consistent with the finding that in unsaturated fat 
diets lipid-protein ratios showed less lipid to be present 
in low density lipoprotein than in saturated fat diets 
(115), 
A thought provoking caution against abuse of 
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polyunsaturated fat diets has been pointed out by Mead (111) who expressed concern about the uncontrolled auto­
oxidation of these fats. Autooxidation is the spontaneous 
oxidation of a compound by molecular oxygen. This process 
is usually very slow; however, unsaturated fatty acids are 
known to undergo autooxidation very readily in a manner 
similar to that shown in Figure 8, The initiator of this 
RH + In 
R • + 02 
ROO • + 
xROO • 
Figure 8: 
R • + Hin Initiation 
ROO • 
� 
Propagation 
RH > ROOH + R •  
> dimers, trimers . . • polymers Termination 
Possible sequences of free radical autooxidation 
reactions, after Mead (111). In = initiator. 
process can be a free radical or a metal. It has been 
pointed out that peroxidized fats are known to be toxic 
materials and can form in biological tissues (111). Thus, 
drastically increasing the quantity of dietary polyun­
saturated fats may be accompanied by a corresponding in­
crease in opportunities for these lipid peroxide and free 
radical reactions to take place. If true, the result would 
be possible increases of tissue damage in excess of that 
which normally occurs. To this caution was added the 
suggestion that polyunsaturated fat diets should be 
accompanied by adequate antioxidant supplementation, such 
as approximately JO mg of d- � -tocopherol per day (111), 
A good source of these compounds is vegetable oils which 
contain not only polyunsaturated fats but also the anti­
oxidants required in nature to prevent the natural poly­
unsaturated compounds from decomposing. 
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Perhaps the best example of reducing serum cholesterol 
levels by enhancement of metabolism and excretion is the 
use of cholestyramine. Cholestyramine is the chloride 
salt of a basic anion exchange resin composed of quater­
nary ammonium groups attached to a polymeric styrene di­
vinylbenzene skeleton with molecular weight in excess of 
one million. This resin lowers low density lipoproteins 
and therefore lowers plasma cholesterol levels, but does 
not affect very low density lipoproteins. By binding bile 
acids it prevents their reabsorption causing increased 
metabolism of cholesterol to bile acids . In addition, 
bile acids are required for intestinal absorption of 
cholesterol and therefore cholesterol reabsorption is also 
decreased. 
In in vitro experiments cholestyramine was capable of 
removing large quantities of bile acids (118). Similarly , 
using cockerels and dogs as experimental animals, 1% 
cholestyramine in the diet prevented increases of blood 
cholesterol levels caused by cholesterol feeding. In 
addition, the resin is capable of lowering blood choles­
terol levels of normocholesterolemic animals , indicating 
that the loss of cholesterol is greater than the 
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compensatory increases of biosynthesis. Similar results 
have been observed in man. Moore et al. (119) found that 
12 grams of cholestyramine per day caused reduction of 
human serum cholesterol levels to 80% of pretreatment 
levels with a concurrent increase of fecal bile acid loss. 
The loss of bile acids continued in spite of the fact 
that serum cholesterol levels became constant at their low 
point, indicating that man responds with a compensatory in­
crease of cholesterol synthesis, mobilization of cholesterol 
from extravascular depots, or both. However, since the low 
blood levels were maintained the compensatory mechanisms 
were not sufficient to return them to pretreatment levels. 
The ma jor drawbacks of cholestyramine therapy include 
the large daily quantities of drug required for positive 
results to be observed. A more serious complication is 
the anion exchange nature of cholestyramine. Since it is 
a basic resin it is capable of binding other drugs which 
are sufficiently acidic. It has been shown to bind chloro­
thiazide , phenylbutazone, phenobarbital, and tetracycline 
(154). This nonselectivity for bile acids could seriously 
compromise concurrent therapy. 
Of the many compounds synthesized for the purpose of 
lowering serum cholesterol levels ethyl o( -(4-chloro­
phenoxy) isobutyrate, also known as clofibrate, has 
received extensive study and application. This compound is 
a safe and effective agent for lowering serum cholesterol 
and triglyceride concentrations in man and has been 
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demonstrated to be useful in all types of hyperlipidemia 
except the rare, fat induced hypertriglyceridemia (120). 
In addition to lowering human plasma cholesterol and tri­
glyceride levels , clofibrate also enhances excretion of 
neutral sterols in the feces , increases mobilization of 
cholesterol from tissue depots (120) ; but does not appear 
to lower plasma triglycerides in rats or rabbits (121), 
Other workers have confirmed the finding that both choles­
terol and triglyceride levels are lowered in man , although 
some patients do not respond at all (127), The mo�t pro­
found hypolipidemic effect is often seen in those indi­
viduals who had the highest blood lipid levels prior to 
treatment. Furthermore , Byers and Friedman also observed 
a 74% reduction of incorporation of HJ -acetate into cho­
lesterol in the liver (121); however , the liver mass of 
treated animals was considerably greater than that of 
controls , causing cholesterol content per liver to increase . 
. On the other hand , cholesterol content per gram of liver 
was indistinguishable for treated and control experiments . 
This led to the proposal that elofibrate reduees the rate 
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of hepatic cholesterol biosynthesis and thereby lowers the 
influx of cholesterol into the blood rather than increasing 
its efflux from the circulation. The increase of liver 
mass has also been studied by Platt and Thorp who found 
that when given 0. 25% clofibrate in the diet the liver mass 
increased rapidly, remained constant for approximately 
sixty days, then slowly returned to normal by the termina­
tion of a two year regimen (122). For up to 29 days the 
dosage of clofibrate significantly increased protein content 
in rat liver; this effect appeared to precede the increase 
of liver mass and continued until total protein reached 
an equilibrium level. It is not known if the agent caused 
an increase of synthesis of all liver proteins or of a 
specific protein. 
It was initially thought that clofibrate acted by po­
tentiation of the metabolic effects of adrenal steroids and 
was therefore claimed to have maximum efficiency when used 
in combination with androsterone (126). This combination, 
known as Atromid, gained widespread clinical acceptance. 
Other investigators (12J, 124) administered clofibrate to 
large numbers of human subjects for extended periods both 
with and without androsterone. Under both dosage regimens 
effects on serum proteins, side effects, and toxic effects 
were minimal. Both regimens were found to be equally 
effective in ability to lower elevated serum cholesterol 
levels, although 15-25% of the patients did not exhibit 
adequate or sustained reduction of either cholesterol or 
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triglycerides. The therapeutic effects were so similar to 
each other that it was concluded that the addition of 
androsterone to clofibrate was a therapeutically useless 
tactic (123), 
The only ma jor side effect of this drug is its inter­
action with anticoagulant agents (124, 125), Concurrent 
clofibrate and anticoagulant therapy requires reduction of 
the anticoagulant dose by 33-50% (125) in order to main­
tain optimum anticoagulant activity. No correlation was 
observed between hypolipidemic effects which appeared 
within two weeks and the alteration of coagulation proper­
ties which became noticeable within four weeks. 
Many investigators have studied the mechanism of 
action of clofibrate and a large body of often contradic­
tory evidence has resulted. It was initially thought that 
clofibrate was bound to serum albumin and other blood 
proteins at the same sites which normally bind L-thyroxine 
(122, 128). In order to bind at these sites the drug dis­
placed thyroxine which was then taken up by liver cells. 
This hypothesis provided no function for the drug other 
than physical displacement of thyroxine, and the effects 
associated with clofibrate were actually thought to be due 
to normal hepatic response to the thyroid hormone. Sup­
port for this proposal was provided by the work of Chang 
et al. (128) who studied protein binding in vitro. In man 
the vast ma jority of thyroxine is normally bound to pre­
albumin, albumin, and thyroxine binding o<.-globulin. 
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Addition of 6 mM clofibrate to these binding proteins 
lowered the amount of thyroxine bound to prealbumin 
although higher concentrations were necessary to displace 
thyroxine from albumin and no displacement from thyroxine 
binding ot.. -globulin was observed (128), Similar results 
were obtained in the dog. Thes� experiments suggest that 
the drug acts by displacing the bound thyroid hormone, but 
do not exclude other possible mechanisms. 
Best and Duncan (129) observed that adrenalectomized 
and gonadectomized rats responded to this agent with normal 
reductions of serum cholesterol levels. This experiment 
showed that clofibrate did not act by enhancing the action 
of endogenous steroid hormones. If these animals were 
made hypothyroid with thiouracil clofibrate caused no hypo­
lipidemic effects. Similarly, thyroidectomized animals 
exhibited only a small reduction of serum cholesterol 
concentration in response to the drug. This work lent 
further support to the thyroid hormone displacement mecha­
nism of action. On the other hand , administration of the 
drug to humans with complete primary myxedema resulted in 
lowered blood cholesterol and triglyceride concentrations 
(127) indicating that in man displacement of thyroxine may 
not be an important mechanism of action. 
Early indications that clofibrate actually inhibits 
cholesterol biosynthesis resulted from in vitro experiments 
with cell free homogenates of bovine aorta (130). In this 
system the drug inhibited the conversion of labeled 
mevalonic acid to nonsaponifiable material. Support for 
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the suggestion that inhibition of cholesterol biosynthesis 
was involved came from the experiments of Avoy et al. (131). 
Using a rat liver system these investigators showed that 
clofibrate drastically lowered the incorporation of labeled 
acetate into digitonin precipitable sterols, but when 
labeled mevalonic acid was employed as the precursor in­
corporation was not significantly inhibited. Similarly, 
in vivo experiments also showed that inhibition did not 
take place late in cholesterol biosynthesis. It was there­
fore concluded that clofibrate acted by inhibiting mevalonic 
acid synthesis from acetate but did not inhibit fatty acid 
or ketone body synthesis. Results of this type have also 
been reported by Sodhi et al, (132) using human Type II  
and Type IV hyperlipidemias. It should be noted that it 
is in this portion of cholesterol biosynthesis that the 
important regulatory reaction mediated by HMG CoA reductase 
is located, 
The recent, definitive experiments of White (133) 
provided proof that a mechanism of action of clofibrate is 
indeed inhibition of cholesterol biosynthesis. At 0. 3% 
in the diet it had no effect on food consumption or weight 
gain but consistently reduced rat plasma cholesterol levels 
by a mean of 35%, Using rat liver slices and cell free 
homogenates it was demonstrated that incorporation of radio­
active acetate into cholesterol was decreased, but incor­
poration of labeled mevalonic acid was not changed. This 
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was in complete agreement with previous results (131). 
Furthermore, the incorporation of radioactivity into carbon 
dioxide and fatty acids was not altered by the drug and 
acetoacetate formation was increased in treated animals. 
This narrowed the location of inhibition to being between 
acetoacetyl CoA and mevalonic acid. Finally , clofibrate 
feeding was associated with no alteration of HMG CoA con­
densing enzyme but did cause decreased incorporation of 
radioactive HMG CoA into mevalonic acid. Thus , the in­
escapable conclusion (133) is that clofibrate acts , at 
least partially , by inhibiting hepatic microsomal HMG CoA 
reductase, the most appropriate site of action for max­
imum inhibitory efficiency. Although it was shown that 
the drug also interferes with the soluble enzyme system 
which activates acetate to acetyl CoA this is a secondary 
mechanism of action. 
The recent work of Witiak et al. (155) emphasizes the 
fact that clofibrate has several modes of action. These 
investigators found that treatment of rats with clofibrate 
caused a significant increase of hepatic microsomal 
cytochrome P-450, This was interpreted (155) as an indi­
cation that another mode of action of clofibrate is in­
creased catabolism of cholesterol due to the enhancement of 
hepatic cytochrome P-450, 
Triparanol or 1- [Q-( � -diethylaminoethoxy)pheny� -1-
(Q-tolyl)-2-(Q-chlorophenyl) ethanol (MER-29) is an agent 
which was initially thought to be a promising inhibitor of 
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Triparanol 
cholesterol biosynthesis. Although it does inhibit the 
biosynthesis and reduce blood cholesterol levels, this 
compound is an excellent example of the disadvantages which 
accompany inhibition late in the biosynthetic sequence. 
Much of the promise of triparanol was due to early reports 
of its apparent ability to reduce total sterol synthesis . 
It was found that after feeding the compound to rats, in­
corporation of radioactive acetate into digitonin pre­
cipitable material was essentially unchanged with respect 
to untreated animals (134). However, when cholesterol was 
separated from the digitonin precipitate and purified it 
was discovered that the conversion of labeled substrate 
to cholesterol had been almost totally inhibited. 
Further examination of the total digitonin precipitable 
material provided results applicable to the mechanism of 
action of triparanol. As previously reported, separation 
of cholesterol as its dibromide accounted for very small 
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amounts of total radioactivity; the ma jority stayed in the 
remaining digitonide. Investigation of the noncholesterol 
precipitate demonstrated that most of the labeled acetate 
had been incorporated into 24-dehydrocholesterol (des­
mosterol) (135), The_s�_. �xp�_riments provided evidence that 
the reaction inhibited by triparanol was the reduction of 
24-dehydrocholesterol to cholesterol and that desmosterol 
is a biosynthetic precursor of cholesterol. Further sup­
port for this mechanism was provided by the finding of 
very large amounts of desmosterol in the serum and liver of 
triparanol treated sub jects, and undetectable amounts in 
control animals (136), Thus, triparanol treatment was 
associated with accumulation of desmosterol, and even 
though eholesterol synthesis was inhibited, very little 
reduction of the total sterol levels took place. Final 
proof of the biosynthetic relationship between desmosterol 
and cholesterol was made by Steinberg and Avigan (137) who 
conclusively demonstrated the precursor nature of des­
mosterol both in vitro and in vivo. 
The high levels of desmosterol found in triparanol 
treated sub jects is a serious drawback to the use of this 
agent to accomplish reduction of serum cholesterol levels 
because of the possibility that desmosterol itself may con­
tribute to the atherosclerotic process. By experiments 
with rabbits, Avigan and Steinberg (138) were able to show 
that dietary desmosterol was indeed incorporated into 
atherosclerotic lesions. Examination of the grossly 
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normal aorta and lesions of desmosterol fed and triparanol 
treated rats showed that the ratio of desmosterol to cho­
lesterol in these tissues was the same as the ratio of these 
sterols in the serum. Therefore, it appeared that tri­
paranol inhibition of cholesterol biosynthesis was a�com­
panied by at least partial replacement of cholesterol in 
lesions by desmosterol. From these studies it can be con­
cluded that if desmosterol is present in the circulation 
it will be incorporated into developing atherosclerotic 
plaques at a rate which is proportional to its concentra­
tion in the serum. In view of these data, use of tri­
paranol as a hypocholesterolemic agent would depend upon 
desmosterol being deposited in plaques - at a slower rate 
than cholesterol. In humans treated with the drug for 
two to nine months desmosterol has been found in both un­
involved aorta tissue and in plaque, while no evidence of 
it could be detected in these tissues of untreated patients 
(1J9) , This accumulation took place over a period of 
months while an entire plaque requires decades for de­
velopment. This suggests a more rapid deposition of des­
mosterol than of cholesterol. 
Because of the atherogenic properties of desmosterol 
and its rapid accumulation in lesions, the use of tri­
paranol is not a rational method of treatment for athero­
sclerotic diseases. This compound clearly illustrates the 
ma jor disadvantage of inhibiting cholesterol biosynthesis 
at one of the reactions close to the end product . The 
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result is the accumulation of cholesterol precursors which 
have no metabolic purpose and for which there are no alter­
nate metabolic pathways available. In the case of tri­
paranol, an additional danger is present because the ac­
cumulated intermediate is an atherogenic compound. 
Thyroid function and thyroid hormones have been shown 
to have an effect on the development of atherosclerosis; 
normal, healthy, or supplemented thyroid function appears 
to lend protection against these diseases (20). Hyper­
thyroid individuals often exhibit low concentrations of 
cholesterol in plasma. Hypocholesterolemia is associated 
with thyroxine administration partly because the hormone 
causes increased conversion of cholesterol to bile acids 
to a greater extent than it causes increased cholesterol 
biosynthesis (146). These and similar considerations have 
been the basis of attempts to treat hypercholesterolemia 
with thyroid hormones and their analogs. In general, the 
thyroid hormone L-thyroxine causes significant reductions 
of serum cholesterol levels (140). Other effects of this 
compound include a general increase of metabolic rate,· 
increase of heart rate, and increased oxygen consumption. 
Even though the serum cholesterol lowering properties of 
L-thyroxine are desirable the concurrent increase of heart 
rate and oxygen consumption may precipitate an anginal 
attack in a patient suffering from coronary heart disease. 
Thus, the goal of using thyroid hormones and their analogs 
as hypocholesterolemic agents is to separate the general 
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metabolic stimulatory properties of the hormones from their 
cholesterol lowering ability. 
The dextrorotatory stereoisomer of thyroxine has been 
found to possess a partial separation of these properties 
(141-143) , Although L-thyroxine causes a greater reduction 
of serum cholesterol concentrations it is also almost 100 
times more potent than the D-isomer in causing cardiac 
hypertrophy and increased heart rate (140). This may be 
due to the greater localization of L-thyroxine in cardiac 
tissue while dextrothyroxine is localized mainly in liver 
tissue (140, 144). Similarly, the D-isomer causes much less 
stimulation of the general metabolic rate than L-thyroxine. 
Studies of D-thyroxine in human myxedematous patients 
indicate that the separation of metabolic stimulation is so 
pronounced that serum cholesterol levels are lowered with 
ne observable increase of the basal metabolic rate (141). 
Other human studies of longer duration- report similar suc­
cess. Patients with idiopathic hypercholesterolemia and 
cardiovascular diseases are able to tolerate this agent 
with no serious side effects. Perhaps most significantly, 
patients with angina pectoris exhibit cholesterol lowering 
with no deterioration of the electrocardiogram and no 
change in cardiac compensation (142). This is important 
because the increases of oxygen consumption and heart 
rate caused by L-thyroxine aggravate this condition. 
Finally, this study shows that those subjects with the 
highest pretreatment blood cholesterol levels exhibit the 
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greatest lowering effects. 
Studies of the mechanism by which D-thyroxine acts 
have produced some interesting results. Early work by 
Rabinowitz et al. (14J) showed that radioactive cholesterol 
administered to humans was cleared from the serum two to 
threefold faster by those treated with D-thyroxine than by 
untreated subjects. Further, the expired carbon dioxide 
containing radioactive label was considerably increased in 
treated patients. These data led to the conclusion that 
the observed reductions of serum cholesterol level may have 
been due to enhanced metabolic destruction of cholesterol. 
Other experiments indicate that thyroid hormones may 
act as enzyme inhibitors rather than stimulators of cho­
lesterol catabolism. When examined in an in vitro system, 
triiodothyronine was found to inhibit the incorporation of 
labeled acetate into cholesterol more efficiently than 
thyroxine or other iodinated tyrosine analogs (145), When 
labeled mevalonic acid was the substrate the thyroid 
hormones provided much les s inhibition of incorporation of 
the label into cholesterol. The greater activity of tri­
iodothyronine than thyroxine observed in this system has 
been explained by the indication that thyroxine was bound 
much more firmly to nonspecific proteins than was tri­
iodothyronine. This implies that the inhibitory activity 
was in fact a function of the concentration of unbound 
hormone rather than due to structural influences of the 
compounds. The ability to inhibit cholesterol biosynthesis 
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before but not after mevalonic acid is a familiar pattern 
which has previously been the source of preliminary 
suggestions that HMG CoA reductase was involved. 
The hypothesis that HMG CoA reductase is a possible 
site of action for thyroid hormones gained clear support 
from the work of Eskelson et al , (146). Thyroidectomized 
animals exhibited low levels of HMG CoA reductase which 
were increased by thyroxine administration resulting in 
enhanced cholesterol biosynthesis. It has also been shown 
that the addition of L-triiodothyronine and L-thyroxine to 
rat liver homogenates from rats with normal thyroid func­
tion decreased cholesterol biosynthesis (145), Using rat 
liver homogenates Eskelson and co-workers observed 50% 
inhibition of cholesterol biosynthesis from radioactive 
acetate by 10-4 M triiodothyronine but no inhibition when 
labeled mevalonic acid was the substrate. Similarly, 
D-thyroxine inhibited the conversion of labeled acetate 
to cholesterol but L-thyroxine did not (146). By using 
11 3 1-triiodothyronine and 11 3 1-thyroxine it was also shown 
that the thyroid hormones were nonspecifically bound to 
microsomal protein. From these results it was concluded 
that the rate limiting reaction of cholesterol synthesis, 
catalyzed by HMG CoA reductase, is under thyroid hormone 
control and that this reaction is inhibited by triiodo­
thyronine. The high concentrations of thyroid hormones 
which were needed to inhibit the reductase and the protein 
binding study suggest that these compounds actually inhibit 
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the enzyme only after the protein binding sites have become 
saturated. 
These data make it tempting to postulate a dual func­
tion of thyroid hormones in cholesterol biosynthesis: 
very low hormone levels may control enzyme synthesis while 
higher concentrations directly inhibit the rate limiting 
step for the entire sequence of reactions . This provides 
an additional example of the importance of HMG CoA re­
ductase and its central position in cholesterol biosyn­
thesis. 
An example of agents specifically designed to inhibit 
HMG CoA reductase is the azasteroids prepared by Counsell 
and co-workers (147-149), Under the belief that choles­
terol acted as a true feedback inhibitor of cholesterol 
biosynthesis by inhibiting the reductase, it was reasoned 
that if cholesterol was bound to the enzyme by means of van 
der Waals forces and hydrogen bonding then this binding 
association could be strengthened by employing nitrogen iso­
steres of cholesterol as inhibitors of the enzyme (147), 
Several nitrogen isosteres of cholesterol were prepared 
for this purpose. Using the percent reduction of serum 
cholesterol in the rat as a test system the most effective 
inhibitors prepared were the 22, 25-diaza analogs, 20 � ­
(2-dialkylaminoethyl)aminopregn-5-en-J � -ol (147), Initial 
attempts to define the site and mode of action of these 
compounds yielded mixed results. Although 22, 25-diaza­
cholestanol (SC11952) was designed as, and would hopefully 
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act as, an inhibitor of HMG CoA reductase, in vitro in­
corporation of labeled acetate into cholesterol by rat 
liver homogenates was only equal to or lower than that of 
untreated animals (148). However, labeled squalene, lan­
osterol, and desmosterol all exce eded the corresponding 
levels in untreated animals and labeled cholesterol was 
considerably lowered with respect to controls. It was 
concluded that under in vitro conditions the aza analogs 
of cholesterol were capable of inhibiting the desired enzyme 
and little emphasis was placed on the build-up of the 
steroid intermediates. 
The observed accumulation of squalene, lanosterol, 
and desmosterol indicated that the compounds inhibited 
cholesterol biosynthesis at at least one additional site 
late in the pathway. Reexamination of the inhibitory 
properties under in vivo conditions showed that the goal 
of inhibition of HMG CoA reductase was not achieved, 
Rather, 22, 25-diaza cholestanol was conclusively shown to 
inhibit the conversion of desmosterol to cholesterol (149, 
150) as did triparanol and therefore cause accumulation of 
desmosterol in rat liver and plasma. It was later shown 
that this compound is also capable of inhibiting the rat 
7 24 . h liver � as well as the � reductases whic are 
necessary for sterol biosynthesis; the latter enzyme 
catalyzes the conversion of desmosterol to cholesterol 
(152), High concentrations are required to inhibit the 
� 7 reductase and therefore no evidence of this action 
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is observed in vivo. 
A more potent diazacholesterol derivative is the 20, 
25-diaza analog which lowered serum cholesterol and phos­
pholipid concentrations to a greater degree than did tri­
paranol (153), In rats and in man this compound reduced 
serum cholesterol but not total sterol concentrations. As 
in the case of the 22, 25-diaza derivative, subjects treated 
with this compound exhibited an increased level of des­
mosterol (152). Thus, while these analogs of cholesterol 
were rationally designed they are not useful hypocholes­
terolemic agents because, like triparanol, they caused 
accumulation of the potentially atherogenic cholesterol 
precursor desmosterol. 
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RESEARCH RATIONALE 
The previous discussion showed that a high serum cho­
lesterol level is clearly one of the several factors which 
contribute to atherosclerotic disease and its many com­
plications. Because much confusion surrounds the exact 
role of cholesterol and its relationship to atheroscle­
rosis it can only be assumed that lowering the serum cho­
lesterol level is a profitable therapeutic approach to 
treatment of the disease. Regardless of the lack of rig­
orous proof, it is believed that the vast literature con­
cerning this aspect of the disease suggests the validity 
of this central assumption. The goal of this work is to 
contribute to efforts designed to lower serum cholesterol 
levels in mammals by defining some structural aspects of 
a series of compounds designed to inhibit cholesterol bio­
synthesis. 
Several methods are available for the reduction of 
serum cholesterol levels. The currently favored initial 
method is to reduce the quantity of ingested cholesterol 
by strict dietary management. This procedure affords only 
fair results and may be accompanied by considerable 
difficulty on the part of the patient. This problem is 
manifested in the inability or unwillingness of the 
patient to adhere to the required dietary restrictions. 
Another approach is to increase the oxidation of cho­
lesterol to bile acids and thereby reduce cholesterol 
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levels. Bile acids act as feedback regulators of the con­
version of cholesterol to the bile acids. Cholestyramine, 
a polymeric ion exchange resin, decreases the reabsorption 
of the bile acids in the intestinal tract and therefore 
removes the regulator of cholesterol conversion to bile 
acids. This results in an increased oxidation of choles­
terol and lowers serum cholesterol levels. A secondary 
mode of action of this resin is the indirect decrease of 
intestinal cholesterol absorption. As noted previously, 
because of their ion exchange properties these resins 
may also remove other medicinal agents from the gastro­
intestinal tract and therefore, they cannot be used with 
many therapeutic regimens. Finally, an extensively studied 
method for lowering serum cholesterol levels is to inhibit 
cholesterol biosynthesis. The inhibition of cholesterol 
biosynthesis is a delicate problem and requires careful 
consideration but can provide rewarding results. 
Cholesterol biosynthesis from acetyl CoA is a complex 
process which consists of more than twenty known reactions. 
At first, it might appear reasonable that inhibition at 
any one of these steps would effectively lower the total 
quantity of cholesterol biosynthesized and therefore safely 
reduce serum levels. Unfortunately, this is not true and 
has been illustrated above, especially in the case of tri­
paranol and the azasteroids. 
The first step of cholesterol biosynthesis, conversion 
of acetyl CoA to acetoacetyl CoA, is also an important part 
of fatty acid synthesis. Inhibition of this reaction 
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would therefore inhibit fatty acid biosynthesis as well as 
cholesterol biosynthesis and produce undesirable results 
(147, 156-158). Similarly, interference with formation of 
acetyl CoA is undesirable since this compound is the well 
known entrance into the tricarboxylic acid cycle. The next 
step in the biosynthetic pathway consists of condensation 
of acetoacetyl CoA with acetyl CoA to produce HMG CoA. 
This reaction is the branching point in fatty acid and 
cholesterol biosyntheses from which ketone bodies are de­
rived. For this reason the inhibition of HMG CoA formation 
might also inhibit the latter process and is therefore un­
desirable (156, 157), Thus, inhibition of any reaction in 
cholesterol biosynthesis up to and including formation of 
HMG CoA is not an acceptable approach to blocking the path­
way, primarily because the additional metabolic processes 
for which these intermediates are required would also 
suffer inhibition. 
Later steps in the biosynthetic sequence following 
the cyclization of squalene might appear to provide poten­
tial inhibition sites. Unlike earlier steps, the biosyn­
thetic reactions following squalene formation are not 
reversible, For this reason, efficient blockade of one of 
these reactions would be expected to lead to accumulation 
of the corresponding intermediate. Since no alternate 
metabolic pathways exist for these compounds this accumu­
lation would continue unhindered. 
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An excellent example of this problem is the hypocho­
lesterolemic agent triparanol which inhibits reduction of 
24-dehydrocholesterol (desmosterol) to cholesterol (135), 
Blood levels of desmosterol under normal conditions are 
not detectable; however, shortly after triparanol treatment 
desmosterol concentration rapidly increases and its ac­
cumulation is metabolically uninhibited. An additicnal 
danger associated with this example of inhibition late in 
cholesterol biosynthesis is the observation of Herndon 
and Siperstein (139) that desmosterol is incorporated into 
atherosclerotic plaque and that this deposition takes place 
at a more rapid rate than cholesterol deposition. It is 
reasonable that inhibition of any of the several reactions 
in the later stages of cholesterol biosynthesis would 
lead to similar results. Since these intermediates appear 
to have no function other than as cholesterol precursors 
and since this portion of the pathway does not contain 
any reversible reactions, the most likely method of dis­
position of these compounds is their accumulation. The 
total quantity of cholesterol synthesized would be lowered 
but the total sterol concentration would increase. There­
fore, it is believed that the inhibition of the reactions 
between squalene and cholesterol does not provide a ra­
tional approach to lowering serum cholesterol levels. 
Similar views have been expressed by other investigators 
( 13 3, 156 , 157) , 
The above considerations severely limit but do not 
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preclude the choice of a biosynthetic reaction on which 
rational attempts to inhibit cholesterol biosynthesis may 
be focused, For the purposes of this work HMG CoA re­
ductase , which mediates the reduction of HMG CoA to meva­
lonic acid, is the reaction which is believed to provide 
the most appropriate opportunity for effective inhibition 
of cholesterol biosynthesis. The properties which bestow 
this unique quality on this enzyme are many. 
All biosynthetic processes take place at a rate which 
can be described and measured. For those processes which 
consist of a series of reactions leading to a final product 
one of the reactions will be the slowest, or rate limiting, 
step under a given set of conditions. In cholesterol bio­
synthesis the rate limiting step is mediated by HMG CoA 
reductase (66, 63), Because of this property, inhibition 
of the reductase will cause a greater proportional decrease 
in the total quantity of cholesterol synthesized than the 
same degree of inhibition at any other reaction in the 
entire pathway. Since this is a general kinetic charac­
teristic of the biosynthetic pathway, alterations of the 
physiological condition should not interfere with the 
relative efficiency of inhibition. 
Although the rate limiting nature of HMG CoA reduc­
tase is an important reason for its choice as the in­
hibition target, several other positive aspects enhance its 
desirability. It will be noted that the formation of aceto­
acetyl CoA and HMG CoA are reversible reactions. The 
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biosynthesis of acetoacetyl CoA is directly reversible, 
that is, both the formation and the cleavage of aceto­
acetyl CoA are catalyzed by the same enzyme. On the other 
hand, the biosynthesis of HMG CoA is indirectly reversible 
since the condensation and cleavage reactions .are mediated 
by separate enzymes. However, the following step, reduc­
tion of HMG CoA to mevalonic acid, is the first irrever­
sible reaction of cholesterol biosynthesis (62). In 
marked contrast to the later stages of the pathway where 
sterols are abundant, inhibition of HMG CoA reductase will 
cause no accumulation of intermediates by virtue of the 
reversibility of the formation of its immediate precursors. 
Any accumulation of HMG CoA in response to inhibition of 
HMG CoA reductase will be disposed of through ketone body 
synthesis. Similarly, acetoacetyl CoA accumulation will 
be disposed of through fatty acid synthesis. Thus, the 
irreversible reduction means that only cholesterol bio­
synthesis will be inhibited with no concurrent accumulation 
of intermediates. The importance of this reductase is 
emphasized by the fact that it is also the major site of 
physiological control of cholesterol biosynthesis under 
both normal and experimental conditions. This function 
of the enzyme is discussed in detail in the preceding 
section. 
For these reasons HMG CoA reductase is believed to be 
the ideal site for efficient inhibition of cholesterol 
biosynthesis and was therefore chosen as the target enzyme 
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in the present work. Although this conclusion is in agree­
ment with the work of other investigators (159, 160) this 
view is not unanimous. 
Holmes and DiTullio (156) have pointed out that 
mevalonic acid is a precursor not only of cholesterol but 
also of coenzyme Q which is associated with electron trans­
port . Inhibition of HMG CoA reductase was therefore 
claimed to be accompanied by inhibition of coenzyme Q bio­
synthesis. In order to avoid possible harmful effects these 
investigators suggested that the best site for inhibition 
of cholesterol biosynthesis lies between mevalonic acid 
and squalene (156). Closer examination of the reductase 
reveals these fears to be less serious than they originally 
appeared to be. Since cholesterol is a vital steroid from 
which many others are produced complete blockade of its 
synthesis is not desirable. Partial inhibition of HMG CoA 
reductase should provide the greatest possible decrease of 
total cholesterol synthesis while allowing some mevalonic 
acid to be synthesized. Partial, rather than complete, 
inhibition of the enzyme therefore makes the mevalonic acid 
formed available for both coenzyme Q and cholesterol bio­
syntheses. Serious blockade of electron transport w�uld be 
rapidly expressed by metabolic deficiencies. No investi­
gations specifically concerning any relationship between 
coenzyme Q or electron transport and the inhibition of 
HMG CoA reductase are available .  However, in studies of 
the administration of clofibrate [an agent which acts, in 
1 0 1  
part, by inhibiting HMG CoA reductase (133 � to animals 
(122) and man (120) no indications of coenzyme Q deficiency 
have been reported. Therefore, it is believed that the 
reasoning of Holmes and DiTullio (156) does not completely 
describe the relationship of mevalonic acid to both co­
enzyme Q and cholesterol biosyntheses, Thus, HMG CoA 
remains the ideal site for the inhibition of cholesterol 
biosynthesis. 
Pop j�k (161) has expressed the opinion that the in­
hibition of HMG CoA reductase as a means of blocking cho­
lesterol biosynthesis is a rational approach only on the 
basis of preliminary considerations. The major ob jection 
to this site of inhibition is one of selectivity. Pop jak 
argues that inhibition of HMG CoA reductase without con­
current inhibition of dehydrogenase enzymes seems to be 
"a  remote possibility. " (161). This assertion appears to 
have been made on the assumption that the active sites of 
these enzymes must be similar because of similar functions 
of the enzymes and therefore an inhibitor of one would also 
interfere with the normal functioning of the rest. It 
should be noted that this assumption is not necessarily 
true. Even though similar enzymes may mediate similar 
chemical conversions, the geometry of the active site is 
not solely dependent on the type of reaction taking place. 
The structure of the substrate in regions remote from the 
reaction site may be an important determinant of the 
structure of the enzyme active site since the substrate 
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must be accomodated. For this reason two enzymes which 
mediate very similar reactions could conceivably have very 
different active sites. An illustration of this is the 
striking specificity of HMG CoA reductase for HMG CoA as 
substrate (62); peripheral selectivity is seen in the ob­
servation that HMG-S-pantetheine is not reduced by the 
enzyme (76). 
In presenting his ob jection to HMG CoA reductase as 
the ideal site for the inhibition of cholesterol biosyn­
thesis Pop jak proposed the inhibition of prenyl transferase 
on the basis of alternate metabolic pathways for the allylic 
phosphate precursors of farnesyl pyrophosphate (161). In­
hibition of prenyl transferase, which mediates farnesyl 
pyrophosphate formation, would result in accumulation of 
3, 3-dimethylallyl pyrophosphate. It was suggested that 
this compound would be hydrolyzed to the corresponding 
free alcohol, which should be a good substrate for hepatic 
alcohol dehydrogenases. The coenzyme A thioester of the 
resulting acid is known to be carboxylated to trans-J­
methylglutaconyl CoA, which is reversibly hydrated to HMG 
CoA (Figure 9), Thus, the overall result of inhibiting 
prenyl transferase is the production of more precursor 
of the substrate for this enzyme. 
It should be noted that if prenyl transferase is 
chosen as an inhibition site several advantages of HMG 
CoA reductase are lost. Specifically, the site no longer 
corresponds to the rate determining step of cholesterol 
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biosynthesis which is represented by HMG CoA reductase. 
Rather, inhibitory efficiency will be lost to the many 
slow reactions involved. 
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The above discussion shows that HMG CoA reductase is 
clearly the most appropriate site for the inhibition of 
cholesterol biosynthesis. For these reasons this enzyme 
has been chosen as the target enzyme for inhibitors designed 
and synthesized in the course of the present investigation. 
Palazzo et al. (162) reported that a series of aryl­
alkyl hydrogen succinates and glutarates I exhibited in 
vivo hypocholesterolemic activity in rats as well as the 
ability to inhibit in vitro cholesterol biosynthesis from 
labeled acetate. This investigation included the first 
report of the hypocholesterolemic and cholesterol biosyn­
thesis inhibitory activities of the general class of 
1-(4-biphenylyl)-rr-alkyl hydrogen succinates and hydrogen 
glutarates. However, the effects of structural changes in 
these compounds on the hypocholesterolemic activity were 
not adequately explored by these workers. For this reason 
the only conclusion which can be drawn from this investi­
gation is that esters I are capable of lowering serum 
cholesterol levels in the rat. 
These results suggested to Boots et al. (158) that 
considerable information concerning the structural re­
quirements for activity could be obtained by the incor­
poration of structural alterations into c0mpounds similar 
to esters I. These investigators also noted the structural 
d-H 
-@ R 
X b-C-(CH )-CO H 
tt 2 n 2 
I 
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similarities between esters I and HMG CoA (I I). Both 
contain free carboxyl and ester groups and for the series 
of hydrogen glutarates the distance between these two 
functional groups in the substrate and in the inhibitors 
can be identical. This led to the suggestion that these 
compounds might adopt similar conformations at their active 
sites and that these sites are located on HMG CoA reductase. 
In an extensive investigation of the inhibitory properties 
of some esters I in a yeast HMG CoA reductase system it 
was found (158) that as the alkyl group R was increased 
from hydrogen to rr-hexyl in a series of compounds where 
X = £-phenyl, the activity reached a maximum when R was 
rr-butyl or rr-pentyl. This indicates that the R group of 
I contributes to binding by participating in hydrophobic 
interactions with the enzyme and that the hydrophobic 
binding area on the enzyme is large enough to accept an 
rr-pentyl group. 
A similar investigation was carried out to study the 
effects of substituents X on the binding of esters I (158). 
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While maintaining R as rr-butyl, the substituent X was varied 
in such a manner that the electronic properties of the 
aromatic ring were known. Since these compounds exhibited 
no significant alteration of inhibitory activity, no elec­
tronic effects on inhibitor binding were observed, How­
ever, it was found that as the hydrophobic nature of the 
group X increased inhibition activity also increased; the 
most active compound contained X = Q-phenyl. The excellent 
inhibition observed when the aromatic group was 2-fluorenyl 
showed that when X = Q-phenyl the two aromatic rings were 
probably coplanar when bound to the enzyme. These ex­
periments indicated that the aromatic rings also partici­
pate in binding by hydrophobic association with the target 
enzyme. Part of the site at which these compounds bind can 
therefore be envisioned as including a hydrophobic area 
which accomodates an rr-alkyl group and a planar hydrophobic 
area at least large enough for bonding of a 4-biphenylyl 
moiety. �he location of these areas relative to each 
other is a matter of surmise and is limited only by the 
conformations which inhibitors I can assume. 
The acid-ester portion of these inhibitors also con­
tains functional groups which may contribute to enzyme­
inhibitor binding. Two such groups are the free carboxylic 
acid (-COOH) and the ester ( - o-8- ) function. In a study of 
possible distance requirements between these two functional 
groups during binding, Boots et al. (164) prepared a series 
of esters I I I  in which the distance between the acid and 
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the ester groups was varied while the remainder of the 
molecule was maintained constant. Although a distance 
corresponding to one to four methylene groups betwe en the 
ester and the acid moieties provided the most active in­
hibitors, no consistent increase or decrease of activity 
was observed throughout the series; only slight differences 
in activity were observed as the chain was lengthened. 
If the distance between the carboxylic acid group and the 
alcohol moiety of the ester was required to meet very 
demanding conditions in order to contribute to binding 
it would be anticipated that one member of this series 
would show a distinct maximum of inhibition while the 
other compounds would gradually increase to and/or decrease 
from maximum activity as the chain length was altered, 
However, the oxalate ester III (m = 0) exhibited very poor 
activity, indicating that when the distance betwe en the 
ester and carboxylic acid groups was too small, proper 
binding of the carboxylic acid and alcohol moiety of the 
ester could not take place. These experiments lead to the 
conclusion that the carboxylic acid group does contribute 
PH2-CH2 -CH2-CH3 
C-H 
0-C-(CH )-CO H 
II 2 m 2 
III (m = 0-6) 
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to binding and that as the chain length between the car­
boxylic acid and the ester group increased, the chain 
became sufficiently flexible to allow the carboxylic acid 
group and the alcohol moiety of the ester to reach their 
respective binding points. 
Another potential binding point of inhibitors I is the 
ester group. By replacing each atom of this functional 
group the several possible modes of binding of which it 
is capable may be individually examined. Using succinate 
III (m = 2) as a reference inhibitor Boots et al. (164) 
prepared ester analogs for this purpose. Replacement of 
the carbonyl group of the ester with a methylene group 
afforded an ether which exhibited activity nearly identical 
to that of the reference ester. Similarly, replacement 
of both the carbonyl group and the ether oxygen of the ester 
with a pair of methylene groups caused a slight decrease 
in the inhibitory activity. These experiments suggest 
that the ester group is not necessary for binding. 
Finally, the previously noted structural similarities 
between these inhibitors and the enzyme substrate (158) 
caused Boots et al. (164) to prepare the direct substrate 
analog IV. This compound was found to be an extremely 
active inhibitor and exhibited an elevenfold increase 
of inhibition over the corresponding unsubstituted ester 
III (m = J), This showed that the 3-hydroxy group par­
ticipated in binding to the enzyme. 
It should be emphasized that all of the structural 
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influences on inhibition activity discussed above have 
been a measure of reversible interactions with some region 
of the enzyme surface. When an enzyme and its normal sub­
strate interact, an enzyme-substrate complex (ES) forms. 
Similarly, in the case of the above inhibitors an enzyme­
inhibitor complex (EI) is formed which decreases the ability 
of the enzyme to properly catalyze the reaction, In both 
cases, these complexes (ES and E I) are reversible in nature ; 
that is, they may dissociate and form the unchanged enzyme 
and substrate or inhibitor species. 
One of the immediate goals of the present work was to 
contribute to elucidation of some potential enzyme binding 
points of the above arylalkyl hydrogen succinates and 
hydrogen glutarates. The initial phase of this study was 
centered around the previously prepared substrate analog 
IV. Having suggested that the J-hydroxy group of ester IV 
actively participates in binding to the enzyme, the question 
of the nature of this binding naturally followed. Two 
possibilities exist : A) the hydroxyl hydrogen could func­
tion as a hydrogen donor in hydrogen bonding with the enzyme 
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or B) the hydroxyl oxygen could act as a hydrogen acceptor 
in hydrogen bonding with the enzyme. These possible modes 
of binding are illustrated in Figure 10. It was therefore 
proposed to structurally modify inhibitor IV in such a 
manner to determine which, if either, of these binding 
modes was operating. The compound 1-(4-biphenylyl)-n­
pentyl hydrogen 3-methyl-J-methoxyglutarate (V) was designed 
for this purpose. 
Replacing the 3-hydroxyl hydrogen with a methyl 
group results in a compound which is not capable of acting 
as a hydrogen donor during hydrogen bonding (possibility A, 
above and Figure 10) but retains the ability to function 
as a hydrogen acceptor for hydrogen bonding (possibility B, 
above and Figure 10). If the first possibility accurately 
describes the contribution of the 3-hydroxy group, inhibi­
tor V would be expected to exhibit decreased inhibition 
with respect to ester IV. Conversely , if the second pos­
sibility holds , little change of activity would be antici­
pated. The first phase of the present work consisted of 
synthesis of the J-methoxy ester V which is described in 
the experimental section. 
?
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Figure 1 0 :  Pos s ible modes of binding of  the J -hydroxy group of e s ter IV c ompared 
to the J -me thoxyl group of e s te r  V .  A ,  hydrogen bond donor ; B ,  
hydrogen bond ac c eptor . 
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The sec ond phase of this  work involving structural 
changes of possible binding points conc erned the e s ter 
func tion . As d is cussed above , replac ement of the carbonyl 
group and e ther oxygen of the e ster moiety with methylene 
groups did not s ignificantly alter ac tivity of I I I  ( m  = 2 ) . 
Under usual c ond itions the e s ter group can act as a hydrogen 
acc eptor in hydrogen bonding by virtue of the fre e pairs 
of electrons on oxygen . As indicated above , this  does  not 
take plac e in this  sys tem . 
Even though the above experiments show that the e ster 
group is not ne c e s sary for bind ing of the inhibitor to 
the enzyme , it is  poss ible that the enzyme surfac e c ontains 
unused func tional groups capable of a binding c ontribution 
in the region where the e ster moiety is normally located . 
The mos t  l ike ly character of such a group would be a hydro­
gen acc eptor for hydrogen bonding s ince other s imilar pos­
sibilities  have been exc luded .  To determine if such an 
enzyme surfac e exists the e ster group of the inhibitor 
mus t  be replaced with a func tional group which maintains 
as much as pos s ible the s iz e , shape , and electronic pro­
perties of an e ster but which also inc ludes the ability 
to act as a hydrogen donor for hydrogen bonding . The 
c losest  approximation of the se  requirements is the amide . 
Amides VI  and V I I  were prepared in an effort to probe this  
region of the enzyme and perhaps increase binding . Pre senc e 
of a properly positioned enzymic hydrogen ac ceptor would 
be detec ted by an increase of inhibition by amides V I  and 
VI, m = 2 
VII, m = 3 
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VII  with respect to the corresponding ester, ether, and 
carbon analogs. Synthesis of these compounds is described 
in detail in the experimental section. 
It has been noted that the previously prepared com­
pounds and, in all probability, the compounds proposed for 
the present investigation are reversible inhibitors. In 
addition, it has been shown that succinate I I I  exhibits 
noncompetitive kinetics and there is reason to suggest 
that a stable ternary complex of enzyme, substrate and in­
hibitor is formed (158). The kinetic behavior of these 
compounds indicates that they probably bind to HMG CoA 
reductase at some site other than the binding site for 
substrate and may therefore form an enzyme-substrate-in­
hibitor complex (ESI) which is not able to reduce HMG CoA 
to mevalonic acid, For this reason the mechanism of in­
hibition may be explained in a number of ways including 
alteration of enzyme conformation and interference with 
possible enzyme subunit interactions. Regardless of where 
on the enzyme these inhibitors bind, the reversible nature 
of the interaction means that inhibition will be temporary 
and limited by availability of the inhibitor to the bio­
phase. 
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The elegant work of Baker (163) provided an alter­
native to the transient nature of reversible inhibitors. If 
an inhibitor can be designed which has the ability to form 
covalent bonds with the enzyme inhibition will become ir­
reversible and more effective than reversible inhibition. 
The ma jor portion of the present investigation consisted 
of the synthesis of structural analogs of esters I which 
contain a functional group which could be attacked by a 
nucleophile located on the surface of the enzyme. Such 
an attack would result in irreversible binding of the in­
hibitor to the enzyme surface. 
The design aspect of incorporating into the inhibitors 
a functional group which is susceptible to nucleophilic 
attack is important. Many amino acids contain groups 
capable of acting as nucleophiles including the thiol 
group of cysteine , the hydroxyl group of serine and 
threonine, and the nitrogen of histidine. Since it is 
known that HMG CoA reductase requires free thiol groups 
for activity (62) an important nucleophile is certainly 
present on the enzyme surface and may attack the inhibitors. 
Even though these compounds presumably do not interact 
with the enzyme at its active site a covalently bound 
enzyme-inhibitor complex could do severe damage to cata­
lytic efficiency since the attacking nucleophile may 
normally function as an aid to maintain the proper catalytic 
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conformation of the enzyme. 
The compounds designed for this purpose were intended 
for examination of both reversible and irreversible inhibi­
tion properties. To maintain maximum reversible binding, 
as determined from previous investigations, the potential 
irreversible inhibitors contained the 4-biphenylyl group 
for its hydrophobic characteristics and the succinic or 
glutaric acid-ester groups. The epoxide function was 
chosen as the alkylating group. A major reason for the 
choice of the epoxide group as the alkylating moiety is 
the ease with which it is known to open when attacked by 
nucleophiles. A reasonable mechanism for opening the ring 
b� an enzymatic nucleophile is shown in Figure 11. Ad­
ditionally, this group is small and therefore would hope­
fully cause a minimum of steric hinderance problems with 
respect to approach of the inhibitor to the enzyme surface 
and subsequent reversible binding. The position at which 
the epoxide group was incorporated was the terminal point 
of the alkyl group R of esters I. In this manner the chain 
length can be increased and the area over which the epoxide 
can "search" for a nucleophile becomes considerable 
(Figure 12). In this manner it was hoped that an enzymic 
nucleophile at or near the inhibitor binding site could be 
found. The compounds proposed for this investigation 
include the alkenyl esters VIII which are reversible in­
hibitors and from which the potential irreversible inhibit­
ing epoxyalkyl esters IX were prepared. The synthesis of 
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Figure 11: A mechanism by which irreversible inhibition might take place. 
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Figure 12: Under the assumption that the aryl and ester 
moieties always bind at the same location the 
shaded area represents the volume in which the 
epoxide group of inhibitors IXa-f may react 
with a nucleophile, The actual area over which 
the epoxide may alkylate is, of course, limited 
by the shape of the enzyme surface in the 
designated volume. 
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these compounds is described in the experimental section. 
Finally, it was also desired to examine compounds of 
the type XI  and X I I  containing the alkene function located 
at an internal position of the alkyl chain, This would 
allow stereochemical examination of the enzyme surface 
in the hydrophobic region where the alkyl group binds. 
From these compounds the corresponding internal epoxides 
could be prepared. Similarly, alkyne X, from which al­
kenes XI and XII could be synthesized, is structurally 
locked into linearity about the triple bond and could 
provide further information concerning the geometry of 
the enzyme in this binding region. As described in the 
discussion of the experimental section, synthetic dif­
ficulties precluded preparation of the unsaturated esters 
X-XII. However, it was possible to prepare alkynyl ester 
XIII which should provide similar information to that 
desired from X-XII 
The most desirable system for evaluation of the above 
compounds is a pure preparation of the enzyme HMG CoA 
reductase. Such a preparation would assure that the altera­
tions of inhibitory activity are accurate reflections of 
structural changes of the test compounds. In this manner 
interactions between the inhibitor and the enzyme could be 
studied without interference from effects due to absorption, 
distribution, or. metabolism. However, a pure enzyme test 
system is not feasible because the enzyme is attached to 
the endoplasmic reticulum (65), Additionally, once it has 
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been removed from the endoplasmic reticulum, HMG CoA 
reductase is extremely fragile (69, 70) and may present 
handling problems if the solubilized preparation is used 
regularly for testing purposes. 
These difficulties contributed to the decision to 
employ rat hepatic microsomal preparati0ns of the target 
enzyme for inhibitor evaluation. A limitation to the use 
of microsomal preparations is the presence of other enzymes, 
some of unknown function. These enzymes represent possible 
sites of metabolic and absorption loss for the inhibitor. 
Even though the microsomal test system presents some dis­
advantages with respect to pure preparations it is not 
entirely without merit. Any inhibitor which proves to be 
especially promising will be examined in a whole animal 
system. Microsomes are a close approximation to the whole 
animal system because numerous enzymes are present in any 
whole animal system and in order to be effective a drug 
must be capable of evading possible deleterious effects of 
these enzymes. Therefore , the loss of the ideality 
inherent in pure enzyme systems is _ more than compensated 
for by a closer resemblance of microsomal systems to actual 
in vivo conditions. 
EXPERIMENTAL 
A. General 
Reaction solvents were stored over the appropriate 
121 
size molecular sieves (194) except dimethylformamide which 
was distilled from barium oxide prior to storage over 
molecular sieves and pyridine which was distilled from and 
stored over barium oxide , Tetrahydrofuran was stored over 
molecular sieves until the alkynyl systems were investigated. 
Following that time, this solvent was stored over lithium 
aluminum hydride and distilled immediately prior to use. 
Petroleum ether used for column chromatography was dis­
tilled prior to use, the 60-70° C fraction being collected. 
Removal of solvents under reduced pressure was done with 
a Buchler Flash Evaporator at water aspirator pressure and 
was followed by drying under a vacuum of less than one 
mm Hg. 
Melting points are uncorrected and were determined on 
a Thomas Hoover melting point apparatus. Combustion 
analyses were performed with a Perkin-Elmer Model 240 
Elemental Analyzer , or by Galbraith Laboratories, Knoxville, 
Tennessee. Infrared spectra were determined on a Perkin­
Elmer Model 257 spectrophotometer either neat or as a 
solution in the indicated solvent. The strong, sharp band 
of polystyrene film at 1601. 4 cm-1 was used as a reference 
marker for infrared spectra. Nuclear magnetic resonance 
1 2 2  
(nmr) spectra were measured on a Perkin-Elmer Model R-24 
spectrometer or on a Varian A-60 spectrometer. Chemical 
shifts are given in units of parts per million (S), in . 
the indicated solvent, downfield frem tetramethylsilane 
which was used as an internal standard. Liquid scintil­
lation counting was performed on a Nuclear-Chicago Mark I 
Liquid Scintillation System and counting was corrected 
for efficiency by· the external standard quench correction 
method. 
All compounds are numbered with roman numerals. The 
S-benzylthiuronium salts are denoted by the number of the 
parent carboxylic acid followed by a capital S. For 
example, the salt of acid number VIIIc is denoted VIIIc-S. 
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B. Compounds Synthesized 
4-Hydroxy-4-methyl-1,6-heptadiene (XIV) . - The method 
of Tschesche and Machleidt (165) was used. To a three­
necked flask fitted with a magnetic stirrer, pressure com­
pensating dropping funnel, reflux condenser, and drying tube 
was added 19,05 g (0, 78 g-atom) of magnesium turnings. The 
system was then flame-dried under a stream of dry nitrogen . 
When the system had cooled, JO ml of dry ether, JO ml of 
tetrahydrofuran and a crystal of iodine were added to the 
flask. To the magnesium mixture was added, in a dropwise 
manner over a period of 2-2. 5 hours, a solution of 19. 5 ml 
of ethyl acetate (0. 198 mole), 57 ml of allyl bromide 
(0. 66 mole), 75 ml of ether, and 225 ml of tetrahydrofuran. 
During the addition the reaction mixture was maintained 
at a gentle reflux and when the addition was complete the 
mixture was stirred at reflux for 2. 5 hours. The mixture 
was poured onto an ice-water slurry and the aqueous phase 
was ad justed to pH 2 with 5% hydrochloric acid solution and 
extracted twice with ether. The combined organic phases 
were washed with water until the aqueous phase was pH 6, 
then .�ith 5% sodium hydroxide solution, water, and then 
with a saturated sodium chloride solution, and dried 
over anhydrous sodium sulfate. Removal of the solvent 
under reduced pressure afforded an orange liquid which was 
distilled to give 24. 8 g (89%) of XIV as a clear, colorless 
liquid bp 51° (15 mm), literature (165) bp 50-51
° (12 mm). 
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The infrared spectrum showed A neat 3360 cm-1 (strong, 0-H), max 
1645 cm-1 (strong, C=C). The nmr spectrum (CDc13) showed 
maxima for 2 protons as a multiplet at 5,60-6,37 ppm 
(-CH=C�)2, 4 protons as a multiplet at 4,83-5,16 ppm 
(�C=CH2)2, 1 proton as a singlet at 2. 38 ppm (R-0-H), 4 
protons as a doublet at 2,1 7  ppm (-CH2-C=)2, and 3 protons 
as a singlet at 1, 15 ppm (R3C-CH3). 
4-Methoxy-4-methyl-1,6-heptadiene (XV). - The method 
of Anderson and Cree (166) was used. To a three-necked 
flask fitted with a gas inlet tube, drying tube, pressure 
compensating dropping funnel, and magnetic stirrer was 
added 3,7 g of sodium hydride as a 57% oil dispersion 
[2. 1 g (0. 088 mole) as sodium hydride] • The powder was 
washed three times by mixing with dry ether and allowed to 
settle, the supernatant being decanted after each wash, 
and dried by sweeping the vessel with dry nitrogen. Fifty 
ml - of dry dimethylsulfoxide was then added with stirring to 
the system. To the stirred suspension was added at room 
temperature and in a dropwise manner a solution of 7,76 g 
(0. 062 mole) of the previously prepared diene XIV in 25 ml 
of dry dimethylsulfoxide and the reaction mixture was 
stirred until gas evolution ceased. The flask was placed 
in an ice bath and to the system was added in a dropwise 
manner 26 g (0. 18 mole) of methyl iodide. The mixture was 
stirred at room temperature for 18 hours, then the opaque 
orange solution was poured into ether and water. The 
organic phase was washed 7 times with water, followed by a 
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saturated solution of sodium chloride and dried over 
anhydrous sodium sulfate. Removal of the solvent under 
reduced pressure afforded a brown liquid which was distilled 
to give 5,64 g (65%) of XV as a clear , colorless liquid , 
bp 149-151° at atmospheric pressure. The infrared spectrum 
showed l �!�t 1645 cm-1 (strong , C=C). The nmr spectrum 
(CDClJ) showed maxima for 
2 protons as a multiplet at 5 , 50-
6. 16 ppm (-CH=C:)
2
, 4 protons as a multiplet at 4. BJ-5,16 
ppm (:c=CH2)2 , J protons as a singlet at J. 20 ppm (R-OCH3) ,  
4 protons as a doublet at 2. 25 ppm (=C-CH
2
-)
2
, and J protons 
as a singlet at 1. 10 ppm (R-CH3). 
Anal. Calcd. for c9H16o : C ,  77,1 ; H , 11,5, Found: 
C ,  77,2; H ,  11. 6, 
3-Methyl-3-methoxyglutaric acid (XVI). - The method 
of Tschesche and Machleidt (165) was used, To a vacuum trap 
was added a solution of 7,36 g (0. 05J mole) of previously 
prepared 1 , 6-heptad iene XV , 7,0 ml of glacial acetic acid , 
and 85 ml of methylene chloride. The system was put into 
a Dewar flask containing an acetone-dry ice slurry and 
cooled for 0 , 5  hour; then ozone (Welsbach ozone generator , 
Model T-408; 0. 4 1. /min ,  0. 562 kg/cm2 , 110 volt) was passed 
through the solution for J,5 hours , The blue solution was 
removed from the acetone-dry ice slurry and allowed to 
warm to room temperature. To the resulting clear , color­
less solution was added 50 ml of glacial acetic acid and 
the methylene chloride was removed under reduced pressure. 
To the residue was added 50 ml of glacial acetic acid , and 
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50 ml of JO% hydrogen peroxide; then the resulting solution 
was heated at reflux for 8 hours . Removal of the acetic 
acid under high vacuum afforded 7, 39 g of a colorless oil 
which crystallized on standing under high vacuum . Re­
crystallization from ether-petroleum ether (60-70°) gave 
7,08 g (76%) of XVI as a white solid, mp 78-80°, The infra-
') CHCl -1 ( red spectrum showed .A max 3 2500-2700 cm strong, broad, 
0-H), 1710 cm-1 (strong , C=O), The nmr spectrum (acetone­
d6) showed maxima for 2 protons as a broad singlet at 9, 93 
ppm (-COOH)2, 4 protons as a singlet at J . 26 ppm (-CH2-)2, 
3 protons as a singlet at 2 . 76 ppm (R-OCH3), and J protons 
as a singlet at 1.40 ppm (R-CH
3) .  This material was used 
as an analytical sample with no further preparation. 
Anal. Calcd . for c7H12o5: C, 47, 7; H, 6,9, Found: 
C, 47,7; H, 7,0, 
1-(4-Biphenylyl)-pentan-1-ol (XVII), - The method of 
Palazzo et al, (162) as modified by S. G .  Boots (personal 
communication) was used . To a three-necked flask fitted 
with a gas inlet tube, magnetic stirrer, reflux condenser, 
and pressure compensating dropping funnel was added 2. 20 g 
(0 . 09 g-atom) of magnesium turnings. The system was then 
flame-dried under a stream of dry nitrogen . When the 
system had cooled a crystal of iodine was added to the 
mixture; then, with stirring and cooling in an ice bath, 
a solution of 7,2 g (0 . 052 mole) of n-butyl bromide in 70 
ml of dry ether was added in a dropwise manner over a 
period of 1 hour while maintaining a gentle reflux. The 
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ice bath was removed and to the reaction mixture was added, 
in a dropwise manner with stirring, a solution of 9,2 g 
(0. 05 mole) of 4-biphenylcarboxaldehyde, mp 52-55
° (Aldrich), 
in 125 ml of dry ether while maintaining the system at a 
gentle reflux . The reaction mixture was stirred at reflux 
for 1 hour , cooled to room temperature and filtered to 
remove residual magnesium turnings. To the filtrate was 
added , in a slow dropwise manner with stirring, a saturated 
solution of ammonium chloride which had been ad justed to 
pH 7 with concentrated ammonium hydroxide solution. When 
no further precipitate formed the mixture was filtered, the 
solid was washed thoroughly with ether and the organic 
phase was dried over anhydrous sodium sulfate . Removal of 
the solvent under reduced pressure afforded 12. 2 g of a 
yellow solid which was recrystallized from ether-petroleum 
ether (60-70°) to give 7, 17 g (60%) of alcohol XVII as a 
white solid, mp 79-80°, literature (158) mp 78-79°, The 
infrared spectrum showed , CHClJ J590 cm-1  (medium, free A max 
0-H), J240 cm-1 (medium, broad, hydrogen bonded 0-H). The 
nmr spectrum showed maxima for 9 aromatic protons at 7,20-
7, 70 ppm , 1 proton as a triplet at 4, 57 ppm (R3C-H), 1 
proton as a singlet at 2,87 ppm (R-0-H), and 9 protons as 
a multiplet at 0, 85-1, 77 ppm (R-C4H9). 
1-(4-Biphenylyl)-n-pentyl Hydrogen J-Methyl-J-methoxy­
glutarate (V), - The ester was prepared by the procedure of 
Biichi et al, (167), To a solution of 880 mg (5, 0 mmoles) 
of the previously described J-methyl-J-methoxyglutaric acid 
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(XVI) , mp 78-80°, in 25 ml of dry chloroform was added 
1 . 20 g (5 . 0  mmoles) of alcohol XVII , mp 79-80°, and 1. 59 g 
of N ,  N-dimethylformamide dineopentyl acetal (Aldrich); 
then the clear, yellow solution was stirred at room tem­
perature for 68 hours. The solvent was removed under 
reduced pressure and the residue was dissolved in ether and 
washed with water followed by 5% sodium hydroxide solution. 
The alkaline aqueous phase was acidified to pH 1 with 5% 
hydrochloric acid and extracted with ether; then the 
organic phase was washed with water, saturated sodium 
chloride solution, and dried over anhydrous sodium sulfate. 
Removal of the solvent under reduced pressure afforded 1. 18 
g (59%) of V as a viscous, clear brown oil. The infrared 
spectrum showed A CHClJ 1713 cm-1 (strong, C=O), 1740 cm
-1 
max 
· (strong , C=O). The nmr spectrum (CDC13) showed maxima for 
1 proton as a singlet at 10. 0 ppm (-COOH), 9 aromatic pro­
tons at 7. 00-7. 79 ppm, 1 proton as a triplet at 5,71 ppm 
(R3C-H), J protons as a singlet at J, 15 ppm (-OCH3
), J pro­
tons as a singlet at 2. 72 ppm (R-CH
3
), and 1J protons as 
multiplets at 0. 67-2. 00 ppm (methylene and g-C4H9). The 
compound was analytically characterized as described below. 
S-Benzylthiuronium Salt of 1-(4-Biphenylyl)-n-pentyl 
Hydrogen J-Methyl-J-methoxyglutarate (V-S). - The salt was 
prepared by the precedure of Donleavy (168) as modified by 
Boots et al. (158). To a solution of J06 mg (0,77 mmole) 
of the aforementioned hydrogen glutarate V in 15 ml of 95% 
ethanol was added 2. 56 ml (0. 77 mmole) of O. J N sodium 
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hydroxide solution followed by a solution of 1. 1 g (5,0 
mmoles) of S-benzyl-2-thiopseudourea hydrochloride (Eastman) 
in 8 ml of hot 95% ethanol. The resulting cloudy suspen­
sion was made up to 100 ml with distilled water and re­
frigerated for 12 hours. The mixture was filtered, the 
precipitate washed thoroughly with water and air dried. 
Two recrystallizations from ethyl acetate-petroleum ether 
(60-70°) afforded an analytical sample of the S-benzyl­
thiuronium salt V-S as a white solid, mp 94, 5-96°. 
Anal. Calcd. for c32tt40N2o5s : C, 68. 0; H, 7,1; 
N, 5,0. Found : C, 68. 2; H, 7,1; N, 5,1. 
Preparation of the Jones Reagent. - The method of 
Bowden et al. (169) was used to prepare the reagent. To 
a solution of 28 g (0. 28 mole) of chromium trioxide in 
150 ml of distilled water was added slowly with stirring 
25 ml of concentrated sulfuric acid. The resulting red 
solution was diluted to a total volume of 200 ml with 
distilled water to give a solution of 14 mmoles of the Jones 
reagent per 10 ml of solution. 
1-(4-Biphenylyl)-pentane-1-one (XVII I). - The ketone 
was prepared by the procedure of Bowers et al. (170). To 
a , solution of 1. 02 g (4. 2 mmoles) of alcohol XVI I, mp 79-
800, in 10 ml of dry acetone was added 9 ml (12. 6 mmoles) 
of Jones reagent in a dropwise manner with stirring and 
cooling in an ice bath to maintain the temperature below . 
10°. The resulting brown mixture was stirred for 0,5 hour 
at o0. Ten ml of iso-propyl alcohol was added to destroy 
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excess Jones reagent, and the mixture was stirred for 1 
hour at room temperature. The green reaction mixture was 
extracted with ether and water, and the combined organic 
phases were washed with a saturated solution of sodium 
chloride and dried over anhydrous sodium sulfate, Removal 
of the solvent under reduced pressure afforded 1. 11 g of 
ketone XVIII as white plates, mp 74-77°, which was re­
crystallized from absolute ethanol to give 802 mg (80%) of 
large white plates, mp 79,5-80. 5°, The infrared spectrum 
showed A ���13 1669 cm-1 (strong, C=O). The nmr spectrum 
(CDC13) showed maxima for 9 aromatic protons at �.27-
7, 93 ppm, 2 protons as a triplet at 2,78 ppm (-g-CH2-), 
and 7 protons as a multiplet at 0, 67-1, 83 ppm (-CH2-CH2-ctt3). 
Anal. Calcd. for c17tt18o :  C, 85,7; H, 7,.6. Found: 
C ,  85,6; H, 7, 5, 
1-(4-Biphenylyl)-pentane-1-methoxylimine (XIX). -
The method of Feuer and Braunstein (171) was used. To a 
solution of 1. 19 g (5. 0 mmoles) of the previously described 
ketone XVIII, mp 79, 5-80. 5°, in 50 ml of absolute ethanol 
and 50 ml of pyridine (distilled from and stored over 
barium oxide) was added 431 mg (5,0 mmoles) of methoxyl­
amine hydrochloride (Eastman). The solution was stirred at 
reflux for 24 hours, cooled to room temperature and then 
poured onto a slurry of ice and 5% hydrochloric acid. The 
mixture was extracted with ether and the organic phase was 
washed with water, saturated sodium chloride solution, and 
dried over anhydrous sodium sulfate. Removal of the 
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solvent under reduced pressure afforded 1. 21 g of viscous, 
yellow oil which solidified upon cooling and was recrys­
tallized from ether-petroleum ether (60-70°) to give 610 
mg (53%) of methoxylimine XIX as white needles, mp 43,5-45,5
°, 
The infrared spectrum showed J neat 1610 cm-1 (weak, C=N-). max 
The nmr spectrum (CDC13) showed maxima for 9 aromatic 
protons at 7,23-7,90 ppm, 3 protons as a singlet at 3,97 
ppm (-OCH3
), 2 protons as a triplet at 2. 75 ppm (-S-cH2- ), 
and 7 protons as multiplets at 0. 67-1. 67 ppm (-CH2-CH2-cH3). 
Anal. Calcd. for c18H21NO: C ,  80,9; H ,  7,9; N, 5,2, 
Found: C ,  80,7; H, 8. 1; N, 5,4, 
1-(4-Biphenylyl)-1-aminopentane Hydrochloride (XX). -
The method of Boots et al. (172) was modified. To a solution 
of 1. 83 g (6. 85 mmoles) of the aforementioned methoxyl-
imine XIX, mp 43,5-45,5, in 25 ml of 1, 2-dimethoxyethane 
(DME; distilled from lithium aluminum hydride) in a three­
necked flask fitted with reflux condenser, pressure com­
pensating dropping funnel, acetone bubbler, and magnetic 
stirrer was added 660 mg (17,2 mmoles) of sodium borohydride 
(Fisher). To the resulting mixture was added, in a drop­
wise manner, with stirring and cooling in an ice bath, 3,2 g 
(22 . 6  mmoles) of boron trifluoride etherate (Eastman) at 
a rate which controlled gas evolution and foaming . The 
reaction solution was stirred at room temperature for 1 
hour, at reflux for 2 hours; then with stirring and cooling 
3,0 ml of water was added in a dropwise manner followed by 
15 ml of 5% hydrochloric acid solution. The resulting 
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solution was stirred at reflux for 1 hour then at room 
temperature for 14 hours. Removal of the DME under reduced 
pressure afforded a slurry which was ad justed to pH 12 
with 5% sodium hydroxide solution and extracted with ether. 
The organic phase was washed with water, saturated sodium 
chloride solution, and dried over anhydrous sodium sulfate. 
Removal of most of the solvent under reduced pressure 
afforded . a  solution to which was added, with stirring at 
room temperature, 50 ml of ethereal hydrogen chloride 
[prepared (195) from addition of 5 ml of concentrated 
hydrochloric acid to 50 ml of ether followed by drying 
with 15 g of anhydrous magnesium sulfate and filterinaj . 
Filtration of the resulting mixture afforded a white 
solid which on drying gave 1. 60 g (85%) of amine hydro­
chloride XX as a white solid, mp 250-253°. The nmr spectrum 
(DMSO-d6) showed maxima for 9 aromatic protons at 7,30-
7,63 ppm, 3 protons as a singlet at 4. 60 ppm (-NH3
+) which 
was destroyed by the addition of sodium deuteroxide solu­
tion, and 9 protons as multiplets at 0. 62-1,53 ppm (n-C4H9). 
Recrystallization of this material from ethyl acetate 
afforded an analytical sample of XX as a white powder, mp 
252-253,5°. 
Anal. Calcd. for c17H22NC1: C, 74,0; H, 8. 0; N, 5,1, 
Found: C, 74,4; H, 8. 2; N, 5,4, 
Succinic anhydride (XXI). - The procedure of Fieser 
and Martin (173) was used. To a flask fitted with a reflux 
condenser and gas trap leading to a solution of sodium 
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hydroxide was added 100 g (1.0 mole) of succinic acid, mp 
182° (Fisher), and 315 ml (4,5 moles) of acetyl chloride. 
The reaction mixture was heated at reflux for 4 hours, 
cooled to room temperature and then refrigerated for 14 
hours. The mixture was filtered and the solid was washed 
with ether. Concentration of the mother liquor afforded 
13 g of white solid. The combined solids were dried under 
reduced pressure to give 79,4 g (79%) of succinic anhydride 
as white needles, mp 118, 5-120 , 5°, literature (173) mp, 
118-119°, The infrared spectrum showed A ���13 1785 cm-1 
( strong, C=O), 1862 cm-1 (strong, C=O). The nmr spectrum 
(DMSO-d6)��h�wed a maximum as a singlet at 2,97 ppm 
(-CH2-CH2-). 
N- [i-( 4-Biphenylyl )-n-pentyl] -succinamic Acid (VI), -
The method described by Vogel (174) was used. A solution 
of 0. 50 g (1. 82 mm0les) of the aforementioned amine hydro­
chloride XX, mp 250-253
°, in 18 ml of ice-cold 5% sodium 
hydroxide solution was extracted with 50 ml of benzene. 
The organic phase was washed with water, a saturated sodium 
chloride solution, and dried over anhydrous sodium sulfate. 
Filtration of the mixture afforded a solution of 435 mg 
(1. 82 mmoles) of the desired 1- (4-biphenylyl)-1-amino­
pentane (XLIII) in dry benzene. To the solution was added 
200 mg (2. 0 mmoles) of the previously prepared succinic 
anhydride (XXI), mp 118. 5-120. 5°, and the resulting solu­
tion was stirred at room temperature for 3 hours, then 
extracted with 5% sodium hydroxide solution. The alkaline 
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aqueous phase was ad justed to pH 2 with ice-cold 5% hydro­
chloric acid solution, and the acidic material was extracted 
with ether. The organic phase was washed with water, 
saturated sodium chloride solution, and dried over anhy­
drous sodium sulfate. Removal of the solvent under re­
duced pressure gave 573 mg of a white solid, mp 165-170°, 
which was recrystallized from ethyl acetate-petroleum ether 
(60-70°) to give 259 mg (40%) of succinamic acid VI as 
white needles, mp 176, 5-178°. Thin layer chromatography 
of this material on neutral silica gel plates (Mallinkrodt) 
developed with 80% benzene-20% ethanol and visualized with 
both iodine vapor and bromcresol green showed the acid-
-1 cm 
amide to be pure within limits of detection with an Rf 
value of 0. 65. The infrared spectrum showed J !!� 3250 
(strong, N-H), 1725 cm-1 (strong, C=O), and 1640 cm-1 
(strong, C=O amide). The nmr spectrum (DMSO-d6) showed 
maxima for 1 proton as a singlet at 8. 44 ppm (-COOH), 1 
proton as a singlet at 8. JO ppm (-CONH), 9 aromatic protons 
at 7, 34-7, 84 ppm, 4 protons as a singlet at 2,54 ppm (suc­
cinamic acid methylenes), and 9 protons as multiplets at 
0. 67-2. 00 ppm (n-c4tt9). 
Anal. Calcd. for c21tt25No3: C ,  74, J; H, 7, 4; N, 4. 1 .  
Feund: C, 74, 1; H, 7, 4; N, 4, 2, 
N- [j.-(4-Biphenylyl)-n-penty� -glutaramic Acid (VII). -
The method described by Vogel (174) was used. To a solu­
tion of 1. 03 g (4. J mmoles) of 1-(4-biphenylyl)-1-amino­
pentane (XLIII) in 75  ml of dry benzene, prepared as 
1 3 5 
previ ous ly described for succ inamic acid V I , was added 
500  mg ( 4 , 3  mmoles ) of glutaric anhydride , �P 52-56 ° 
( Aldrich ) .  The resulting solut ion was s tirred at room 
temperature for 7 2 hours and then extracted with 5% sodium 
hydroxide solution .  The alkaline aque ous phase was ad justed 
to  pH 1 w i th i c e -c o ld 5% hydrochloric acid solution and 
the ac idic material was extrac ted w i th ethe r .  The organic 
phase was dried over anhydrous sodium sulfate and removal 
of the solvent at reduc ed  pre ssure afforded 1 , 2 7 g of a 
white  solid , mp 1 31 . 5- 1 3 3 , 5
° , which was recrys tallized  from 
e thanol�water to give 7 54 mg ( 50%)  of  glutaramic ac id V I I  
a s  a white  s o l id , mp 1 3 6 - 1 3 7
°
. The infrared spec trum 
showed A �!� 3 240 cm- l ( s trong , N-H ) , 1 7 05  cm-l ( strong , 
C= O ) , and 1 63 0  cm-1 ( s trong , C=O amide ) .  The nmr spec trum 
( DMS O-d6 ) showed maxima f or 1 proton as a s inglet  at 8 . 44 
ppm ( -C OO:-I ) , 1 proton as a s ingl e t  at 8 . 3 0  ppm ( -C ONH ) , 
9 aromatic pro tons at 7 , 34-7 , 7 5  ppm , 1 proton as a broad 
doublet  at 4 , 92 ppm ( R
3
C -H ) , 6 protons as a multipl e t  at 
1 , 58 -2 . 42 ppm ( glutaramic ac id me thylenes ) ,  and 9 pro tons 
as a multiple t at 0 , 67 -1 , 50 ppm ( rr-C4H9 ) .  
Anal , Calcd . for c2 2H27 N o3 : C ,  74 , 8 ;  H ,  7 , 7 ;  N ,  4 . o .  
Found : C ,  74 , 6 ; H ,  8 . 0 ;  N ,  3 , 9 , 
1 - (4-Biphenylyl)-J-buten-1 -ol  (XX I I) . - The proc edure 
of Tschesche and Machle idt ( 1 65 )  was used . To a thre e ­
necked flask f it ted  w i th a mechanical s tirrer , reflux c on­
dens e r ,  pre ssure c ompensating dropping funne l ,  and dry ing 
tube was added 0 . 97 g ( 0 . 04 g-atom ) of magnes ium turnings . 
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The system was flame-dried under a stream of dry nitrogen, 
and when it had cooled 10 ml of dry ether, 10 ml of dry 
tetrahydrofuran, and a small crystal of iodine were added 
to the flask. To the magnesium mixture was added in a 
dropwise manner over a period of 0. 5 hour a solution of 3. 46 
ml (0. 04 mole) of allyl bromide (Fisher), 3,64 g (0. 02 
mole) of 4-biphenylcarboxaldehyde (Aldrich), 25 ml of dry 
ether, and 75  ml of dry tetrahydrofuran. During the ad­
dition the reaction mixture was maintained at a gentle 
reflux and when the addition was complete the mixture was 
stirred at reflux for 1 hour. To the mixture was added in 
a slow, dropwise manner with cooling and stirring a satu­
rated solution of ammonium chloride which had been ad justed 
to pH 7 with concentrated ammonium hydroxide solution. When 
no further precipitate formed the mixture was filtered 
and the white solid was washed with ether. The resulting 
solution was washed with a saturated sodium chloride 
solution and dried over anhydrous sodium sulfate. Removal 
of the solvent under reduced pressure afforded 4. 05 g of 
a light tan solid, mp 60. 5-62°, which was recrystallized 
from hexane to give 3,09 g (69%) of butenyl alcohol XXI I  
as white plates, mp 63. 5-65° . The infrared spectrum 
'1 CHCl 1 -1 ( showed A max 3 3590 cm
- (medium, 0-H), 1640 cm medium, 
C=CH2). The nmr spectrum (CDc13) showed maxima for 9 
aromatic protons at 7. 20-7. 70 ppm, 1 proton as a multiplet 
at 5. 48-6. 18 ppm (-CH=), 2 protons as multiplets at 4, 87-
5. 27 ppm (=CH2), 1 proton as a triplet at 4. 65 ppm (R3C-H), 
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1 proton as a singlet at 2,68 ppm (0-H), and 2 protons as 
a triplet at 2,47 ppm (-CH2-). 
Anal. Calcd. for c16H16o : C ,  85,7; H, 7,2, F0und: 
C, 86,0; H , 7,2, 
1-(4-Biphenylyl)-3-butenyl Hydrogen Succinate · (\fIIIa). 
The method of Steglich and Hoffle (175) was modified. To 
a solution of 546 mg (2. 44 mmoles) of the aforementioned 
butenyl alcohol XXII, mp 63, 5-65°, in 10 ml of N , N-dimethyl­
formamide (DMF) , which had been distilled from barium oxide, 
was added 244 mg (2. 44 mmoles) of succinic anhydride (XXI), 
mp 118,5-120. 5° , and 297 mg (2. 44 mmoles) of 4-dimethyl­
aminopyridine , mp 108-110° (Aldrich). The resulting solu­
tion was stirred at room temperature for 72 hours and then 
poured into a slurry of ice and 5% hydrochloric acid and 
extracted with ether. The organic phase was washed with 
water, saturated sodium chloride solution and dried over 
anhydrous sodium sulfate. Removal of the solvent under 
reduced pressure afforded 624 mg (79%) of hydrogen succinate 
VIIIa as a viscous, clear, yellow oil. The infrared 
spectrum showed ) CHClJ 1715 cm-l (strong, C=O), 17J8 cm-l max 
(strong, C=O) , and 1642 cm-1 (weak, C=C). The nmr spectrum 
(CDC13) showed maxima for 1 proton as a singlet at 9, 47 ppm 
(-COOH) , 9 aromatic protons at 7, 17-7, 56 ppm, 2 protons as 
a multiplet at 5,34-5, 90 ppm (=CH2) , and 6 protons as a 
singlet (succinate methylenes) superimposed on a triplet 
(butenyl methylene) at 2. 55 ppm. This compound was 
analytically characterized a£ described below. 
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S-Benzylthiuronium Salt of 1-(4-Biphenylyl)-3-butenyl 
Hydrogen Succinate (VIIIa-S). - To a solution of 233 mg 
(0, 72 mmoles) of hydrogen succinate VIIIa in 15 ml of 95% 
ethanol was added 2,56 ml (0. 77 mmole) of 0. 3 N sodium 
hydroxide solution and a solution of 1. 1 g (5, 0 mmoles) of 
S-benzyl-2-thiopseudourea hydrochloride (Eastman) in 8 ml 
of hot 95%- ethanol. The volume was made up to a total of 
100 ml with distilled water and the resulting opaque 
white mixture was cooled in an ice bath, filtered, and the 
precipitate was washed thoroughly with water . Two recrys­
tallizations from ethyl acetate-petroleum ether (60-70°) 
afforded an analytical sample of S-benzylthiuronium salt 
VIIIa-S as a white solid, mp 143-144°. 
Anal, Calcd. for c
28H30N2 o4s • !H2 0: C ,  67, 3; H, 6. 2; 
N, 5, 6, Found: C ,  67. 4; H, 6. 2; N, 5,6. After drying 
under a pressure of 1 mm Hg for 8, 5 hours at 110° the one­
half mole of water was successfully removed. The resulting 
elemental analyses were as follows: 
Anal. Calcd. for c
28H30N2 o4s: C, 68. 6; H, 6. 2; N, 
5,7, Found: C ,  68, 5; H, 6. 1; N, 6. 1. 
1-(4-Biphenylyl)-3-butenyl Hydrogen Glutarate(VIIIb). -
The method of Steglich and Hoffle (175) was modified. To a 
solution of 896 mg (4. 0 mmoles) of butenyl alcohol XXII, mp 
63,5-65°, in 10 ml of N , N-dimethylformamide were added 
456 mg (4. 0 mmoles) of glutaric anhydride (Aldrich), mp 52-
560, and 488 mg (4 . 0  mmoles) of 4-dimethylaminopyridine 
(Aldrich), mp 108-110°. The resulting solution was stirred 
1J9 
at room temperature for 48 hours, then poured onto a slurry 
of ice and 5% hydrochloric acid and extracted with ether . 
The organic phase was extracted with a cold 5% sodium 
hydroxide solution; then the alkaline aqueous phase was 
ad justed to pH 2 with ice-cold 5% hydrochloric acid. The 
acidified material was extracted with ether and the organic 
phase was washed with water, saturated sodium chloride 
solution, and dried over anhydrous sodium sulfate. Re­
moval of the solvent under reduced pressure afforded 417 
mg (26%) of hydrogen glutarate VIIIb as a viscous, light 
brown oil. The infrared spectrum showed A CHClJ 17JO cm-1 max 
(strong, C=0), . 1715 cm-1 (strong C=O), and 1645 cm-1 (weak, 
C=C). The nmr spectrum (CDC13) showed maxima for 1 proton 
as a broad singlet at 9. 20 ppm (-COOH), 9 aromatic protons 
at 7,17-7,60 ppm, 2 protons as multiplets at 5,37-5,94 ppm 
(R3C-H and -CH=), 2 protons as a multiplet at 4. 80-5,24 ppm 
(=CH2), and 8 protons as multiplets at 1 , 17-2, 74 ppm 
(glutarate and butenyl methylenes). This compound was 
analytically characterized as described below. 
S-Benzylthiuronium Salt of 1-(4-Biphenylyl)-J-butenyl 
Hydrogen Glutarate (V I I Ib-S). - The salt was prepared by 
the method of Donleavy (168) as modified by Boots et al. 
(158) from the aforementioned hydrogen glutarate VI IIb in 
the same manner as previously described using 260 mg (0,77 
mmole) of the ester. Two recrystallizations of the crude 
salt from ethyl acetate-petroleum ether (60-70°) afforded 
an analytical sample of S-benzylthiuronium salt VIIIb-S, 
mp 146 . 5-147
°. 
Anal. Calcd. for c29H32N2o4s :  C, 69,0 ; H ,  6. 4 ;  N, 
5. 6. Found : C, 69,2 ; H ,  6. 5 ;  N ,  5,5 , 
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1-(4-Biphenylyl)-3,4-epoxybutan-1-ol (XXV) . - The 
method described by Fieser and Fieser (176) was used. To 
a solution of J,36 g (15,0 mmoles) of the previously 
described butenyl alcohol XXI I, mp 63. 5-65°, in 25 ml of 
dry chloroform was added in a dropwise manner with stirring 
and cooling in an ice bath a solution of 5, 06 g (25,0 
mmoles) of 85% fil-chloroperbenzoic acid (Eastman) in 100 
ml of dry chloroform. The clear, colorless reaction solu­
tion was stirred at room temperature for 18 hours and then 
with 75  ml of a 10% solution of sodium sulfite until the 
starch-potassium iodide test was negative. The organic 
phase was washed with a 5% solution of sodium hydrogen 
carbonate, then with water, saturated sodium chloride 
solution, and dried over anhydrous sodium sulfate, Removal 
of the solvent under reduced pressure gave J,50 g (97%) of 
epoxyalcohol XXV as a brown oil. The infrared spectrum 
showed A CHClJ 3600 cm-1 (medium, free 0-H), J450 cm-1 max 
(medium, broad, hydrogen bonded 0-H), and 835 cm-1 (epoxide). 
The nmr spectrum (CDc 13) showed maxima for 9 aromatic pro­
tons at 7, 27-7 ,66 ppm, 1 proton as a triplet at 4. 84 ppm 
(R3C-H), 1 proton as a singlet at 3. 48 ppm (R-0-H), 3 A 
protons as a multiplet at 2. 32-3. 22 ppm (-CH-CH2), and 2 
protons as a triplet at 1. 90 ppm (-CH2-). Molecular 
distillation using a Hickman still provided an analytical 
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sample of this compound as a clear, colorless oil, 
Anal. Calcd. for c16H16o2 : C ,  80,0; H, 6,7, Found: 
C, 79,8; H, 6,5, 
1-(4-Biphenylyl)-3,4-epoxybutyl Hydrogen Succinate 
(IXa). - The ester was prepared from _the aforementioned 
epoxybutanol as previously described for the butenyl hydrogen 
succinate VIIIa to give 896 mg ( 57%) of epoxybutyl hydrogen 
succinate IXa as a viscous, yellow oil. The infrared 
'l CHCl -1 1 spectrum showed A max J 1740 cm ( strong, C=O), 1719 cm
-
( strong, C=O), and 840 cm-1 ( strong, epoxide). The nmr 
spectrum (CDC13) showed maxima for 1 proton as a singlet 
at 8,55 ppm ( -COOH), 9 aromatic protons at 7,21-7,64 ppm, 
1 proton as a triplet at 5,94 ppm ( R3C-H), 4 protons as a .  
singlet at 2. 60 ppm ( succinate methylenes) superimposed 
/o, 
upon 5 protons as a multiplet at 1,8J-J. 1J ppm ( -CH2-CH-CH2) .  
This compound was analytically characterized as described 
below. 
S-Benzylthiuronium Salt of 1-(4-Biphenylyl)-3,4-
epoxybutyl Hydrogen Succinate (IXa-S). - The salt of the 
aforementioned epoxybutyl hydrogen succinate IXa was pre­
pared in the previously described manner using 261 mg ( 0,77 
mmole) of the hydrogen succinate. Two recrystallizations 
of the crude salt from ethyl acetate-petroleum ether ( 60-
700) afforded an analytical sample of S-benzylthiuronium 
salt IXa-S as a light brown solid, mp 114-116°. 
Anal. Calcd. for c
28H30N2 o5s • !H2 0 : C ,  65,2; H , 6. 0; 
N ,  5,4, Found: C, 65,J; H ,  6. 0; N, 5,4, 
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1-(4-Biphenylyl)-3,4-epoxybutyl Hydrogen Glutarate 
( IXb). - The ester was prepared from the aforementioned 
epoxybutanol XXV as previously described for the butenyl 
hydrogen succinate VIIIa to give 325 mg (47%) of hydrogen 
glutarate IXb as a viscous, clear, yellow oil. The infra-
red spectrum showed ') CHC13 max 1735 cm 
-1 
(strong, C=O), 1715 
-1 (strong, C=O), and 835 cm -1 (strong, epoxide), The cm 
nmr spectrum (CDC13) showed maxima for 1 proton as a broad 
singlet at 8. 39 ppm (-COOH), 9 aromatic protons at 7,18-
7, 62 ppm, 1 proton as a triplet at 5, 95 ppm (R3C-H), and 
8 protons as multiplets at 0, 93-3, 00 ppm (methylenes). 
This compound was analytically characterized as described 
below, 
S-Benzylthiuronium Salt of 1-(4-Biphenylyl)-3,4-· 
epoxybutyl Hydrogen Glutarate (IXb-S). - An analytical 
sample of the S-benzylthiuronium salt of the aforementioned 
hydrogen glutarate was prepared as previously described 
using 259 mg (0,73 mmole) of the ester. Recrystallization 
of the crude salt twice from ethyl acetate-petroleum ether 
(60-70°) afforded an analytical sample of S-benzylthiur�nium 
salt IXb-S as a white solid, mp 13 2-13 3 °. 
Anal. Calcd. for c29H32N2 o5s, !H2 0: C, 65, 8; H, 6. 2; 
N ,  5 , 3 ,  Found: C, 65,6; H ,  6. 2; N, 5 , 3 ,  
1-(4-Biphenylyl)-4-penten-1-ol (XXIII). - To a three­
necked flask fitted with a reflux condenser, .drying tube, 
pressure compensating dropping funnel, and mechanical 
stirrer was added 486 mg (0. 02 g-at0m) of magnesium turnings 
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and the system was flame-dried under a stream of dry 
nitrogen. To the cooled system was added, in a dropwise 
manner with heating and stirring, a solution of 2,74 g 
(0. 02 mole) of 4-bromo-1-butene (K&K Laboratories) in 50 
ml of ether. To the resulting Grignard reagent was added 
a solution of 1. 82 g (0. 01 mole) of 4-biphenylcarboxaldehyde, 
mp 57-59
° (Aldrich), in 50 ml of ether in a dropwise manner 
with stirring and heating at reflux over a period of 1,5 
hours, followed by stirring at room temperature for 3 hours . 
To the reaction mixture was added in a slow, dropwise 
manner with stirring and cooling a saturated solution 
of ammonium chloride which had been adjusted to pH 7 with 
concentrated ammonium hydroxide solution. When no more 
precipitate formed the mixture was filtered, the solid was 
washed with ether, and the solution was dried over an­
hydrous sodium sulfate. Removal of the solvent at reduced 
pressure afforded 2,27 g (94%) of pentenyl alcohol XXIII 
as a white solid, mp 66. 5-67,5°. Thin layer chromatography 
on silica gel (Eastman Chromotogram Sheet 6060) developed 
with 50% benzene-50% methanol and visualized with iodine 
vapor showed this material to be pure within the limit£ of 
'l CHCl -1 detection. The infrared spectrum showed A max 3 3600 cm 
(medium, free 0-H), 3443 cm-1 (weak, broad, hydrogen 
bonded 0-H), and 1641 cm-1 (medium, C=C) .  The nmr spectrum 
(CDC13) showed maxima for 9 aromatic protons at 7,21-7,68 
ppm, 1 proton as a multiplet at 5,53-6,10 ppm (-CH=), 2 
protons as a multiplet at 4. 81-5, 20 ppm (=CH2), 1 proton 
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as a triplet at 4, 63 ppm (R3C-H), 1 proton as a singlet 
at 2 . 50 ppm (0-H), and 4 protons as a multiplet at 1. 67-
2. 34 ppm (-CH2-CH2-). Recrystallization of this compound 
from petroleum ether (60-70°) afforded an analytical 
specimen of alcohol XXIII as white needles, mp 68-68. 5°, 
Anal. Calcd. for c17H18o : C ,  85,7; H, 7, 6, Found: 
C, 85, 6; H, 7, 7, 
1-(4-Biphenylyl)-4-pentenyl Hydrogen Succinate (VI I Ic). 
The ester was prepared from the aforementioned pentenyl 
alcohol XXII I  as previously described for the butenyl 
hydrogen glutarate VI I Ib to give 1. 05 g (57%) of hydrogen 
succinate V I I Ic as a viscous yellow oil . The infrared 
spectrum showed 1 CHCl3 1718 cm-1 (strong, C=O), 1730 cm-l max 
(strong, C=O). The nmr spectrum (CDC13) showed maxima for 
1 proton as a singlet at 9, 94 ppm (-COOH), 9 aromatic pro­
tons at 7, 25-7, 71 ppm, 2 protons as a broad multiplet at 
5 , 50-6 . 09 ppm (R3C-H and -CH=), 2 protons as a multiplet 
at 4. 84-5, 22 ppm (=CH2), 4 protons as a singlet at 2, 58 ppm 
(succinate methylenes), and 4 protons as a broad band 
centered at 2. 04 ppm (butenyl methylenes) . This compound 
was analytically characterized as described below. 
S-Benzylthiuronium Salt of 1-(4-Biphenylyl)-4-pentenyl 
Hydrogen Succinate (VI I Ic-S). - The salt of the aforemen­
tioned hydrogen succinate V I I Ic was prepared as previously 
described from 270 mg (0, 37 mmole) of the ester. Two re­
crystallizations of the crude salt from ethyl acetate­
petroleum ether (60-70°) gave an analytical sample of 
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S-benzylthiuronium salt VIIIc-S as a white solid, mp 118-
1190. 
Anal. Calcd. for c29H32N2o4S : C ,  69, 0; H ,  6. 4; N, 
5, 6, Found: C ,  68. 8; H ,  6.4; N ,  5, 6, 
1-(4-Biphenylyl)-4-pentenyl Hydrogen Glutarate (VIIId). 
The ester was prepared from the aforementioned pentenyl 
alcohol XXIII as previously described for the butenyl 
hydrogen glutarate VII Ib to give 7J5 mg (JS%) of hydrogen 
glutarate VIIId as a viscous, yellow oil. The infrared 
""I CHClJ 1 1 spectrum showed A max 1712 cm
- (strong, C= O), 1729 cm-
(strong, C=O). The nmr spectrum (CDClJ) showed maxima for 
1 proton as a single t at 9, 90 ppm (-COOH), 9 aromatic pro­
tons at 7, 17-7, 66 ppm, 2 protons as a broad band at 5, 45-
6. 0J ppm (R3C-H and -CH=), 
2 protons as a multiple t at 
4, 78-5, 19 ppm (=CH
2), and 10 protons as multiple ts at 1, 67-
2. 67 ppm (glutarate and butenyl methylenes). This compound 
was analytically characterized as described below. 
S-Benzylthiuronium salt of 1-(4-Biphenylyl)-4-pentenyl 
Hydrogen Glutarate (VII Id-S). - The salt of the aforemen­
tioned hydrogen glutarate VIIId was prepared as previously 
described from 128 mg (O. J6 mmole) of the ester. Two re­
crystallizations of the crude salt from e thyl ace tate­
pe troleum e ther (60-70°) afforded an analytical sample of 
the S-benzylthiuronium salt VIIId-S as a light brown 
solid, mp 122-12J0 • 
Anal. Calcd. for c30H34N2 o4s
• !H20: C ,  68. J; H , 6. 4; 
N ,  5, J, Found: C ,  68. 4; H ,  6, 5 ;  N ,  5, 4, 
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1-(4-Biphenylyl)-4,5-epoxypentan-1-ol (XXVI). - The 
method described by Fieser and Fieser (176) was used. To 
a flask fitted with a magnetic stirrer, pressure compen­
sating dropping funnel, and drying tube was added a solution 
of 1,19 g (0. 05 mole) of the previously prepared pentenyl 
alcohol XXIII, mp 66. 5-67, 5°, in 25 ml of dry chloroform. 
To the flask was added in a dropwise manner with stirring 
and cooling over a period of 1 hour a solution of 1. 41 g 
(0. 07 mole) of 85% m-chloroperbenzoic acid (Eastman) in 
75 ml of dry chloroform. The reaction solution was stirred 
at room temperature for 20 hours, and then with 50 ml of a 
10% solution of sodium sulfite until the starch-potassium 
iodide test was negative. The organic phase was washed with 
a 5% sodium hydrogen carbonate solution, water, saturated 
sodium chloride solution, and dried over anhydrous sodium 
sulfate. Removal of the solvent at reduced pressure af­
forcled 1. 23 g (96%) of epoxyalcohol XXVI as a brown oil. 
• I"\ CHCl 5 -1 ( 
· f The infrared spectrum showed A
max 
3 359 cm medium, ree 
0-H), 3430 cm-1 (medium, broad, hydrogen bonded 0-H), and 
835 cm-1 (medium, epoxide). The nmr spectrum showed maxima 
for 9 aromatic protons at 7,24-7,67 ppm, 1 proton as a 
triplet at 4. 66 ppm (R3C-H), 1 proton as a singlet at 3,25 
ppm (0-H), and 7 protons as multiplets at 1,17-2,79 ppm 
( epoxy butyl) . 
Several attempts were made to prepare an analytical 
sample of this compound. Molecular distillation with a 
Hickman still at temperatures up to 180° and pressure below 
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1 mm Hg afforded a clear, colorless oil which exhibited 
carbon analysis which was consistently approximately 1. 6% 
below the theoretical value . Infrared and nmr spectra of 
this compound were satisfactory. In addition, the infra­
red and nmr spectra as well as elemental analysis for 
pentenyl alcohol XXIII, from which epoxyalcohol XXVI was 
synthesized, and for esters IXc and IXd which were syn­
thesized from epoxyalcohol XXVI were all .completely satis­
factory. On this basis it was concluded that the desired 
epoxyalcohol XXVI had been obtained. 
1-(4-Biphenylyl)-4,5-epoxypentyl Hydrogen Succinate 
(IXc). - The ester was prepared from the aforementioned 
epoxypentanol XXVI as previously described for the butenyl 
hydrogen glutarate VIIIb to give 924 mg (73%) of hydrogen 
succinate IXc as a viscous, yellow oil. The infrared 
spectrum showed A ���13 1720 cm-1 (strong, C=O), 1735 cm-1 
(strong, C=O), and 835 cm-1 (medium, epoxide). The nmr 
spectrum (CDC13) showed maxima for 1 proton as a singlet 
at 9. 22 ppm (-COOH), 9 aromatic protons at 7,06-7,67 ppm, 
1 proton as a broad band at 4,98 ppm (R3C-H), 4 protons as 
a singlet at 2. 62 ppm (succinate methylenes), and 7 protons 
as multiplets at 0,77-2,17 ppm (epoxybutyl). This compound 
was analytically characterized as described below. 
S-Benzylthiuronium Salt of 1-(4-Biphenylyl)-4,5-
epoxypentyl Hydrogen Succinate (IXc-S). - The salt of the 
aforementioned hydrogen succinate was prepared as previously 
described from 272 mg (0, 77 mmole) of the ester. Two 
148 
recrystallizations of the crude salt from ethyl acetate­
petroleum ether (60-70°) afforded an analytical sample of 
S-benzylthiuronium salt IXc-S as a light brown solid, mp 
97-99°, 
Anal, Calcd . for c29H32N2o5s · tH20 :  C ,  65,8; H , 6. 0; 
N ,  5,3, Found: C, 65, 7; H ,  6. 1; N ,  5,4, 
1-(4-Biphenylyl)-4,5-epoxypentyl Hydrogen Glutarate 
(IXd), - The ester was prepared from the aforementioned 
epoxypentanol XXVI as previously described for the butenyl 
hydrogen glutarate VIIIb to give 707 mg (42%) of hydrogen 
glutarate IXd as a clear, viscous yellow oil. The infra­
red spectrum showed A ���13 1730 cm-1 (strong, C=O), 1720 
cm-1 (strong, C=O), and 835 cm-l (weak, epoxide), The nmr 
spectrum (CDC13) showed maxima for 1 proton as a singlet 
at 7,86 ppm (-COOH), 9 aromatic protons at 7, 14-7,64 ppm, 
1 proton as a broad band at 4, 96 ppm (R3C-H), and 10 
protons as multiplets at 0. 80-2. 80 ppm (glutarate methylenes 
and epoxybutyl). This compound was analytically charac­
terized as described below. 
S-Benzylthiuronium Salt of 1-(4-Biphenylyl)-4,5-
epoxypentyl Hydrogen Glutarate ( IXd-S). - The salt of the 
aforementioned hydrogen glutarate IXd was prepared as pre­
viously described using 176 mg (0. 48 mmole) of the ester. 
Two recrystallizations of the crude salt from ethyl acetate­
petroleum ether (60-70°) afforded an analytical sample of 
S-benzylthiuronium salt IXd-S as a tan solid, mp 115-117°. 
Anal. Calcd. for c30H33N2 o5s
,tH20: C ,  66,3; H, 6. 3; 
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N ,  5, 2., Found: C ,  66. 1; H ,  6. 4; N ,  5, 0, 
1-(4-Biphenylyl)-5-hexen-1-ol (XXIV). - To a three­
necked flask fitted with a reflux condenser , mechanical 
stirrer, drying tube, and pressure compensating dropping 
funnel was added 607 mg (0. 025 g-atom) of magnesium turnings 
and the system was flame-dried under a stream of dry nitrogen, 
To the cooled system was added a small crystal of iodine 
and, in a dropwise manner with stirring over a period of 
15 minutes, a solution of 2. 98 g (0. 02 mole) of 5-bromo-
1-pentene (K&K Laboratories) in 50 ml of dry ether and the 
resulting mixture was stirred at reflux for 20 minutes. To 
the resulting Grignard reagent was added a solution of 
J, 09 g (0. 017 mole) of 4-biphenylcarboxaldehyde, mp 52-
550 (Aldrich), in 75 ml of dry ether and 15 ml of tetra­
hydrofuran in a dropwise manner over a period of 1 hour with 
stirring and heating at reflux, followed by stirring at 
room temperature for 2 hours. To the reaction mixture was 
added in a slow, dropwise manner with cooling and stirring 
a solution of saturated ammonium chloride which had been 
ad justed to pH 7 with concentrated ammonium hydroxide 
solution. When no more precipitate formed, the mixture 
was filtered, the solid was washed with ether, and the 
solution was dried over anhydrous sodium sulfate. Rem�val 
of the solvent under reduced pressure gave J. 01 g of a 
soft , brown solid which was recrystallized from petroleum 
ether (60-70 °) to give 1,99 g (46%) of hexenyl alcohol XXIV 
as a white, fluffy solid, mp 54-57°, The infrared spectrum 
showed Ji ���13 3599 cm-1  (medium, free 0-H), 3435 -1  cm 
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(weak, broad, hydrogen bonded 0-H), and 1641 cm-1 (medium, 
C=C). The nmr spectrum (CDC13) showed maxima for 9 aromatic 
protons at 7. 16-7. 67 ppm, 1 proton as a multiplet at 5, 45 
ppm (-CH=), 2 protons as a multiplet at 4, 77-5, 21 ppm 
(=CH2), 1 proton as a triplet at 4. 61 ppm (R3C-H), 1 proton 
as a broad singlet at 3, 02 ppm (0-H), and 6 protons as 
multiplets at 1, 15-2, 25 ppm (-CH2-CH2-CH2-). Recrystal­
lization of this compound from petroleum ether (60-70°) 
provided an analytical specimen, mp 55-58°. 
Anal. Calcd. for c18H20o :  C, 85, 7 ;  H ,  8. 0. Found : 
C, 85. 5; H, 7, 6, 
1-(4-Biphenylyl)-5-hexenyl Hydrogen Succinate (V I I Ie), 
The ester was prepared from the aforementioned 5-hexen-1-
ol XX IV as previously described for the butenyl hydrogen 
glutarate V I I Ib to give 612 mg (58%) of hydrogen succinate 
V I I Ie as a beautiful, golden, viscous, clear oil. The 
infrared spectrum showed A CHCl3 1730 cm-1 (strong, C=O), max 
1720 cm-1 (strong, C=O). The nmr spectrum (CDC13) showed 
maxima for 1 proton as a singlet at 8. 55 ppm (-COOH), 9 
aromatic protons at 7, 18-7, 74 ppm, 1 proton as a multiplet 
at 5, 45-6. 08 ppm (-CH=), 2 protons as a multiplet at 4. 80-
5, 20 ppm (=CH2), 1 proton at 4. 65 ppm (R3C-H), 4 protons 
as a singlet at 2. 60 ppm (succinate methylenes), and 6 
protons at 1. 08-2, 25 ppm (-CH2-cH2-CH2-). This compound 
was analytically characterized as described below. 
S-Benzylthiuronium Salt of 1- (4- Biphenylyl)-5-hexenyl 
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Hydrogen Succinate (VIIIe-S). - The salt of the aforemen­
tioned ester VIIIe was prepared as previously described 
from 168 mg (0. 48 mmole) of the ester. Two recrystal­
lizations of the crude salt from ethyl acetate-petroleum 
ether (60-70°) provided an analytical sample of the S­
benzylthiuronium salt VIIIe-S as a white solid, mp 125-
1270, 
Anal. Calcd. for c30H34N2o4s • 1H20 : C ,  67 , 2 ;  H , 6, 3 ;  
N ,  5, 2, Found : C ,  67, 3 ;  H, 6, 5 ;  N, 5, 3, 
1-(4-Biphenylyl)-5-hexenyl Hydrogen Glutarate (VIIIf). 
The ester was prepared by the method of Steglich and 
Hoffle (175) from the aforementioned hexenyl alcohol XXIV 
as previously described for the butenyl hydrogen glutarate 
VIIIb. This afforded 457 mg (42%) of hydrogen glutarate 
VIIIf as a clear, viscous brown oil. The infrared spectrum 
'"\ CHCl -1 ( ) -1 showed A
max 
3 1730 cm strong, C=O , 1725 cm (strong, 
C=O). The nmr spectrum (CDC13) showed maxima for 1 proton 
as a broad singlet at 10. 0 ppm (-COOH), 9 aromatic protons 
at 7 , 30-7,75 ppm, 2 protons as multiplets at 5,46-6. 07 
ppm (-CH= and R3C-H), 2 protons 
as a multiplet at 4. 67-
5. 20 ppm (=CH2), and 12 protons as 
multiplets at 1. 17-
2. 62 ppm (-CH2-CH2-CH2- of hexenyl 
and glutarate moieties). 
This compound was analytically characterized as described 
below. 
S-Benzylthiuronium Salt of 1-(4-Biphenylyl)-5-hexenyl 
Hydrogen Glutarate (VIIIf-S). - The salt of the previ0usly 
described 5-hexenyl hydrogen glutarate VIIIf was prepared 
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as previously described using 174 mg (0 . 48 mmole) of the 
ester. Two recrystallizations of the crude salt from ethyl 
acetate-petroleum ether (60-70°) afforded an analytical 
sample of S-benzylthiuronium salt VIIIf-S as white plates, 
mp 100-101. 5°. 
Anal. Calcd. for c31tt36N2o4s :  C ,  68, 7 ;  H , 6. 6 ;  
N, . 5. 2. Found : C , 68 , J; H, 6. 5 ;  N, 4, 8. 
1-(4-Biphenylyl)-5,6-epoxyhexane-1-ol (XXVII). -
The method described by Fieser and Fieser (176) was employed. 
To a flask equipped with a pressure compensating dropping 
funnel, magnetic stirrer and drying tube was added a 
solution of 1. 00 g (4. 0 mmoles) of the previously described 
hexenyl alcohol XXIV, mp 54-57 °, dissolved in 25 ml of dry 
chloroform. To the resulting solution was added in a 
dropwise manner with stirring and cooling over a period 
of one hour a solution of 1. 21 g (6. o mmoles) of 85% m­
chloroperbenzoic acid (Eastman) dissolved in 75 ml of dry 
chloroform. On completion of the addition , the clear, 
colorless reaction solution was stirred at room temperature 
for 24 hours, then stirred at room temperature with 50 
ml of 10% sodium sulfite solution until a negative starch­
iodide test was observed. The organic phase was then 
washed with 5% sodium hydrogen carbonate solution, water, 
saturated sodium chloride solution, and dried over an­
hydrous sodium sulfate. Removal of the solvent under 
reduced pressure afforded 989 mg (92%) of epoxyalcohol 
XXVII as a clear, light brown oil. The infrared spectrum 
showed ) 
CHCl3 3595 cm
-1 ( medium, free 0-H), and 3440 max 
1 53 
-1 cm 
( medium, broad, hydrogen bonded 0-H). The nmr spectrum 
(CDC13) showed maxima for 9 aromatic protons at 7,17-
7,70 ppm, 1 proton as a triplet at 4. 60 ppm (R3c-H), 1 
proton as a singlet at 3,1 7  ppm ( 0-H), 3 protons as a 
multiplet at 2. 24-2. 90 ppm ( -CB�H2), and 6 protons as a 
broad band at 1 . 22-2. 00 ppm ( -CH2-CH2-CH2-). This compound 
was used as an analytical specimen with no further pre­
paration. 
Anal. Calcd. for c1 8H20o2: C ,  80. 6; H , 7,5, Found: 
C , 80. 6; H ,  7 . 2. 
1-(4-Biphenylyl)-5,6-epoxyhexyl Hydrogen Succinate 
(IXe). - The ester was prepared from the aforementioned 
epoxyalcohol XXVII as previously described for the butenyl 
hydrogen glutarate VIIIb. This provided 560 mg of clear, 
golden, viscous oil which was composed of a mixture of the 
desired ester and starting epoxyalcohol XXVII as determined 
by infrared and nmr spectra. A 157 mg portion of this oil 
was dissolved in 1 ml of dry chloroform and chromatographed 
on 1 0  g of washed silicic acid ( 196). The starting epoxy­
alcohol ( 51 mg) was removed from the column by elution 
with 20% ether in petroleum ether. Further elution.with 
50% ether in petroleum ether afforded 78 mg of hydrogen 
succinate IXe as a clear, colorless oil, The infrared 
'l CHCl -1 spectrum showed A 3 1 720 cm max 
(strong , C= O), and 
1 730 cm-1 (strong, C=O). The nmr spectrum (CDC13) showed 
maxima for 1 proton as a broad singlet at 8. 38 ppm ( -COOH), 
., 
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9 aromatic protons at 7,23-7,74 ppm, 1 proton as a triplet 
at 5,83 ppm (R3C-H), 4 protons as a sharp singlet at 2. 64 
ppm (succinate methylenes) superimposed on 3 protons as a 
multiplet at 2,37-2,98 ppm (-CB�H2), and 6 protons as a 
broad band at 1. 27-2, 12 ppm (-CH2-CH2-CH2-). This compound 
was analytically characterized as described ·below. 
S-Benzylthiuronium Salt of 1-(4-Biphenylyl)-5,6-
epoxyhexyl Hydrogen Succinate (IXe-S), - The salt of the 
aforementioned hydrogen succinate IXe was prepared as pre­
viously described from 283 mg (0,77 mmole) of the ester. 
Two recrystallizations of the crude salt from ethyl acetate­
petroleum ether (60-70°) afforded an analytical sample of 
S-benzylthiuronium salt IXe-S as a white solid, mp 105-
1070. 
Anal. Calcd, for c30H34N2o5s : C, 67 , 39; H, 6. 4; 
N , 5, 2, Found 1 C, 67, 5; H, 6. 4; N, 5,2, 
1-(4-Biphenylyl)-5,6-epoxyhexyl Hydrogen Glutarate 
(IXf). - The ester was prepared from 891 mg (3. 31 mmoles) 
of the aforementioned epoxyalcohol XXVII as previously 
described for the butenyl hydrogen glutarate VIIIb to give 
340 mg (27%) of hydrogen glutarate IXf as a clear, yellow 
""\ CHCl -1 
viscous oil. The infrared spectrum showed A max 3 1715 cm 
(strong, C=O), 1730 cm-1 (strong, C=O). The nmr spectrum 
(CDC13) showed maxima for 9 aromatic protons at 7,16-7, 71 
ppm, 1 proton as a broad singlet at 6. 66 ppm (-COOH), 1 
proton as a singlet at 4,67 ppm (R3C-H), and 15 protons as 
broad intermingled multiplets at 0,83-3,00 ppm (epoxyalkyl 
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and glutarate methylenes). This compound was analytically 
characterized as described below . 
S-Benzylthiuronium Salt of 1-(4-Biphenylyl)-S,6-
epoxyhexyl Hydrogen Glutarate (IXf-S) . - The salt of the 
aforementioned hydrogen glutarate IXf was prepared as pre­
viously described from 165 mg (0 . 4J mmoles) of the ester . 
Two recrystallizations of the crude salt from ethyl acetate­
petroleum ether gave an analytical sample of S-benzyl­
thiuronium salt IXf-S as a white solid, mp 79-82° . 
Anal . Calcd . for c31tt36N2o5s • !H20 :  C ,  66 . 8; H, 6 . 4; 
N �  5,0, Found: C ,  66 , 9; H, 6 . 4; N, 5,J, 
1-Bromo-2-butyne (XXVIII) . Method A. - The method of 
Sharifkanov and Skhmedova (177) was used . To a round­
bottomed flask fitted with a magnetic stirrer, pressure 
compensating dropping funnel, and drying tube was added 8 . 9 
g (JJ mmoles) of phosphorous tribromide and 0 . 1  ml of 
pyridine . To the resulting solution was added in a drop­
wise manner with stirring and cooling in an ice-sodium 
chloride bath over a period of 1 hour a solution of 7,0 
g (0 . 1  mole) of 2-butyn-1-ol (Research Organic/Inorganic 
Chemical Corporation) and 0 . 1 ml of pyridine . Following 
the addition, the cloudy brown reaction solution was stirred 
at room temperature for 1, 5 hours, then distilled to give 
5,90 g (44%) of 1-bromo-2-butyne (XXVIII) as a clear, 
colorless liquid, bp 84-87
° (150 mm), literature (177) bp 
80° (1JO mm) . The infrared spectrum 
-1 ( - ) 22J5 cm -C=C- . The nmr spectrum 
1 CHCl showed A max J 
(CDClJ) showed maxima 
for 2 protons as a quartet at J ,94 ppm (=C-CH2-Br) and 
J protons as a triplet at 1. 89 ppm (ctt3-c=), 
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1-Bromo-2-butyne (XXVIII). Method B. - Slight modi­
fications in the method of Black et al, (179) and of Coe 
et al. (180) were used. Thus, to a round-bottomed flask 
equipped with a magnetic stirrer, pressure compensating 
dropping funnel, and drying tube were added 1 6. o g (0,05 
mole) of triphenylphosphite (Aldrich) and 50 ml of dry 
ether. To the resulting solution was added in a drop-
wise manner over a period of 0,5 hour with stirring and 
cooling in an ice bath 8. 00 g (0. 05 mole) of liquid bromine 
(Matheson, Coleman and Bell) and the resulting mixture was 
stirred at room temperature for 20 minutes. To the above 
solution of triphenylphosphite dibromide was added, in a 
dropwise manner with stirring and cooling in an ice bath, 
over a period of 1 hour a solution of J,50 g (0. 05 mole) 
of 2-butyn-1-ol (Research Organic/Inorganic Chemicals 
Corporation) and J,95 g (0. 05 mole) of pyridine. On 
completion of the addition, the reaction mixture was stirred 
at room temperature for 21 hours, filtered, and the white 
solid was washed with ether. The filtrate was poured into 
an ether-water mixture, the phases separated, and the 
aqueous phase extracted twice with ether. The combined 
organic phases were washed with 5% sodium hydroxide solu­
tion, water, saturated sodium chloride solution, and dried 
over anhydrous sodium sulfate. Removal of the solvent 
under reduced pressure and distillation of the residue 
afforded 3,83 g (58%) of 1 -bromo-2-butyne (XXVIII) as a 
clear, colorless liquid, bp 84-88
° (1 53 mm), literature 
(177) bp 80° (1 30 mm). The infrared spectrum showed 
1 57 
� CHCl -1 -
� max 
3 2235 cm (strong, C=C). The nmr spectrum (CDc13) 
showed maxima for 2 protons as a quartet at 3,94 ppm 
(Br-CH2-C=C-) and 3 protons as a triplet at 1. 88 ppm 
(-C=C-CH3). 
Attempted preparation of 1-(4-Biphenylyl)-J-pentyn-
1-ol (XXIX) , Method A. - To a three-necked flask fitted 
with a mechanical stirrer ; reflux condenser, gas inlet 
tube, pressure compensating dropping funnel, and drying 
tube was added 215 mg (0. 009 g-atom) of magnesium turnings 
and the system was flame-dried under a constant stream of 
dry nitrogen. When the system had cooled, a small crystal 
of iodine and 0 , 5  ml of dry ether were added to the flask. 
To the resulting mixture was added over a period of 1 8  
minutes, with stirring, a solution of 961 mg (7. 2 mmoles) 
of previously prepared 1-bromo-2-butyne (XXVIII) dissolved 
in 1 ml of ether. To the Grignard reagent was added in a 
dropwise manner, at a rate sufficient to maintain gentle 
reflux, a solution of 1. 27 g (7. 0 mmoles) of 4-biphenyl­
carboxaldehyde, mp 57-59° (Aldrich), dissolved in 5 ml of 
dry ether and 5 ml of dry tetrahydrofuran; then the reaction 
mixture was stirred at room temperature for 1 , 5  hours. To 
the mixture was added in a slow dropwise manner with 
stirring at room temperature a solution of saturated am­
monium chloride which had been ad justed to pH 7 with 
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concentrated ammonium hydroxide solution. When no more 
precipitate formed, the mixture was filtered, the solid 
washed with ether and the cloudy, yellow filtrate was washed 
with 5% hydrochloric acid solution, water, saturated sodium 
chloride solution, and dried over anhydrous sodium sulfate. 
Removal of the solvent under reduced pressure afforded 
1 �24 g of a viscous red-brown oil. The infrared spectrum 
� CHCl -1 . -1 showed � max 3 2825 cm (medium, aldehyde C-H), 2730 cm 
(medium, aldehyde C -H), and 1695 cm-1 (strong, C=O) and 
was identical to the infrared spectrum of an authentic 
sample of 4-biphenylcarboxaldehyde (Aldrich). 
Attempted preparation of 1-(4-Biphenylyl)-3-pentyn-
1-ol (XXIX) .  Method B. - The method of Henbest et al. 
(178) was used. To a flask equipped with a magnetic stirrer 
were added 1. JO g (0. 02 g-atom) of zinc powder (Fisher) and 
10 ml of a 5% hydrochloric acid solution. The zinc powder 
was etched by stirring the resulting mixture for 15 minutes 
at room temperature, then washed J times with water, twice 
with absolute methanol, and J times with ether by allowing 
the zinc powder to settle after a brief period of stirring 
and decanting the resulting supernatant solution before 
the next wash. Finally, the zinc was covered with dry 
benzene which was evaporated under a gentle stream of dry 
nitrogen until a total volume of 0. 5-1,0 ml was obtained. 
The flask was fitted with a reflux condenser, pressure 
compensating dropping funnel, and to the system were added 
over a period of 15 minutes, with stirring initially at 
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room temperature, a solution of 798 mg (6. o mmoles) of 
the previously described 1-bromo-2-butyne (XXVIII), 1. 09 g 
of 4-biphenylcarboxaldehyde (6. 0 mmoles), mp 57-59° 
(Aldrich), and 3, 8 ml of dry tetrahydrofuran. After ap­
proximately 1 ml of the above solution had been added to 
the zinc slurry a trace of mercuric chloride was added 
and· the remainder of the addition was completed at a rate 
which allowed maintenance of steady reflux. After completion 
of the addition, the reaction mixture was refluxed for 0,5 
hour then poured onto 50 ml of ice-10% acetic acid slurry. 
The resulting mixture was extracted with ether and the 
organic phase was washed with water, 5% sodium hydroxide 
solution, water, saturated sodium chloride solution, and 
dried over anhydrous sodium sulfate. Removal of the sol­
vent under reduced pressure afforded 905 mg of a light 
yellow liquid which was not completely characterized since 
it proved to be an undesired product as shown below by the 
. � COCl spectral data. The infrared spectrum showed A max 3 
-1  ( . ) 4 
-1 ( . 3590 cm medium, free 0-H , 3 10 cm broad, medium, 
hydrogen bonded 0-H), and ·1963 cm-1 (medium, allene). 
The conspicuous absence of infrared absorption in the 2100-
2300 cm-1 region and the presence of the sharp 1963 cm-1 
absorption indicated that an allene was obtained rather 
than the desired alkynyl alcohol. 
1-Phenyl-3-butyn-1-ol (XXX). A Model System. - The 
method of Lauger et al. (181) was used. To a three-necked 
flask equipped with a magnetic stirrer, pressure compensating 
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dropping funnel, and drying tube were added 1. 78 g (0. 066 
g-atom) of aluminum, 25 ml of dry tetrahydrofuran, and a 
trace of mercuric chloride, The aluminum was prepared by 
cutting 0,13 mm thick aluminum sheet into 0. 5 cm X 4. 0 cm 
strips which were rolled into small cylinders. To the 
above mixture was added in a dropwise manner with stirring 
over a period of 0 , 5  hour a solution of 11. 9 g (0. 10 mole) 
of 1-bromo-2-propyne (Aldrich) dissolved in 25 ml of tetra­
hydrofuran. During the addition the reaction mixture was 
maintained at 25-30 ° and on completion of the addition it 
was stirred at 35-40° for 0.5 hour. To the resulting 
black mixture was added, in a dropwise manner over a 
period of 40 minutes while stirring at 30° , a solution of 
10. 6 g (0. 10 mole) of benzaldehyde (Matheson, Coleman and 
Bell) dissolved in 50 ml of dry ether. The resulting 
opaque, brown mixture was stirred at 35-40 ° for 0 . 5  hour, 
then poured onto 200 ml of an ice-water slurry and stirred 
until the mixture reached room temperature. The phases 
were separated and the aqueous phase was washed with ether. 
The organic phase was washed with water until the washings 
were pH 6, then with saturated sodium chloride solution and 
dried over anhydrous sodium sulfate. Removal of the solvent 
under reduced pressure provided a brown liquid which was 
distilled to afford 8. 08 g (55%) of alcohol XXX as a clear, 
colorless liquid, bp 77-80 ° (0. 8 mm), literature (181) bp 
1 CHCl 85-87° (0,5 mm). The infrared spectrum showed max 3 
3590 cm-1 (strong, free 0-H), 3420 cm-1 (strong, broad, 
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-1  hydrogen bonded 0-H), JJOO cm (strong, alkyne C-H), 
and 2110 cm-1 (weak, C=C). The nmr spectrum (CDClJ) 
showed maxima for 5 aromatic protons at 7, 47 ppm, 1 proton 
as a triplet at 4,75 ppm (R3C-H), 1 proton as a singlet at 
J, 52 ppm (R-0-H), 2 protons as a pair of doublets centered 
at 2,52 ppm (-CH2-), and 1 proton as a triplet at 1,97 ppm 
(-C=C-H), 
Attempted preparation of 1-(4-Biphenylyl)-3-Eentyn-
1-ol (XXIX). Method C. - The method of Lauger (181) as 
previously described for the model system 1-phenyl-J­
butyn-1-ol (XXX) was followed using 189 mg (0. 007 g-atom) 
of aluminum in 10 ml of tetrahydrofuran and 1,JJ g (0. 01 
mole) of the previously described 1-bromo-2-butyne (XXVIII) 
in 10 ml of tetrahydrofuran to generate the alkynyl 
aluminum complex. Failure of the complex to form was in­
dicated by the almost complete lack of degradation of the 
aluminum surface after four hours at 45°. After a total 
of 20 hours at 45° evidence of aluminum degradation was 
observed and to the resulting mixture was added over a 
period of 15 minutes, while stirring at room temperature, 
a solution of 1. 82 g (0. 01 mole) of 4-biphenylcarboxaldehyde 
mp 52-55° (Aldrich), dissolved in 10 ml of tetrahydro­
furan. The resulting mixture was stirred for J hours at 
room temperature then poured onto an ice-water slurry and 
stirred until the mixture reached room temperature. The 
phases were separated and the aqueous phase was washed 
with ether. The combined organic phases were washed with 
r, 
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water, saturated sodium chloride solution, and dried over 
anhydrous sodium sulfate. Removal of the solvent under 
reduced pressure afforded 1. 84 g of an opaque, black liquid. 
The infrared spectrum of this material showed ) neat 
max 
2825 cm-1 (medium , aldehyde C-H), 27JO cm-1 (medium, aldehyde 
C-H), and 1700 cm-1 (strong, C=O) indicating that the 
desired alkynyl alcohol had not been obtained. 
Trimethylsulfoxonium Iodide (XXXI). - The method of 
Kuhn and Trischmann (182) was used , To a one-necked, 
round-bottomed flask equipped with gas inlet tube, reflux 
condenser, heating mantle and magnetic stirrer were added 
96 g (1. 2J moles) of dimethylsulfoxide (Fisher) and 410 g 
(2, 9  moles) of methyl iodide (Columbia Organic Chemicals 
Co. ) and the resulting solution was maintained at reflux 
for 72 hours under a nitrogen atmosphere. The reaction 
mixture was then cooled to room temperature , filtered, and 
the solid was washed with chloroform. The resulting white 
powder was recrystallized twice from hot water to give 
large, white needles which were crushed and dried in a 
vacuum desiccator to provide 52,9 g (19,5%) of trimethyl­
sulfoxonium iodide (XXXI) as a light brown solid, mp 195° 
(dee), literature (182) mp 200° (dee). The infrared 
spectrum was identical to that published by Kuhn and 
Trischman ( 182). 
1-Phenyl-1,2-epoxyethane (XXXII). A Model System. -
The method developed by Corey and Chaykovsky (18J) was used. 
To a three-necked flask fitted with reflux condenser, 
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pressure compensating dropping funnel, magnetic stirrer and 
gas inlet system (184) was added 1. 26 g (0. 03 mole) of 
sodium hydride as a 57% oil dispersion. The sodium hydride 
was washed 3 times with petroleum ether (30-60°) by stir­
ring and allowing the powder to settle while the system 
was flushed with a continuous stream of dry nitrogen. 
After each wash the petroleum ether was decanted and finally 
the sodium hydride was dried by alternately evacuating and 
flushing the system with dry nitrogen. To the remaining 
powder there was added 30 ml of tetrahydrofuran; then, 
while the system was maintained under positive nitrogen 
pressure, 6. 66 g (0. 03 mole) of the previously described 
trimethylsulfoxonium iodide (XXXI) was added as a solid 
over a period of 15 minutes while stirring at room tem­
perature. The resulting mixture was heated at reflux for 
2 hours; then, to the opaque white suspension was added, 
while stirring at reflux, over a period of 1,5 hours a 
solution of 2. 86 g (0. 027 mole) of benzaldehyde (Matheson, 
Coleman and Bell) in 30 ml of tetrahydrofuran. The 
resulting mixture was stirred at reflux for an additional 
1 hour followed by removal of the solvent under reduced 
pressure until approximately 15 ml remained. The residue 
was poured into 75 ml of water and extracted with ether . 
The combined ether extracts were washed with saturated 
sodium chloride solution and dried over anhydrous sodium 
sulfate. Removal of the solvent at reduced pressure 
provided an orange liquid which was distilled to give 
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0 , 95 g (29%) of 1-phenyl-1, 2-epoxyethane (XXXII) as a 
clear, colorless liquid, bp 26-28° (1 mm) , The infrared 
spectrum was identical to that of an authentic sample of 
the desired epoxide (Aldrich). The nmr spectrum (CDc 13
) 
showed maxima for 5 aromatic protons at 7,21 ppm, 1 pro­
ton as a pair of doublets centered at 3,77 ppm (He Figure 
13, . R = H), 1 proton as a pair of doublets centered at 
3 , 08 ppm (Hb Figure 13, R = H), and 1 proton as a pair of 
doublets centered at 2,74 ppm (Ha Figure 13, R = H). The 
nmr spectrum was identical to the spectrum of an authentic 
sample of styrene oxide (Aldrich). 
Figure 13: Proton positions in styrene oxide. 
1-(4-Biphenylyl)-1,2-epoxyethane (XXXIII), Method A. -
The method of Corey and Chaykovsky (183) as previously 
described for the model system 1-phenyl-1, 2-epoxyethane 
(XXXII) was employed. The ylide was generated from 1. 29 g 
of sodium hydride as a 56% dispersion in oil (0. 03 mole) 
and 6. 60 g (0. 03 mole) of trimethylsulfoxonium iodide 
(Aldrich). To the resulting ylide suspension was added, 
in a dropwise manner, with stirring over a period of 45 
minutes at reflux temperature a solution of 5 , 46 g (0. 03 
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mole) of 4-biphenylcarboxaldehyde, mp 52-55° (Aldrich), 
dissolved in 35 ml of tetrahydrofuran. Following the ad­
dition, the reaction mixture was stirred and maintained 
at reflux for 1 , 25 hours; then the solvent was removed 
under reduced pressure until approximately 25 ml of the 
mixture remained. The residue was poured into 100 ml of 
water, extracted 3 times with ether and the combined 
organic phases were washed with water, saturated sodium 
chloride solution, and dried over anhydrous sodium sulfate. 
Removal of the solvent under reduced pressure afforded 
5,25 g of an oily, yellow solid, mp 39-45°, which resisted 
recrystallization attempts. A 1. 02 g portion of this 
material was dissolved in 1 , 5  ml of chloroform, and 
chromatographed on 25 g of 60-100 mesh Florisil (Fisher). 
Elution with 600 ml of petroleum ether afforded 369 mg 
(representing an overall reaction yield of 32%) of the 
desired epoxyethane XXXIII as a white solid, mp 86-89°. 
') CHCl -1 The infrared spectrum showed A max 3 1245 cm (medium, 
) 
-1 ( · ) T t epoxide and 1072 cm medium, epoxide . he nmr spec rum 
(CDC13) showed maxima for 9 aromatic protons at 7 , 20-7,70 
ppm, 1 proton as a pair of doublets centered at 3,85 ppm 
(H Figure 13, R = phenyl), 1 proton as a pair of doublets 
C 
centered at 3, 14 ppm (Hb Figure 13, R = phenyl), and 1 
proton as a pair of doublets centered at 2. 80 ppm (Ha 
Figure 13, R = phenyl). This material was employed as 
an analytical sample with no further preparation. 
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C ,  85,7; H ,  6. 4. 
Preparatien of Diethylaluminum Chloride Stock Solu­
tien. - The method of Nagata and Yoshioka (185) was 
employed. A cylinder of diethylaluminum chloride (Alpha­
Ventron) was connected with tygon tubing to a two-way 
stopcock which was connected with tygon tubing to a straight 
drying tube. The drying tube was fitted to a straight 
vacuum take-off adapter which was fitted to a round­
bottomed flask which had been equipped with a magnetic 
stirrer (Figure 14). To the flask was added 150 ml of 
petroleum ether (60-70°) and the system was alternately 
evacuated and flushed with dry nitrogen. The reagent 
cylinder valve was opened and J8. J g (O. J2 mole) of di­
ethylaluminum chloride was slowly drained into the stirred 
petroleum ether at room temperature. The cylinder valve 
was closed and the system was alternately evacuated and 
flushed with dry nitrogen, then the flask was disconnected 
from the system and a rubber septum was quickly inserted 
and wired onto the neck of the flask. The resulting clear, 
colorless solution contained approximately 2J4 mg (1, 94 
mmoles) of diethylaluminum chloride per ml of solution. 
Attempted Synthesis of 1-Phenvl-3-pentyn-1-ol (XXXV) . 
A Model System. - The methods of Fried et al. (186) and of 
Hooz and Layton (187) were modified. To a round-bottomed 
flask equipped with a magnetic stirrer, straight vacuum 
take-off, and pressure compensating dropping funnel equipped 
with a rubber septum were added 1. 84 g (40 mmoles) of 
T 
diethylaluminum chloride 
cylinder 
two-way 
stork 
straight
�
ing tube 
---? to vacuum 
and N2 
straight vacuum 
take-off 
round-bottomed 
flask 
Figure 14: Aparatus for preparation of diethylaluminum 
chloride stock solution. 
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propynyllithium (Alpha-Ventron) and 25 ml of dry petroleum 
ether (60-70°). The system was alternately evacuated and 
flushed with dry nitrogen and then 21 ml (approximately 41 
mmoles) of the previously described stock solution of di­
ethylaluminum chloride (XXXIV) was transfered to the drop­
ping funnel by means of · a nitrogen filled syringe. The 
alane was added to the propynyllithium suspension in a 
dropwise manner over a period of 20 minutes with stirring 
and cooling in an ice bath; then the reaction mixture was 
stirred at room temperature for 1 hour. To the resulting 
solution was added, in one portion, 10 ml of ether followed 
by the addition, over a period of 15 minutes with stirring 
and cooling in an ice bath, of a solution of 2. 40 g (20 
mmoles) of styrene oxide (Aldrich) dissolved in 10 ml of 
dry petroleum ether (60-70°). The resulting mixture was 
stirred at room temperature for 19 hours, then added to an 
Erlenmeyer flask and, with stirring and cooling in an ice 
bath, a saturated solution of ammonium chloride which had 
been ad justed to pH 7 with concentrated ammonium hydroxide 
solution was added in a dropwise manner until no further 
precipitation was observed. The resulting mixture was 
poured into a mixture of ether and water, the phases 
separated and the aqueous phase was extracted with ether. 
The organic phase was washed with water, saturated sodium 
chloride solution, and dried over anhydrous sodium sulfate, 
Removal of the solvent under reduced pressure gave 2. 64 g 
(81%) of clear, golden yellow mobile oil. The infrared 
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1 CHCl -1 . 
spectrum showed A max 3 3585 cm (medium, free 0-H), 
3450 cm-1 (medium, broad, hydrogen bonded 0-H) and 2235 
cm-1 (weak, -C=C-). The nmr spectrum (CDc1
3) showed 
maxima for 5 aromatic protons at 7,26 ppm, 2 protons as 
a sharp singlet at 3,67 ppm (-CH2- 0-) superimposed on 1 
proton as a multiplet at 3,37-3,96 ppm (R3C-H), 1 proton 
as a singlet at 2,17 ppm (0-H), and 3 protons as a doublet 
at 1,83 ppm (-G=C-CH3). These spectral data are not 
consistent with the structure of the desired alkynyl alcohol 
XXXV and suggest that the reaction product was probably 
2-phenyl-J-pentyn-1-ol (XXXVI). 
2-Phenyl-1-pentanol (XXXVII). - To a Parr hydrogena­
tion bottle was added 960 mg (6. 0 mmoles) of the previously 
described compound suspected to be 1-phenyl-J-pentyn-1-ol 
(XXXV), 70 mg of 5% palladium on charcoal (Englehard 
Industries), and JO ml of absolute ethanol and the mixture 
was shaken on a Parr hydrogenator under 2, 11 kg/cm 
2 
hydrogen pressure for 18 hours at room temperature. The 
mixture was filtered through a Celite pad and the pad was 
washed with ten ml of absolute ethanol. Removal of the 
solvent under reduced pressure afforded 852 mg of dark 
brown, mobile oil. Molecular distillation of 242 mg of 
this material provided 154 mg (an overall yield of 55%) of 
alcohol XXXVII as a clear, colorless mobile oil. The 
. 'i CHCl 6 -1 ( 
· 
infrared spectrum showed A max 3 3 00 cm medium, free 
0-H), and 3460 cm-1 (medium, broad, hydrogen bonded 0-H). 
The nmr spectrum (CDC13) showed maxima for 5 aromatic 
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protons at 7,20 ppm, 2 protons as a doublet at 3. 68 ppm 
(-CH2-o-) , 1 proton as a multiplet centered at 2. 74 ppm 
(R3C-H), 1 
proton as a singlet at 1. 82 ppm (-0-H), and 7 
protons as multiplets at 0,63-1,78 ppm (-CH2-CH2-ctt3). 
Anal. Calcd. for c11tt16o :  C, 80. 4; H, 9, 8, Found: 
C, 80, 0; H, 9, 7, 
1-Phenyl-3-pentyn-1-ol (XXXV). A Model System. 
Method B. - Minor modifications were made in the method of 
Fries (188), To a round-bottomed flask equipped with 
magnetic stirrer, pressure compensating dropping funnel 
and nitrogen atmosphere were added 966 mg (21 mmoles) of 
propynyllithium (Alpha-Ventron) and 15 ml of dry dimethyl­
sulfoxide. To the resulting suspension was added in a 
dropwise manner with stirring at room temperature over a 
period of 20 minutes a solution of 1. 28 g (10,7 mmoles) of 
the previously described 1-phenyl-1, 2-epoxyethane (XXXII), 
dissolved in 5 ml of dry dimethylsulfoxide. The opaque, 
black reaction mixture was stirred for 15 hours at room 
temperature, then slowly poured into 150 ml of stirred 
ice-water slurry and the resulting mixture was extracted 
with ether. The organic phase was washed with water, 
saturated sodium chloride solution and dried over anhydrous 
sodium sulfate. Removal of the solvent under reduced 
pressure afforded 659 mg (38%) of pentynyl alcohol XXXV as 
a clear, yellow liquid. The infrared spectrum showed 
A CHCl3 3600 cm-1 (medium, free 0-H), 3450 cm-1 (medium, max 
broad, hydrogen bonded 0-H), and 2220 cm-1 (weak, alkyne). 
The nmr spectrum (CDC13) showed maxima for 5 aromatic 
protons at 7, 27 ppm, 1 proton as a triplet at 4, 75 ppm 
(R3C-H) , 1 proton as a moderately broad band at 2. 67 ppm 
(0-H) which was partially obscured by 2 protons as a 
multiplet at 2. 42-2, 65 ppm (-CH2-), and J protons as a 
1 7 1  
sharp triplet at 1, 75 ppm (-CH3). Several attempts to 
prepare an analytical specimen of this compound by molecular 
distillation with a Hickman still were unsuccessful, 
1-(4-Biphenylyl)-3-pentyn-1-ol (XXIX). Method D. -
The method of Fries (188) was employed. To a round-bottomed 
flask fitted with a magnetic stirrer, pressure compensating 
dropping funnel , and nitrogen atmosphere were added 184 mg 
(4. 0 mmoles) of propynyllithium (Alpha-Ventron) and 10 ml 
of dry dimethylsulfoxide, To the resulting mixture was 
added , in a dropwise manner, with stirring at room temperature 
over a period of 10 minutes a solution of 392 mg (2. 0 
mmoles) of the previously described 1-(4-Biphenylyl)-1, 2-
epoxyethane (XXXIII) dissolved in 5 ml of dry dimethyl­
sulfoxide. The reaction mixture was stirred at J6-�2° for 
48 hours, then slowly poured onto 100 ml of an ice-water 
slurry and extracted with ether. The organic phase was 
washed with water, a saturated sodium chloride solution, 
and dried over anhydrous sodium sulfate. Removal of the 
solvent under reduced pressure provided 219 mg of clear, 
dark brown oil which was not structurally clearly defined 
by spectral means. A portion of this material (164 mg) was 
dissolved in 0, 75 ml of chloroform and chromatographed on 
172 
18 g of 60-100 mesh Florisil (Fisher) and eluted in 100 ml 
fractions. The fractions eluted with 10% ether in petro­
leum ether afforded 57 mg (16%) of a white solid, mp 109-
1110. Recrystallization of this material from petroleum 
ether (60-70°) provided 4J mg of pentynyl alcohol XXIX as 
0 a white solid, mp 110,5-111,5 . The nmr spactrum (CDC13) 
showed maxima for 9 aromatic protons at 7,15-7� 65 ppm, 1 
proton as a triplet at 4. 82 ppm (R3C-H), 3 protons as a 
multiplet at 2, 40-2,72 ppm (0-H and -CH2-C=), and J 
protons as a sharp triplet at 1,77 ppm (-C=C-CH3) .  This 
material was used as an analytical sample with no further 
preparation . 
Anal, Calcd. for c17H16o :  C, 86. 4; H, 6. 8. Found: 
C, 86, 2; H, 6, 8, 
Triphenylmethylphosphonium Bromide (XXXVIII) . - The 
method of Wittig and Schoellkopf (189) was followed. 
Approximately 8 ml (0. 145 mole) of methyl bromide (J. T. 
Baker) . .  was distilled into a three-necked round-bottomed 
flask fitted with a dry ice condenser, gas inlet tube, 
drying tube, and iso-propyl alcohol-dry ice cooling bath. 
The clear, colorless liquid was added in one portion to 
a pressure bottle which contained a solution of 26. 2 g 
(0. 10 mole) of triphenylphosphine (Aldrich) dissolved in 
28 ml of benzene and was cooled in an ice-salt bath. The 
stopper was wired into place and the reaction mixture was 
allowed to reach room temperature and then allowed to 
remain at this temperature for 48 hours. The resulting 
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white cake was crushed, slurried with 400 ml of hot benzene, 
filtered, and air dried for 0,5 hour. Drying in a vacuum 
oven (water aspirator) at 100° for 20 hours provided 35. 0 g 
(98%) of triphenylmethylphosphonium bromide (XXXVIII) as a 
white solid, mp 230-231°, literature (189) mp 232-233°. 
(4-Biphenylyl)ethene (XXXIX). - The method of Greenwald 
et al. (190) was used. To a three-necked round-bottomed 
flask fitted with a gas inlet tube and magnetic stirrer was 
added 471 mg (11 mmoles) of sodium hydride (Alpha-Ventron) 
as a 56% dispersion in oil which was washed three times 
under a nitrogen atmosphere by stirring with petroleum 
ether (60-70° ) . After each wash, the powder was allowed 
to settle and the supernatant solution was decanted. After 
the final wash the flask was fitted with a reflux condenser 
and pressure compensating dropping funnel and the system 
was alternately evacuated and flushed with dry nitrogen 
until the sodium hydride was dry. In one portion, 25 ml 
of dimethylsulfoxide was added to the residue and the re­
sulting suspension was heated to 75° while stirring for 50 
minutes to give a clear, brown solution of methyl sulfinyl 
carbanion. The system was cooled in an ice bath and a 
solution of 3,57 g (10 mmoles) of the previously described 
triphenylmethylphosphonium bromide (XXXVIII) in 25 ml of 
dimethylsulfoxide was added in a dropwise manner with 
stirring over a period of 5 minutes. The resulting ylide 
was stirred at room temp�rature for 15 minutes f0llowed 
by the dropwise addition over a periQd of 5 minutes of 
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1. 82 g (10 mmoles) of 4-biphenylcarboxaldehyde, mp 57-59
° 
(Aldrich), dissolved in 10 ml of dimethylsulfoxide. The 
dark green reaction solution was stirred at room tempera­
ture for 2 hours, at 65° for 1 hour, then cooled to room 
temperature and poured onto 150 ml of an ice-water slurry. 
The resulting mixture was extracted with 200 ml of petro­
leum ether (60-70
°) and the emulsion which formed was 
extracted in 25 ml portions with 200 ml of ether. The 
organic phase was washed with water, saturated sodium 
chloride solution and dried over anhydrous sodium sulfate. 
Removal of the solvent under reduced pressure provided 
2. 02 g of light yellow solid which was dissolved in J. O  
ml of chloroform and chromatographed on 50 g of neutral 
alumina (80-200 mesh , Brockman Activity I). Elution with 
two liters of petroleum ether afforded 725 mg (40%) of 
alkene XXXIX as a white solid, mp 118,5-119,5°, literature 
(191) mp 120-122°, The nmr spectrum showed maxima for 9 
protons of aromatic nature at 7,18-7,65 ppm, 1 proton as 
a pair of doublets centered on 6,74 ppm (Ar-CH=) , 1 proton 
as a doublet at 5,70 ppm (trans =C-H , J = 18 Hz), and 1 
proton as a doublet at 5,21 ppm (cis =C-H , J = 10 Hz). 
This material was used as an analytical specimen with no 
further preparation. 
Anal. Calcd. for c14H12 : C ,  93,J; H, 6. 7. Found : 
C, 93 , 5; H, 6. 8. 
1 -(4-Biphenylyl)-112-epoxyethane (XXXIII). Method B. -
The method described by Fieser and Fieser (176) was used, 
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To a round-bottomed flask equipped with a pressure compen­
sating dropping funnel  and magnetic stirrer and which con­
tained 520 mg (2 . 87 mmoles) of the previously described 
(4-biphenylyl)ethene (XXXIX), mp 118, 5-119,5°, in 20 ml 
of dry chloroform was add ed, in a dropwise manner over a 
period of 1 hour with stirring and cooling in an ice bath, 
a solution of 875 mg (4,3 mmoles) of 85% m-chloroperbenzoic 
acid dissolved in 45 ml of c hloroform. The resulting c lear, 
colorless solution was stirred at room temperature for 20 
hours, then with 50 ml of a 10% sodium sulfite solution 
until a negative starch-iodide test was observed .  The 
phases were separated and the organic phase was washed 
with 5% sodium hydrogen carbonate solution, water, saturated 
sodium chloride solution, and dried ove r  anhydrous sodium 
sulfate. Removal of the solvent unde r  reduc ed pressure 
provide d  67 0 mg of a waxy white solid, mp 59-74 °. A 559 mg 
portion of this material was chromatographed on 27 g of 
60-100 mesh Florisil (Fishe r), Elution with 1% ether­
petroleum ether  afforde d  269 mg ( an overal l  yie ld of 57%) 
of epoxide XXXIII  as a white solid, mp 90-91° . The infrared 
spectrum showed 1 CHCl3 1247 cm-1 (medium, epoxide), 877 max 
cm-1 (sharp, strong, epoxide), and 837 cm-1 (sharp, strong, 
epoxide). The nmr spectrum (CDC13) showed maxima for 9 
aromatic protons at 7,18-7,7 1 ppm, 1 proton as a pair of 
I 
doublets c entered at 3,86 ppm (Ar-y-H), 1 proton as a pair 
of doublets c entered at 3,12 ppm (Hb Figure 13, R = phenyl), 
and 1 proton as a pair of doublets centered at 2,78 ppm 
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(H Figure 13, R = phenyl) , This material was used as an a 
analytical specimen with no further preparation after chroma-
tography. 
Anal. Calcd. for c14H12o: C, 85 , 7; H ,  6.2. Found: 
C ,  85 , 7; H ,  6. 4. 
1-(4-Biphenylyl)-2-butyn-1-ol (XL). - A modification 
of the procedure of Smith and Kuehn (192) was used , To a 
three-necked flask equipped with a magnetic stirrer, 
pressure compensating dropping funnel, nitrogen atmosphere 
and oil bath were added 506 mg (11 mmoles) of propynyl­
lithium (Alpha-Ventron) and 13 ml of tetrahydrofuran which 
had been freshly distilled from lithium aluminum hydride. 
To the resulting suspension was added, in a dropwise manner 
over a period of 10 minutes with stirring at 40°, a solution 
of 1. 82 g (10 mmoles) of 4-biphenylcarboxaldehyde (Aldrich, 
base washed) dissolved in 2,5 ml of tetrahydrofuran which 
had been freshly distilled from lithium aluminum hydride . 
Following the addition, the reaction mixture was stirred 
at 4o 0 for 5 minutes, then placed into an ice bath and 25 
ml of ether was added in one portion followed by 15 ml of 
saturated ammonium chloride solution which had been ad justed 
to pH 7 with concentrated ammonium hydroxide solution. The 
resulting mixture was stirred for 5 minutes, the phases 
were separated and the organic phase was washed once with 
water, with saturated sodium chloride solution, and dried 
over anhydrous sodium sulfate. Removal of the solvent 
under reduced pressure provided 1 , 79 g of a yellow-brown 
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solid which was dissolved in 4. o ml of chloroform and 
chromatographed on 80 g of 60-100 mesh Florisil (Fisher). 
Elution with 10% ether-petroleum ether afforded 1. 04 g 
(47%) of butynyl alcohol XL as a white solid. Recrystal­
lization from petroleum ether (60-70°) afforded a white 
solid, mp 88-90°. The infrared spectrum showed A CHCl3 max 
3590 cm-1 (medium, free 0-H), 3420 cm-1 (medium, broad, 
hydrogen bonded 0-H), 2280 cm
-1 (weak, C=C), and 2220 cm-1 
(weak, C=C), The nmr spectrum (CDC13) showed maxima for 9 
aromatic protons at 7,24-7, 63 ppm, 1 proton as a quartet 
at 5, 41 ppm (R3C-H), 1 proton as a broad singlet at 2. 42 
ppm (0-H), and 3 protons as a doublet at 1,83 ppm (-CH3). 
Two recrystallizations of this compound from petroleum 
ether (60-70°) afforded an analytical specimen of butynyl 
alcohol XL as a white solid, mp 88-90°. 
Anal. Calcd. for c16H14o :  C, 86,5 ; H, 6. 4. Found : 
C, 86. 2 ;  H, 6. 2. 
1-(4-Biphenylyl)-2-butynyl Hydrogen Succinate (XLI). -
The ester was prepared from the aforementioned butynyl 
alcohol XL as previously described for the butenyl hydrogen 
glutarate VIIIb to give 1. 12 g of clear, brown, very 
viscous oil. A 515 mg portion of this material was chroma­
tographed on 25 g of washed silicic acid (196). Elution 
with 50% ether in petroleum ether afforded 263 mg (33%) of 
hydrogen succinate XLI as a beautiful, clear, colorless oil. 
. ') CHG 1 -1 ( ) The infrared spectrum showed A max 3 2290 cm weak, C=C , 
2230 cm-1 (weak, C=C), 1735 cm-1 (strong, C=O), and 1713 cm
-1 
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(strong, C=O), The nmr spectrum showed maxima for 1 proton 
as a broad singlet at 9,65 ppm (-COOH), 9 aromatic protons 
at 7,21-7,72 ppm, 1 proton as a quartet at 6,49 ppm ( R3
C-H), 
4 protons as a sharp singlet at 2. 64 ppm (-CH2-CH2-), and 
3 protons as a doublet at 1,90 ppm (-CH3). This compound 
was analytically characterized as described below. 
S-Benzylthiuronium Salt of 1-(4-Biphenylyl)-2-butynyl 
Hydrogen Succinate (XLI-S). - The salt of the aforementioned 
hydrogen succinate XLI was prepared as previously described 
from 269 mg ( 0.84 mmole) of the ester . Two recrystallizations 
of the crude salt from ethyl acetate-petroleum ether 
( 60-70°) afforded an analytical sample of S-benzylthiuron-
ium salt 
Anal, 
N, 5 , 7 , 
XLI-S as a white solid, mp 112-114°. 
Calcd. for c2 8H28N2o4s : C, 68,9; H, 5,8; 
Found: C ' 68,7; H, 5 , 7 ; N, 5 , 7 ,  
C. Preparation of Rat Liver Microsomes 
The method of Shapiro and Rodwell ( 82) was used. Male 
Sprague-Dawley rats ( approximately 100 g) obtained from 
Holtzman were fed Purina Laboratory Chow ( Ralston Purina 
Company) ad _ libitum and housed for at_ least 4 days with light 
from 7 AM to 7 PM and dark from 7 PM to 7 AM, A group of 
eight rats was used for each microsome preparation. Between 
12: 05 and 12: 25 AM the animals were stunned by a sharp blow 
to the head, decapitated, and the livers were excised into 
ice-cold ESM solution at pH 6. 0 ( ESM solution is composed 
of JOmM ethylenediamine tetraacetic acid, 70 mM sodium 
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chloride and 10 mM (3 -mercaptoethanol), The mass of the 
livers was determined ; they were minced and forced through a 
tissue press into 2,5 ml of ice-cold ESM solution per gram 
of liver. The resulting tissue mixture was homogenized in a 
Potter-Elvehjem homogenizer with five strokes of a Teflon 
pestle. The homogenate was centrifuged twice for 15 minutes 
at 12 , 000 X g and the pellet was discarded each time. The 
supernatant solution was centrifuged for 1 hour at 48 , 000 
X g, the resulting supernatant was discarded, and the micro­
somal pellets were frozen in a dry ice-iso-propyl alcohol 
bath. The tubes were sealed with Parafilm and stored at 
-60° for up to three weeks. 
D. Assay of Enzyme Inhibitors 
A slight modification of the method developed by Rodwell 
(82, 193) was employed. A portion of the rat liver micro­
some preparation was suspended in 1, 5 ml of the previously 
described ESM solution , pH 6. 8. Each assay mixture con-
tained 9, 7 fa moles of NADP (Sigma), 59 , 7  p. moles of glucose-
6-phosphate dehydrogenase Type X I I  from torula yeast (Sigma), 
0,15 ml of microsome suspension, 0. 1 ml of ethylene glycol 
monoethyl ether (Fisher) and the appropriate concentration 
of inhibitor in a total volume of 2,9 ml. The total assay 
mixture contained 1. 6-2. 1 mg of protein as determined by the 
method of Slakey et al. (84). The enzyme reaction was 
started by the addition of 0. 1 ml of solution containing 
94 nmoles of J-c 14-HMG-CoA. The assay system was incubated 
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for J O minutes with shaking at 37
°, then the reaction was 
stopped by the addition of 0. 2 ml of concentrated 
hydrochloric acid and a known amount of HJ -mevalonic acid 
as the mevalonolactone (New England Nuclear) was added as 
an internal standard. The resulting mixture was set aside 
for 16 hours at room temperature; then it was saturated with 
anhydrous sodium sulfate and the mevalonolactone was ex­
tracted with ether. The organic phase was evaporated to 
dryness under a stream of nitrogen; the residue was dis­
solved in 0. 2 ml of acetone and applied as a streak to an 
activated (JO minutes at 100°) Mylar backed silica gel G 
thin layer chromatography sheet (Eastman). The chromato­
grams were developed with benzene-acetone, 1/1 (v/v). 
The area corresponding to mevalonolactone (Rf = 0. 6-1. 0) 
was removed with a razor blade and placed into a liquid 
scintillation vial for counting. To account for variations 
of enzyme activity in microsomes from different prepara­
tions, one inhibitor, 1-(4-biphenylyl)-g-pentyl hydrogen 
succinate (III, m = 2), was assayed concurrently with 
each of the other inhibitors. Therefore, all inhibition 
activities were directly compared with a compound of 
known inhibitory properties. 
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E. Discussion of Experimen:tal . Prooedures 
The preparation of 1-(4-biphenylyl)-n-pentyl hydrogen 
3-Methyl-3-methoxyglutarate (V) is described below. The 
approaches used in the preparation of this compound are 
illustrated in scheme I .  Synthesis of the 4, 4-disubsti­
tuted heptadiene X IV was smoothly accomplished in 77-89% 
yields. The use of the double addition method developed 
by Tschesche and Machleidt (165) provided a means of 
minimizing side reactions of the highly reactive allyl 
Grignard reagent. The infrared spectrum of this compound 
exhibited absorption bands at 3400 cm-1 due to the 0-H 
stretching vibration of the alcohol and at 1647 cm-1 due 
to double bond vibration. Further evidence that the 
desired unsaturated alcohol was obtained was shown by the 
nuclear magnetic resonance (nmr) spectrum. Multiplets at 
5 . 60-6. 37 ppm and at 4, 83-5,16 ppm proved the presence of 
the terminal vinyl group, and observation of a doublet at 
2, 17 ppm showed the presence and position of the methylene 
groups. Supporting the infrared evidence, the hydroxyl 
group was observed as a sharp singlet at 2. 38 ppm which 
was destroyed by exchange with deuterium oxide. 
The resulting tertiary alcohol X IV was alkylated with 
methyl iodide to give the corresponding ether XV in a yield 
of 65%. Absence of hydroxyl absorption and survival of 
the double bond absorption in the infrared spectrum showed 
that the methylation was complete. Similarly, the nmr 
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spec trum showed no hydroxyl proton ; ins tead , a sharp 
s ingle t  attributed to the me thoxyl protons was observed 
at 3 , 20  ppm .  
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Oz onolysis  of XV followed by very careful oxidative 
destruct i on of the o z onide afforded 3-methyl-3-me thoxy­
glutaric acid ( XV I ) in a yield of 75% ,  This  compound was 
the key intermediate of the entire sequence of reac tions . 
Pre s enc e of the ac id was clearly indicated by the severely 
broadened 0-H s tre tching band in the 2 500-2700 cm
-1  
region of the infrared spec trum and by the carbonyl peak 
at 1 7 1 0  cm-l The s truc ture of the diacid was proved by 
the nmr observation of two exchangeable protons at 9 , 93 
ppm as well as other peaks described above for c orre spond­
ing porti ons of the molecule . 
Several methods of esterification of XVI with 1 - ( 4 -
biphenylyl ) -n-pentanol ( XV I I )  were examined before the 
desired half e s ter-half ac id was obtained . Initially it  
was  thought that the e s ter c ould be  obtained by opening 
anhydride XLI I with the alcohol using the method of Palaz z o  
e t  al . ( 1 62 ) .  Thi s  route exhibited two defic ienc ie s : 
first , dehydration of the diac id XVI provided the anhydride 
XLII as a heavy o i l  which re sisted both spec tral c.harac ­
terization and purification . Furthermore , it  appeared 
that this c ompound was not s table under normal c onditions 
and even attempts to e s terify the crude anhydride were 
unsucc essful . Sec ond , Palaz z o ' s  method of esterification 
require s harsh conditions for extended periods ( heating 
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at reflux in pyridine for 8 hours). 
The esterification method of Steglich and Hoffle (175) 
appeared promising since it takes place under mild condi­
tions with catalysis by 4-dimethylaminopyridine. However, 
this method also requires the anhydride, Perhaps because 
of the necessity of using crude anhydride, this reaction 
afforded very low yields (5%) of impure acid-ester V. 
The method of Bilchi et al. (167) was found to provide 
the desired ester V in acceptable yields. The problem 
of using impure anhydride was surmounted with this technique 
because the diacid XVI is the substrate for esterification. 
Even though a statistical yield (50%) of the desired mono­
ester V was obtained, this reaction was superior to the 
other esterification methods available. 
This acid-ester was spectrally characterized by the 
broadened infrared absorption in the 2500-2800 cm-1 region 
indicating the free carboxylic acid. Additionally, both 
ester (1 740 cm-1 ) and carboxylic acid (1713 cm-1) carbonyl 
bands were observed. A significant aspect of the nmr 
spectrum was the internal consistency of integral ratios 
between the aromatic absorption at 7,00-7 ,79 ppm and both 
the absorptions due to the methoxyl and methyl protons at 
J ,1 5  and 2 ,72 ppm, respectively. Since the latter two 
functional groups were derived from a different reagent 
than the aromatic protons, this self-consistency indicates 
that the desired monoester was obtained in good purity. 
The preparation of N- [1 -( 4-Biphenylyl )-rr-pentyl] 
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Succinamic (VI) and Glutaramic (VII) acids is described 
below. The synthetic sequence followed for the preparation 
of these amides is shown in Scheme II. Oxidation of al­
cohol XVII led smoothly to the corresponding ketone XVIII 
in excellent yields (80-90%), This compound was spectrally 
characterized by the absence of hydroxyl absorption and the 
presence of a strong ketone band (1669 cm-1) in the infra­
red as well as by loss of signals for the exchangeable 
proton as observed in the nmr spectrum. Similarly, con­
version of ketone XVIII to the methoxylimine XIX by the 
method of Feuer and Braunstein (171) took place smoothly 
and in good yield (90%), This conversion was readily 
followed with infrared spectra by the loss of the ketone 
. 6 -1 carbonyl band and the appearance of absorption at 1 10 cm 
in the infrared spectrum due to C=N stretching vibrations. 
Appearance of a very sharp singlet at 3,97 ppm in the nmr 
spectrum (-OCH3) also indicated presence of the desired 
imine. Reduction of this compound by the method of Boots 
et al. (172) proceeded as expected; however, the major 
difficulty in this series of reactions was purification 
and characterization of the free amine XLIII. 
The free amine XLIII was initially obtained as a thick 
and impure oil or semi-solid and spectral characterization 
of this material was not conclusive. This problem was 
solved by a minor modification of the work-up procedure. 
Rather than isolating the free amine as a semi-solid, the 
dry solution of suspected free amine was treated with 
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Scheme I I :  Synthetic sequence for the preparation of 
succinamides and glutaramides. 
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ethereal hydrogen chloride (195). This afforded a pre­
cipitate of the amine hydrochloride XX which was easily 
purified in a yield of 89% and characterized both spectrally 
and by elemental analysis. 
Conversion of the amine to its hydrochloride salt XX 
to facilitate handling required slight modification of 
the subsequent preparation of the amides VI and VII. Thus, 
prior to each amidation reaction a slight excess of amine 
hydrochloride was treated with dilute base, then extracted 
into the solvent to be used for amide formation and dried. 
The use of this solution of the amine XLIII greatly aided 
in the preparation of amides VI and VII in high yields (77-
84%). 
The amides were readily characterized by infrared 
spectroscopy by the N-H vibration in the 3250 cm-1 region 
as well as by a pair of carbonyl bands due to the free 
carboxylic acid and the amide carbonyl vibrations. The 
nmr spectrum of these compounds showed a pair of protons 
as broad singlets (-CONH and -COOH) downfield from the 
aromatic absorption as well as the characteristic methine 
absorption in the 5,0 ppm range. 
The synthesis of 1-(4-biphenylyl)-alkenyl (VIIIa-f) 
and epoxyalkyl (IXa-f) hydrogen succinates and hydrogen 
glutarates is described below. The general approach to 
the synthesis of these acid esters is outlined in Scheme 
III. The Grignard reagents derived from c.> -bromo-1-alkenes 
reacted smoothly with 4-biphenylcarboxaldehyde (XLIV) to 
RMgX
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Scheme I I I: The synthesis of 1-(4-biphenylyl)-alkenyl 
and epoxyalkyl hydrogen succinates and 
hydrogen glutarates. 
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provide the alcohols XXII-XXIV in 70-90% yields. Special 
precautions were necessary only for the synthesis of 
alcohol XXII because of the highly reactive nature of the 
allyl Grignard reagent. The double addition method of 
Tschesche and Machleidt (165) was used in order to maximize 
the yield of the desired alcohol and minimize the occurrence 
of coupling of the Grignard reagent, the ma jor side reaction 
in this system. 
Alcohols XXII-XXIV have several common spectral 
features which were used to structurally identify each 
member of the series. The infrared spectrum was used only 
as an indicator of the presence of the alcohol functional 
group. Absorption bands used for this purpose were those 
derived from the free 0-H (3500-3600 cm-1) and hydrogen 
bonded 0-H (3400-3500 cm-1) vibrations. Proof of structure 
was accomplished with nmr spectrometry. Several of the 
maxima exhibited by these alcohols became important features 
of the spectra of subsequent compounds. The vinyl group 
of XXII-XXIV was observed as a very complex series of mul­
tiplets at approximately 5, 5-6. 1 ppm (-CH=) and as a 
second set of multiplets at 4. 8-5,2 ppm (=CH2). Only in 
the case of XXII  was the methylene group located ff to 
the aromatic ring observed as a separate maximum . In the 
other cases these protons were either partially superim­
posed upon or obscured by absorption due to the remaining 
methylene groups. Finally, the methine proton � to the 
aromatic rings was diagnostic of alcohols XXII-XXIV as well 
as subsequent compounds and consistently appeared as a 
well defined triplet at approximately 4. 6 ppm. 
As with the J-methyl-J-methoxyglutaric acid ester V 
discussed above, a number of methods were investigated 
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for conversion of the 1-(4-biphenylyl)-alkenyl alcohols 
XXII-XXIV to their respective hydrogen succinates and 
hydrogen glutarates before a satisfactory procedure was 
found. Since several of the desired acid-esters are poly­
functional systems bearing delicate functional groups, one 
of the ma jor criteria for the choice of an esterification 
method was the necessity to avoid strenuous reaction con­
ditions. Thus, the method of Palaz zo et al. (1 62) was un­
acceptable due to the extended reaction times and elevated 
temperatures involved. Alternatively, the method of Buchi 
et al. (1 67) provided a gentle method of esterification; - -
however, this method requires the acceptance of only a 
statistical yield (50%) of monoester from a dicarboxylic 
acid. 
With respect to vigor of reaction conditions and 
available yields, the esterification method of Steglich 
and Hoffle (175) provided an acceptable means of synthesis 
of the desired half acid esters. The reaction, catalyzed 
by 4-dimethylaminopyridine, takes place entirely at room 
temperature and has provided satisfactory yields of both 
the alkenyl (40-80%) and epoxyalkyl (J0-70%) hydrogen 
succinates and hydrogen glutarates. In their original 
procedure Steglich and Hoffle employed an excess of 
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triethylamine to bind the free carboxylic ac id as it  was 
f ormed , However , examination of the reaction c onditions 
showed that both the integrity of the produc t and the ac ­
ceptable yield of the reac tion c ould be maintained when 
this  reagent was omitted from the reac tion solution . There­
fore , each of the e s ters illustrated in Scheme I I I  have been 
prepared using this modification of the original procedure . 
Infrared spe c tra of e s ters V I I Ia-f and IXa-f indicated 
that the des ired ac id-e s ters had been obtained . Broadening 
-1  
in the 31 00-JJOO  cm region and the medium very broad 
abs orption obse rved at 2 500-2700 cm-1 is  diagnostic of the 
free c arboxylic acid portion of the se  c ompounds . Ad­
ditionally , for each of the se  e s ters a pair of carbonyl 
peaks was observe d ,  the one at higher wavenumber be ing due 
to the e s ter carbonyl while the lower wavenumber peak is  
attributable to carboxylic acid carbonyl vibration .  
Absorption due t o  the epoxide ring , a s  discussed below for 
epoxyalcohols XXV-XXV I I ,  was also observed . 
Struc tural information obtained from the nmr spec tra 
of V I I Ia-f inc ludes the maxima charac teristic of the 
vinyl group as previous ly discussed for the alkenyl alcohols . 
Similarly , both the alkenyl esters V I I Ia-f and the epoxy­
alkyl e s ters IXa-f exhibited maxima described above for 
the me thine proton o<. to the aromatic rings . In every 
case , the suc c inate e s ters showed a very sharp s ingle t  
caused b y  the four suc c inate me thylene protons . Self­
c ons is tency of the ratio  of the integral of this  peak to 
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that of the aromatic absorption was an important criterion 
of purity since the respective peaks originated from dif­
ferent reagents, This was not always possible with the 
hydrogen glutarates because the glutarate methylene protons 
were observed as a comple x set of multiplets which over­
lapped with the peaks from the methylene protons of the 
alkenyl or epoxyalkyl side chain. 
Epoxidation of the alkenyl alcohols was accomplished 
using the technique described by Fieser (176) which pro­
vided mild reaction conditions. Reaction of alkenyl 
alcohols XXII-XXIV with fil-chloroperbenzoic acid in chloro­
form at and below room temperature provided the desired 
1-(4-biphenylyl)-epoxyalkyl alcohols XXV-XXVII in yields 
of 92-99%, Conversion of alkenes XXII-XXIV to the cor­
responding epoxides XXV-XXVII was readily followed with 
infrared spectra by the appearance of the characteristic 
epoxide peaks around 840, 910, and 1260 cm-1 • Nuclear 
magnetic resonance spectra of these compounds showed a 
very clear loss of absorption due to the vinyl protons and 
the appearance of complex multiplets due to epoxide ring 
protons in the region 1,5-J,O ppm. The triplet due to the 
methine proton cl... to the aromatic rings continued to be 
a useful diagnostic signal. 
Placement of the epoxidation reaction in the complete 
synthetic design is worthy of note. It may appear from 
Scheme III that the epoxidation of alcohols XXII-XXIV could 
conceivably be performed either before or after esterification 
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with equal success. A co-product of the epoxidation 
reaction is m-chlorobenzoic acid which is separated from 
the crude epoxide as its sodium salt. This is accomplished 
by treatment with mild aqueous base. If the epoxidation 
were performed subsequent to esterification, a mixture of 
the sodium salts of m-chlorobenzoic acid and the desired 
hydrogen succinate or hydrogen glutarate would be obtained, 
providing a rather difficult separation problem. For this 
reason , the epoxidation reaction must be performed only 
prior to esterification, In this instance, the sequence 
of reactions means the difference between obtaining the 
desired compounds fairly pure and in good yield or an in­
separable mixture, 
The alkenyl esters VIIIa-f and the epoxyalkyl esters 
IXa-f exist under standard conditions as clear , viscous 
oils. To facilitate elemental analysis of these compounds 
they were converted to the corresponding S-benzylthiuronium 
salts by the method of Donleavy (1 68) as modified by Boots 
et al. (158) as illustrated in equation 6. These salts 
are moderately high melting solids which may be purified 
by recrystallization. Since they were used only for 
elemental analysis , infrared and nmr spectra were not 
determined for these salts. 
Elemental analysis of these salts provided an interest­
ing problem. Several S-benzylthiuronium salts which had 
been prepared from esters whose structure and purity had 
been proved by infrared and nuclear magnetic resonance 
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1 ( eq. 6) 
techniques consistently exhibited carbon analysis 1. 0-1,5 
percent below theory while nitrogen and hydrogen analyses 
were within the acceptable range (± 0. 4%). The explanation 
and solution to this formidable problem lay in the fact 
that the S-benzylthiuronium salts were initially precipi­
tated from aqueous solution before they were recrystal­
lized. The crude salts appear to have precipitated as a 
complex with one-half mole of water associated with each 
mole of salt. Thus, inclusion of one-half mole of water 
in the calculation of theoretical elemental composition 
gave values for percent carbon which were consistently 
1.0-1, 5% lower than the theoretical carbon percent cal­
culated without inclusion of water. The inclusion of 
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one -half mole  of water in the calculation of the ore tical 
nitrogen and hydrogen perc ent gave value s which differed 
from those  calculated without inc lus i on of water by an 
amount less  than the experimental error of measurement , that 
i s , wi thin approximate ly ± 0 . 2 5% of the ory calculated 
without water . In two ins tanc e s  the assoc iation of one 
mole of water per mole of salt was observed . 
Proof of thi s  hypothe sis  required removal of the water 
and subsequent analytical re sults showing agreement with 
the oretical perc entage s . A s ingle salt , the S-benzylthi­
uronium salt of 1 - ( 4-biphenylyl ) -J-butenyl hydrogen 
succ inate ( V I I Ia-S ) had a me lt ing point high enough to 
withs tand the drying proc edures  required to remove the 
firmly assoc iated wate r .  I f  the drying period was t o o  short 
not all of the water was removed and if too long , the salt 
d e c omposed . Drying the above salt for 8 , 5  hours at 1 1 0 ° 
under 1 mm Hg pre ssure afforded the truly dry salt whose 
e lemental analys is  fell  within experimental error of the 
calculated value s .  Further support for this  hypothe sis  
and its  proof i s  the fac t that as  drying c onditions became 
more vigorous ( that is , progress ive ly increas ing time and 
temperature of drying from short periods at room temperature 
to the final c onditions ) the perc ent carbon de termined 
s lowly increased unti l  it was within experimental error of 
the ory when dried under the final c onditions . 
The attempted synthe sis  of alkynyl alc ohol XX IX for 
the s tudy of ge ometrical isomerism in the e ster s ide chain 
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is described below. Each agent described above contains 
the double bond or epoxide functional group in a terminal 
position of the alkyl moiety where geometric isomerism 
is not possible. Therefore, it was of great interest to 
determine the effect of geometrical isomers in the alkyl 
group on the activity of these agents. This would pro­
vide very useful information not only about the structural 
requirements for efficient inhibition of rat liver f3 -
hydroxy- � -methylglutaryl coenzyme A reductase but also 
concerning the structure of the enzyme itself in the region 
where these inhibitors bind. The study of these effects 
requires the synthesis of internal alkenyl hydrogen suc­
cinates and hydrogen glutarates and the proposed synthetic 
sequence to obtain these compounds is outlined in Scheme IV. 
It should be noted that this sequence of reactions provides 
a means of obtaining not only the cis and trans alkenyl 
esters (X I and XII, respectively) but also the alkynyl 
esters X which are structurally locked into linearity in 
the region of interest. The key intermediate in this 
proposed synthetic sequence is the alkynyl alcohol XXIX, 
and several methods were examined in the attempted synthesis 
of this compound. 
The first attempt to prepare alkynyl alcohol XXIX was 
by the Grignard reaction (equation 8), Using the method 
of Sharifkanov and Skhmedova (177), 1-bromo-2-butyne (XXVIII) 
was prepared (equation 7) , The presence of this compound 
-1 was readily demonstrated by infrared absorption at 2235 cm 
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( eq . 7 )  
XXVIII 
XXVIII  
XLIV XXIX ( eq . 8 )  
caused by alkyne stretching vibrations. The nmr spectrum 
exhibited the expected quartet and triplet (methylene and 
methyl protons, respectively) due to coupling across the 
triple bond. 
The reaction of 1-bromo-2-butyne (XXVI I I) with 4-
biphenylcarboxaldehyde (XLIV) in the normal Grignard manner 
afforded in every case unchanged starting aldehyde. The 
double addition technique of Tschesche and Machleidt (165) 
for highly reactive Grignard reagents and the use of con­
centrated solutions did not provide any improvement. 
Failure of the reaction to take place was demonstrated by 
the identical infrared spectra of the recovered material 
and authentic 4-biphenylcarboxaldehyde. 
An alternate route to alcohol XXIX was via a zinc 
complex as described i_11._, the work of Henbest et al. (178). 
These workers were able to carry out Reformatsky-type 
reactions with propargyl bromides ; however, it was not 
1 99 
Ph@i-H + CH3-csc -ctt2Br 
zn @CH2-C=C-CHJ 
II O I iJ > Ph y -H 
XLIV XXVIII 
OH 
XXIX (eq. 9) 
possible to successfully apply their techniques to the 
present work (equation 9), Several variations of the 
reaction conditions were made and in each case an allene 
was obtained rather than the desired alkynyl alcohol. 
tion 
The allene was detected by absence of alkyne absorp­
at 21 00-2300 cm-1 and the presence of a sharp peak at 
-1 . cm in the infrared spectrum. The nmr spectrum of 
the material obtained from the initial attempt to prepare 
the alkynyl alcohol by this method was inconclusive. On 
subsequent attempts if the infrared spectrum indicated 
the presence of an undesired allene the nmr spectrum was 
not recorded. 
Modifications made in the above procedure may be 
briefly described as follows: the crude ether extract of 
the ice-1 0% acetic acid slurry (see experimental section) 
was washed with copious quantities of water rather than 
with mild base. This was an attempt to avoid base catalyzed 
formation of the allene in the work-up procedure. The 
activity of the zinc surface was varied by altering the 
etching time up to 40 minutes. To guard against thermal 
rearrangement, the reaction was conducted at room temperature 
with the addition of reactants being carried out at ice 
2 0 0  
bath temperature, This experiment and one performed 
entirely at -78° were fruitless. In addition, discon­
tinuation of the use of mercuric chloride as an initiator 
and conducting the reaction in dilute solution afforded 
products which were not well defined. Each of these modi­
fications of the reaction conditions gave a clear, yellow 
liquid, the infrared spectrum of which consistently exhibited 
a sharp, medium band at 1962-1965 cm
-1, indicating the 
presence of an allene, and a complete lack of absorption 
in th� region 2100-2300 cm-1, indicating the absence of 
an alkyne. 
Several of the reactions attempted in the present 
investigation were initially tested on a model system in 
order to establish and refine the reaction conditions prior 
to experiments with 4-biphenylcarboxaldehyde (XLIV) , The 
model chosen was benzaldehyde and all structure determina­
tions were made on the basis of infrared and nmr data. In 
general, elemental analyses were not determined for model 
systems. 
An attractive alternative to the Reformatsky-type 
reaction was the work of Lauger et al. (181) who prepared 
propynyl esters. These workers recognized the problem of 
allene formation and claimed that by employing an aluminum 
complex rather than magnesium or zinc the alkyne could be 
formed in high yields while formation of the allene was 
essentially negligible. Using benzaldehyde and 1-bromo-
2-propyne as a model system provided encouraging results; 
Al 
> 
XXVII I , R = CH3 
XLIV , R = Ph 
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-© CH -C=C-R 
I 2 
R c,-H 
OH 
( eq. 10) 
XXIX, R = Ph, R ' = CH3 XXX, R = H, R •  = H 
the infrared spectrum of the product exhibited both alkyne 
and alcohol bands and the nmr spectrum provided structural 
proof of the model alkynyl alcohol (equation 10, R = H, 
' 
R = H). Unfortunately, when the same reaction was attempt-
ed using the biphenyl and the 2-butynyl system (equation 10, 
' 
R = Ph, R = CH3) only the starting aldehyde was recovered. 
Failure of the aluminum method to provide the desired 
alkynyl alcohol led to attempts to open an aryl substituted 
epoxide as a means of synthesizing alcohol XXIX. Extensive 
use of the benzaldehyde model system was employed in this 
series of reactions. The model epoxide XXXII was prepared 
ny the m��hod of Corey and Chaykovsky (183) via the ylide 
derived from trimethylsulfoxonium iodide (XXXI) (182), 
as shown in equations 11-13, This elegant conversion of 
an aldehyde to an epoxide had a single drawback: the yield 
of epoxide obtained in this investigation was very low. 
The infrared spectrum of the epoxide showed the 
expected characteristic peaks due to epoxide C-0 vibrations. 
It is interesting to note that in the nmr spectrum of both 
the phenyl and the biphenylyl epoxides each of the three 
aliphatic protons is observed as a pair of doublets. In 
0 
1 1 $ 
CH -S-CH J I 3 
CHJ 
XXXI 
> 
-f?J + NaH > 
XLIV 
0 
1 1(f) 
CH3-y-CHJ 
CHJ 
XXXI 
0 
II (f) 8 
CH -S-CH 3 1 2 
CHJ 
2 02 
f2> (eq. 11) 
(eq, 12) 
� l, > CH-CH2 (eq, 13) 
XXXII  
the case of the proton o<. to the aroma tic rings the 
multiplicity arises from spin-spin splitting by both � 
protons. The (9 protons are split into doublets by the � 
proton, and the doublets from each � proton are further 
split into a pair of doublets by the other (3 proton, a 
case of geminal spin-spin interactions. 
It was initially thought that the epoxide could be 
opened in the desired direction by means of diethylpropynyl 
aluminum (XLV) prepared (equation 1 4 )  by the method of 
Nagata and Yoshioka ( 185 ) , This reagent wa� used in an 
XXXIV XLV 
(eq. 14 ) 
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attempt to open the model epoxide (equation 15) by the 
method of Fried et al. (186), Surprisingly, the desired 
1-phenyl-J-pentyn-1-ol (XXXV) was not obtained; the nmr 
spectrum indicated that the epoxide may have opened in 
the unanticipated direction to give the primary alcohol 
XXXVI. If XXXV had been obtained, the nmr spectrum would 
be expected to show the methyl group as a triplet, the 
methylene protons as a complex multiplet, and the methine 
proton as the usual triplet. The spectrum of the material 
obtained was clearly not that of the desired alcohol XXXV 
since it exhibited a doublet integrating for the same 
number of protons as a sharp signal superimposed upon a 
complex band. These spectral features can be accounted for 
by the primary alcohol XXXVI, 
+ 
(eq. 15) 
XXXV XXXVI 
Catalytic reduction (equation 16) of the suspected 
2-phenyl-J-pentyn-1-ol (XXXVI) was shown by nmr data to 
2 04 
> ( eq . 1 6 )  
XXXV I XXXV I I  
have produc ed the c orre spond ing alkane 2 -phenyl-1 -pentano l 
( XXXV I I ) . Th i s  c onve rs i on was followed by the appearanc e 
of  broad c omplex mul ti p l e ts at 0 . 6 -1 . 8  ppm ( -CH2 -cH2
-cH
3 ) ,  
a sharp d oubl e t  at J . 68 ppm ( -CH2 - o- ) , and the s ingle 
me th ine pro ton as a mul tiple t c entered on 2 . 74 ppm . The 
nmr spec trum was proof that saturated alc ohol XXXV I I  was 
obtained from reduc t i on of XXXV I and therefore , XXXV I mus t  
have been 2 -phenyl- rathe r than the expec ted 1 -phenyl-J­
pentyn-1 - ol  ( XXXV ) .  The s e  results are s imi lar to tho se  of 
Boireau et al . ( 1 98 )  who s tudied the reac t i on of trime thyl­
aluminum w i th J -phenyl-1 , 2 -e poxypropane . 
Primary alcohol  XXXV I I  i s  the s ingle case of a mod e l  
sys tem where e lemental analys i s  data were de termined 
and the s e  data show that the produc t from the catalytic  
reduc t i on of  alcohol  XXXVI fit  the  theore tical e lemental 
c ompo s i t i on of 2-phenyl-1 -pentanol .  The nmr data f or 
alcohol  XXXVI, the spectral struc ture proof of alcohol 
XXXVII and the analytical data for th is  c ompound c onc lu­
s ive ly show that the propynyl alane reagent caused the 
e poxide  to open in the SN1 d i re c t i on rather than in the 
anti c ipated SN2 d irec ti on .  
205  
It is tempting to speculate on the mechanistic 
implications of these results. Apparently, the aluminum 
atom of the alane reagent is a strong enough Lewis acid to 
preferentially associate with the oxygen atom _ of the 
epoxide. This would weaken the two carbon-oxygen bonds 
and cause some electron deficiency in the epoxide ring (XLVI ) .  Since the o< carbon atom is capable of forming 
a relatively stable carbonium ion by virtue of resonance 
delocalization of the charge into the benzene ring it is 
reasonable to suggest that structure XLVIa provides a 
great contribution to the true electronic structure of the 
suggested alane-epoxide complex. If this is indeed the 
case, then it is plausible that the alane reagent, by 
virtue of its association with the oxygen atom of the 
epoxide, delivers the propynyl group exclusively to the � 
rather than to the � carbon atom of the epoxide (equation 
17), This agrees with the mechanistic proposal of Lundeen 
and Oehlschlager (199) who have studied the reaction of 
triethylaluminum with 1, 2-epoxypropane. These investigators 
have observed evidence that a second alane molecule par­
ticipates in opening the epoxide. 
CHJ-C=C-�l- (C2H5 )2 
I 
I 
I 
@c�t2 
XLVI 
r 
CH
3
-c�c-11- (C2H5) 2 
I 
I 
I 
I 
XLVIa 
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�rolysis 
(eq. 17) 
@t:��:�� 
XXXVI 
In light of these interesting but unproductive results 
with the alane reagent, attempts were made to open the 
model system (equation 1 8, R = H) with propynyllithium. 
For the model epoxide this reaction gave moderately low 
yields (40-50%) of the desired alkynyl alcohol XXXV and 
exhibited a poor material balance. Infrared and nmr 
spectra of XXXV provided clear proof that the anticipated 
product had been obtained , When the same reaction was 
attempted with the biphenylyl epoxide XXX I I I  (equation 18, 
R = Ph) yields and material balance became even worse than 
for the model system. 
XXX I I, R = H 
XXXI II, R = Ph 
XXXV , R = H 
XXIX, R = Ph 
( eq. 18) 
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Since the solvent used for this reaction was dimethyl­
sulfoxide it was considered possible that the desired 
product was not sufficiently soluble in the extraction 
solvent (ether) to be efficiently removed from the reaction 
mixture during the work-up procedure . Testing this pos­
sibility, it was found that the desired alkynyl alcohol 
was indeed sufficiently soluble in ether to have been re­
moved from the reaction mixture . In addition, using known 
alkynyl alcohol, the work-up procedure was scaled down by 
a factor of fifty and the entire work-up was carried out. 
In this experiment 8. 0 mg of a 9,4 mg sample of alkynyl 
alcohol XXIX survived the procedure . This indicated that 
the low yeild and material balance of this reaction was 
not caused by a preferential solubility of the product in 
the dimethylsulfoxide-water phase. 
A possible but untested explanation for the low yields 
and poor material balance of alcohols XXXV and XXIX is 
that propynyllithium may have participated in an exchange 
reaction with the solvent, generating the dimsyl carbanion 
(XLVII, equation 19), The presence of this carbanion in 
XLVII 
Li 9 + HC=C-CHJ 
(eq. 19) 
the reaction mixture would provide a nucleophile capable of 
opening the epoxide (equation 20) to give a polar product 
> 
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@ CH -CH -S-CH 1 2 2 II J 
C-H 0 
OH 
(eq, 2 0 ) 
which could have been trapped in the dimethylsulfoxide­
water phase. However, as noted above, this possibility is 
entirely speculative and untested, 
Because preparation of biphenylyl epoxide XXX I I I  was 
a very low yield reaction, it was decided to employ an 
alternate route to epoxide preparation . .  The route chosen 
is shown in equations 21-24 and utilized the Wittig reaction 
( 1 89 , 1 90 ) , 
(t) 
(Ph) -P-CH J J 
XXXV I I I  
e e 
(Ph) -P-CH 
J 2 
e 
Br 
+ 
Ph--@-CH=CH2 
XXX IX 
@ e 
��-:>;;:i,,. (Ph)3-P-CHJ 
Br 
XXXV I I I  
NaH 
(eq. 21) 
@ 
(Ph)3-P-CH2 
(eq. 22) 
DMSO 
pir@-g
-H > Ph--@-CH=CH2 
( eq, 2J) 
XXXIX 
+ 
� C l  
> Ph---@-c&�btt2 
( eq. 24) 
XXX I I I  
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Both formation of (4-biphenylyl)ethene (XXXIX), 
(equation 23) and its subsequent epoxidation product XXXIII 
(equation 24) took place smoothly and provided the desired 
products in acceptable yields (45 and 50%, respectively) . 
Alkene XXXIX exhibits an nmr spectrum which is similar to 
and lends itself to the same analysis as the spectrum of 
epoxides XXXII and XXXI I I  discussed above. Unfortunately, 
opening of this epoxide by the method of Fries (188) as 
illustrated in equation 1 8  failed to provide the necessary 
key intermediate alkynyl alcohol XXIX in sufficient 
quantities to continue the study of geometrical isomers 
derived from this compound. Therefore, attempts to com­
plete this study were postponed. 
The homologous butynyl system XL also lends itself 
to study of geometrical isomers derived from it. Using 
a slight modification of the work of Smith and Kuehn (192) 
1-(4-biphenylyl)-2-butyn-1-ol (XL) was prepared (equation 
25) by addition of propynyllithium to the carbonyl group 
of 4-biphenylcarboxaldehyde. The conditions of this 
reaction are very delicate and time is a critical factor . 
The expected doublet and quartet of the methyl and methine 
protons respectively were clearly observed in the nmr 
spectrum of XL . It is important to note that since 
propynyllithium will add to the carbonyl group of 4-bi­
phenylcarboxaldehyde, perhaps minor modifications of the 
reaction conditions will provide a means of opening the 
previously discussed epoxides in the desired manner. 
THF 
210 
-@ C=C-CH 
/ 3 
Th �H 
OH 
( eq . 25) 
XL 
Finally, esterification of alkynol XL with succinic 
anhydride has been accomplished by the method of Steglich 
and Hoffle (175) to give the corresponding monoester XLI 
in 31% yield. This ester shows the expected spectral 
characteristics similar to the previously described esters 
and to the parent alcohol XL. This compound provides the 
entrance to a geometrical isomer study similar to that 
depicted in Scheme IV. 
BIOLOGICAL RESULTS 
Hepatic microsomes were obtained from male Sprague­
Dawley rats by the method described in the experimental 
section. In order to maximize HMG CoA reductase content 
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in these preparations, the livers were harvested between 
12: 05 and 12: 25 AM during the peak of the diurnal rhythm. 
In spite of this precaution, the enzyme activity of dif­
ferent preparations was found to vary. Shefer et al. 
(197) have observed that the specific activity of HMG CoA 
reductase is highest in young animals and decreases with 
increasing age; this decrease is more pronounced in females 
than in males. The use of young male rats with a mass 
of approximately 100 g as the source of microsomes pro­
vided preparations with fairly consistent activity of the 
enzyme among different preparations. 
An additional method was employed to ensure that the 
inhibitory activity of all compounds could be compared even 
though they were tested with several different microsomal 
preparations . A previously prepared compound with known 
inhibitory properties, 1-(4-biphenylyl)-rr-pentyl hydrogen 
succinate, (III, m = 2) was tested concurrently with all 
other inhibitors. This allowed comparison of all inhibitors 
to the standard III (m = 2) and therefore also allowed 
valid comparisons to be made among all the inhibitors. 
The unit used to express inhibitory activity is the 
ratio of inhibitor concentration to substrate concentration 
21 2 
which results in 50% inhibition of the conversion of HMG C oA 
to mevalonic ac id . This  uni t is expres sed as ( I/S ) 0 . 5 
and is  de termined by varying the inhibitor c onc entration in 
the test  sys tem . In some cases the solubility of the in­
hibitor limits the degree of inhibition and a reduc tion of 
50% c annot  be obtained . When this 0ccurs , the degree of 
inhibition at the s tated inhibitor c onc entration is spe c if ied . 
Table I lists the inhibitory ac tivity of the J-me thyl­
J-me thoxy substrate analog V as well as the J -me thyl-3 -
hydroxy derivative IV for c omparison .  The fac t that the 
J-me thoxy c ompound V is elevenfold le ss  ac tive than the 
c orre sponding ) -hydroxy analog IV may be interpre ted in two 
ways . The J-me thyl-J -hydroxy analog IV may bind to the 
enzyme in such a manner that the )-hydroxy group is located 
in a pocket or other c onf ining struc ture formed by the 
enzyme surfac e . If  this  area is small enough to acc omodate 
only the hydroxyl group then e ther V may be too large to 
bind in a manner analogous to the normal binding of the 
) -hydroxy l group . If true , this  c ould slightly alter the 
binding p o s ition of other parts of the inhibitor and the 
observed loss  of activity for V would be caused by the 
0-me thyl group blocking the proper approach of the inhibitor 
to the binding subsites . 
A more reas onable explanation of the loss  of ac tivity 
s een with v is based on a d irect binding func tion of the 
)�hydroxy group . As previ ously discussed , this  group could 
partic ipate in bind ing by acting as a hydrogen donor 
Table I: Inhibition of Rat Liver Microsomal HMG CoA 
Reductase by 
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Compound 
(I/S)0. 5 Number R 
IV 
V 
VI 
VII 
I I I  
(m = 2) 
(Reference 
Standard) 
1
H3 
-0-C-CH -C-CH2-c o2H II 2 I 
0 OH 
�HJ 
-O-?i-CH2
-1-cH2-c o2H 
0 0-CHJ 
-�
-�
-CH2-CH2
-c o2H 
H 0 
-N-C-CH2-CH2-CH2-CO?
H 
I II -
H 0 
1 
1 1  
30 
(18% inhibition) 
2 0 
1 1  
1 1  
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(through the hydroxyl hydrogen) or as a hydrogen acceptor 
(through the hydroxyl oxygen) in hydrogen bonding with the 
enzyme. Replacement of the hydroxyl hydrogen of IV with 
the methyl group of V destroys only the ability of the in­
hibitor to act as hydrogen donor, not i·ts ability to act 
as acceptor. Therefore, it can be concluded that the loss 
of activity exhibited by V with respect to IV is caused by 
its inability to participate in hydrogen bonding with the 
enzyme. The demonstration of hydrogen bonding in these 
compounds also clearly shows that a hydrogen bond acceptor 
is located on the enzyme surface at the binding site. This 
is a valuable binding aid and its presence may be exploited 
by future inhibitors to enhance reversible binding. 
The inhibition of HMG CoA reductase caused by the 
amides VI  and VII  is shown in Table i .  As can be seen, the 
succinamide exhibited poor activity while the correspond­
ing glutaramide was approximately one-half as active as 
the reference ester III (m = 2). Previous discussion 
showed that the ester functional group is not necessary 
for binding. However, it should be noted that the com­
pounds examined to prove this contained either no sub­
stituent capable of hydrogen bonding in the ester region 
(carbon analog) or groups capable only of acting as 
hydrogen acceptor (ether and ester analogs). Therefore, 
these experiments not only showed that the ester group is 
not required for binding, but also that the surface of the 
enzyme probably does not contain a hydrogen donor for 
21 5 
hydrogen bonding in proximity to the ester function when it 
is bound. It is possible that a hydrogen acceptor for 
hydrogen bonding is located on the enzyme close to the ester 
group of the inhibitors. If this were true, it would not 
participate in the binding of inhibitors which contained 
no hydrogen donor, such as the esters, ether and carbon 
analogs. Amides VI and VII represent replacement of the 
ester function with a group which is similar to the ester 
group in steric and electronic properties and which also 
has the ability to act as a hydrogen donor for hydrogen 
bonding . If an acceptor is located on the enzyme in this 
region it would be expected that these amides would be 
bound more firmly than the corresponding esters. As Table 
I shows, this is not the case. Glutaramide VII exhibited 
loss of activity and succinamide VI was almost completely 
inactive. It is clear that no hydrogen acceptor for 
hydrogen bonding exists in this region of the enzyme and 
that, in the case of the succinamide, binding of the in­
hibitor actually appears to be blocked rather than un­
changed or favored. 
The total absence of enhanced binding by the carbon, 
ether, or amide analogs with respect to the ester III 
(m = 2) provides information about the enzyme surface in 
this area. Because of the lack of effect from these 
functional groups it is tempting to suggest that the enzyme 
surface contains no functional groups which aid in binding 
in this region. 
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Table II shows the (I/s)0. 5 values for alkenyl esters 
VIIIa-f and epoxyalkyl esters IXa-f, For comparison 
purposes the reference standard compound III (m = 2) is 
also included in the table. These data provide valuable 
information concerning the nature of inhibitor binding as 
well as considerations for future inhibitors. As a group, 
alkenyl esters VIIIa-f exhibited inhibition equal to 
reference standard III (m = 2). This could be an indication 
that the hydrophobic area in which the rr-butyl group of 
III (m = 2) binds (158) is capable of accomodating the 
flat alkene moiety as effectively as the methylene units 
of the reference compound. Binding was not enhanced by 
the alkene function as shown by the essentially unchanged 
activity. Since the �lkene group of esters VIIIa-f is 
terminal, it might 9e _ postulated that the unchanged 
activity could be caused by the unsaturation not partici­
pating in binding in any way. This could take place if 
the alkene moiety pro jects away from the enzyme surface 
when the inhibitor is bound. If this were true, it would 
be anticipated that the inhibition would decrease because 
of loss of hydrophobic binding units as compared to the 
rr-butyl group of III (m = 2). Therefore, it is more 
reasonable to suggest that unsaturation in this region 
contributes to binding as effectively as a fully saturated 
alkyl group. Proposed compounds X-XII would have aided the 
stereochemical examination of this portion of the enzyme; 
however, satisfactory methods of synthesis for these 
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Table II: Inhibition of Rat Live� HMG CoA Reductase by 
@@- R 
1-H 
0-C-(CH )-CO H 
11 2 m 2 
R 
-CH2-CH=CH2 
-CH2-CH2-CH2
-CH=CH2 
lo
\ 
-CH2-CH2-
CH2-CH-C
H2 
-CH2-CH2-CH2-CH3 
Compound 
Number 
VIIIa 
IXa 
VIIIc 
IXc 
VIIIe 
IXe 
III 
(I/S)0, 5 
m = 2 
1 0  
20  
11  
1 3  
1 1  
13 
11 
Compound 
Number 
VIIIb 
(I/S)0,5 
m = 3 
9 
IXb 13 
(26% in­
hibition) 
VIIId 1 1  
IXd 13 
VIIIf 8 
IXf 10 
III 1 1  
2 1 8  
co�pounds could not be developed during this invest igation. 
The inhibition of rat liver HMG CoA reductase by 
epoxyalkyl esters IXa-f is also shown in Table II. As 
with the corresponding alkenyl esters VIIIa-f, these com­
pounds exhibited no general trend of either enhancing or 
decreasing reversible binding to the enzyme. Only in the 
case of the epoxybutyl system IXa and b was inhibition 
lowered with respect to alkenes VIIIa-f and reference 
inhibitor I I I  (m = 2). This slight loss of activity 
appears to be unexplainable since examination of molecular 
models shows that the epoxide group of IX a is able to 
adopt conformations similar to those of the remaining 
epoxyalkyl esters. However, a possible explanation for 
the low activity of epoxy esters IXa and IXb is available. 
These esters are the only members of the entire epoxy ester 
series which are capable of forming a fairly stable ring 
conformation (Figure 15), In this instance the dipole 
interaction between the oxygen electron pair of the epoxide 
and the electron deficient carbonyl carbon atom of the ester 
provide a stabilizing influence for this conformation. It 
is possible that this ring stability retards esters IXa and 
IXb from forming the enzyme-binding open chain conformation� 
It should be noted that ester IXb showed 26% inhibition at 
its maximum solubility in the test system and therefore 
an ( I/S)O,S value could not be obtained. 
The most important aspect of these results is that the 
incorporation of the epoxide functional group into the side 
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Figure 15: A possible stable conformation of esters IXa 
and IXb contributing to the loss of inhibitory 
activity. 
chain definitely did not destabilize reversible binding. 
This is clearly demonstrated by the fact that these com­
pounds are as active as the reference standard III (m = 2). 
It must be emphasized that the epoxide group is more polar 
than the n-butyl chain of I I I  (m = 2) and the alkenyl 
chain of VIIIa-f. In addition, Boots et al. (158) have 
clearly demonstrated that the region in which these groups 
bind to the enzyme is a nonpolar area and that this binding 
is probably hydrophobic in nature. This strongly suggests 
that the epoxide oxygen of IXa-f is oriented away from the 
enzyme surface during binding. This conformation allows 
the most polar portion of the epoxide ring, the oxygen 
atom, to be pro jecting into the polar aqueous medium sur­
rounding the enzyme while the least polar portion of the 
ring is free to contribute to binding on the nonpolar 
enzyme surface. 
The present work includes only the study of the 
reversible binding characteristics of these compounds and 
provides the preliminary evidence required before irrever­
sible binding studies may be initiated. The next phase 
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of this investigation will consist of prolonged preincu-
bation of the enzyme and inhibitor followed by the ad-
dition of substrate. These experiments will provide a 
means of evaluating the possible irreversible inhibition 
of HMG CoA reductase by potential alkylators IXa-f. 
1 .  
2 .  
3 .  
4 .  
5 , 
6. 
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ABSTRACT OF 
SYNTHESIS AND EVALUATION OF SOME ARYLALKENYL AND ARYLEPOXY­
ALKYL HYDROGEN SUCCINATES AND HYDROGEN GLUTARATES AS INHIBI­
TORS OF RAT LIVER (3 -HYDROXY- � -METHYLGLUTARYL COENZYME A 
REDUCTASE 
BY 
Paul Emil Marecki, Department of Pharmaceutical Chemistry, 
Medical College of Virginia, Health Sciences Division, 
Virginia Commonwealth University, May 1974, 
Atherosclerotic disease is an almost universal 
phenomenon and increases in severity and frequency with 
increasing age. Atherosclerosis may contribute to several 
disorders including bursting of an artery, blockage of an 
artery, or induction of arterial clotting. The culmination 
of these diseases is usually premature since at the time of 
death the unaffected organs are in reasonably satisfactory 
condition and could have operated for several more years. 
Among the many factors which act in concert to produce the 
disease, serum cholesterol levels play a central role. It 
has been suggested that the lowering of cholesterol levels 
will provide an effective means of treatment and pro­
phylaxis of atherosclerosis. 
The purpose of this investigation was to rationally 
design, synthesize, and evaluate agents to lower serum 
2 
cholesterol levels by the inhibition of cholesterol bio-
synthesii at the site of the reduction of � -hydroxy-p -
methylglutaryl coenzyme A (HMG CoA) to mevalonic acid. 
This reaction, mediated by HMG CoA reductase, was chosen 
as the inhibition target because it is the first irrever­
sible reaction, the rate limiting step for the pathway, 
and the site of physiological regulation of cholesterol 
biosynthesis. Rat liver HMG CoA reductase provided a con­
venient test system for these agents. 
Using the previously reported compound, 1-(4-biphenylyl)­
n-pentyl hydrogen succinate as parent inhibitor, the present 
study accomplished two goals : first, a contribution toward 
elucidation of reversible binding sites for these inhibi-
tors and second, probing of the suggested nonpolar n-pentyl 
binding area of the enzyme by introduction of a functional 
group capable of alkylating the enzyme and providing ir­
reversible inhibition. The first objective was approached 
by replacing the ester of the parent inhibitor with an 
amide functional group. The resulting glutaramide exhibited 
inhibition comparable to that of the parent inhibitor. This 
may be taken as evidence that isosteric replacement of the 
parent ester group with the amide N-H did not seriously 
alter the ability of the inhibitor to bind to the enzyme 
and that an additional binding site in this region is not 
available. The data also support the suggestion that the 
ester group of the parent agent is not necessary for bind-
ing. 
3 
A similar i�hibition study was made possible by syn­
thesis of 1-(4-biphenylyl)-rr-pentyl hydrogen 3-methyl-3-
methoxyglutarate. With respect to the corresponding 3-
methyl-3-hydroxyglutarate this compound showed an eleven­
fold decrease of activity. This considerable activity 
loss indicates that the 3-methoxy group interferes with 
reversi ble binding of inhibitor to the enzyme. The 
inhibition data indicate that the 3-hydroxy group of the 
3-methyl-3-hydroxy compound contributes to reversible bind­
ing by participating as a hydrogen donor in hydrogen bond­
ing with the enzyme. 
The major portion of this investigation was designed 
to probe a region of the enzyme which is nonpolar and binds 
the rr-alkyl moiety of the parent inhibitor. The purpose 
was to determine the feasibility of incorporating a 
functional group into this region of the inhibitor which 
could act as an acceptor for an enzymic nucleophile located 
in proximity to the reversible binding area. If successful, 
this could provide irreversible inhibition of the enzyme. 
A series of compounds was synthesized which bore a terminal 
alkenyl group two to four carbon atoms removed from the 
ester moiety. Testing showed that, with respect to the 
parent inhibitor, no appreciable loss of binding took place. 
Similarly, a series of epoxyalkyl esters was prepared, the 
epoxide group being the portion of the inhibitor susceptible 
to nucleophilic attack, Reversible binding of these com­
pounds was found to be equal to that of the parent inhibitor 
4 
and it was therefore concluded that the enzyme does 
accomodate this alkylating group with no loss of reversible 
binding. This provided the necessary preliminary work 
upon which subsequent irreversible binding studies will be 
based. 
